{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 529410, "items": [{"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T18:44:35Z", "timestamp": 1576781075075}, "reference-count": 182, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 3, 1]], "date-time": "2003-03-01T00:00:00Z", "timestamp": 1046476800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nat Rev Cancer"], "published-print": {"date-parts": [[2003, 3]]}, "DOI": "10.1038/nrc1014", "type": "journal-article", "created": {"date-parts": [[2003, 2, 28]], "date-time": "2003-02-28T19:53:56Z", "timestamp": 1046462036000}, "page": "203-216", "source": "Crossref", "is-referenced-by-count": 1139, "title": ["Neuroblastoma: biological insights into a clinical enigma"], "prefix": "10.1038", "volume": "3", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "BFnrc1014_CR1", "first-page": "514", "volume": "24", "author": "AGJ Knudson", "year": "1972", "unstructured": "Knudson, A. G. J. & Strong, L. C. Mutation and cancer: neuroblastoma and pheochromocytoma. Am. J. Hum. Genet. 24, 514\u2013522 (1972).", "journal-title": "Am. J. Hum. Genet."}, {"key": "BFnrc1014_CR2", "doi-asserted-by": "publisher", "first-page": "1887", "DOI": "10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7", "volume": "57", "author": "BH Kushner", "year": "1986", "unstructured": "Kushner, B. H., Gilbert, F. & Helson, L. Familial neuroblastoma: case reports, literature review, and etiologic considerations. Cancer 57, 1887\u20131893 (1986).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR3", "doi-asserted-by": "publisher", "first-page": "2264", "DOI": "10.1200/JCO.1999.17.7.2264", "volume": "17", "author": "JM Maris", "year": "1999", "unstructured": "Maris, J. M. & Matthay, K. K. Molecular biology of neuroblastoma. J. Clin. Oncol. 17, 2264\u20132279 (1999).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR4", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1016/S0022-3476(85)80515-1", "volume": "107", "author": "BH Kushner", "year": "1985", "unstructured": "Kushner, B. H. & Helson, L. Monozygotic siblings discordant for neuroblastoma: etiologic implications. J. Pediatr. 107, 405\u2013409 (1985).", "journal-title": "J. Pediatr."}, {"key": "BFnrc1014_CR5", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1200/JCO.1985.3.1.117", "volume": "3", "author": "BH Kushner", "year": "1985", "unstructured": "Kushner, B. H., Hajdu, S. I. & Helson, L. Synchronous neuroblastoma and von Recklinghausen's disease: a review of the literature. J. Clin. Oncol. 3, 117\u2013120 (1985).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR6", "first-page": "3421", "volume": "56", "author": "JM Maris", "year": "1996", "unstructured": "Maris, J. M. et al. Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res. 56, 3421\u20133425 (1996).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR7", "doi-asserted-by": "publisher", "first-page": "526", "DOI": "10.1002/1096-911X(20001201)35:6<526::AID-MPO5>3.0.CO;2-S", "volume": "35", "author": "MJ Weiss", "year": "2000", "unstructured": "Weiss, M. J. et al. Localization of a hereditary neuroblastoma predisposition gene to 16p12-p13. Med. Pediatr. Oncol. 35, 526\u2013530 (2000).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR8", "doi-asserted-by": "publisher", "first-page": "166", "DOI": "10.1016/0165-4608(93)90100-Z", "volume": "69", "author": "NP Bown", "year": "1993", "unstructured": "Bown, N. P., Pearson, A. D. J. & Reid, M. M. High incidence of constitutional balanced translocations in neuroblastoma. Cancer Genet. Cytogenet. 69, 166\u2013167 (1993).", "journal-title": "Cancer Genet. Cytogenet."}, {"key": "BFnrc1014_CR9", "first-page": "176", "volume": "52", "author": "JA Biegel", "year": "1993", "unstructured": "Biegel, J. A. et al. Constitutional 1p36 deletion in a child with neuroblastoma. Am. J. Hum. Genet. 52, 176\u2013182 (1993).", "journal-title": "Am. J. Hum. Genet."}, {"key": "BFnrc1014_CR10", "first-page": "1087", "volume": "10", "author": "G Laureys", "year": "1995", "unstructured": "Laureys, G. et al. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers. Oncogene 10, 1087\u20131093 (1995).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR11", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L", "volume": "36", "author": "PS White", "year": "2001", "unstructured": "White, P. S. et al. Detailed molecular analysis of 1p36 in neuroblastoma. Med. Pediatr. Oncol. 36, 37\u201341 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR12", "first-page": "6651", "volume": "62", "author": "JM Maris", "year": "2002", "unstructured": "Maris, J. M. et al. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. Cancer Res. 62, 6651\u20136658 (2002). The first report of linkage analysis, identifying a candidate locus on 16p12-13.", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR13", "first-page": "311", "volume": "47", "author": "Y Kaneko", "year": "1987", "unstructured": "Kaneko, Y. et al. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res. 47, 311\u2013318 (1987). The first report to associate karyotypic pattern with stage and prognosis, and the first to show the association of near-triploid tumours in infants with whole chromosome gains.", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR14", "doi-asserted-by": "publisher", "first-page": "2005", "DOI": "10.1200/JCO.1990.8.12.2005", "volume": "8", "author": "Y Kaneko", "year": "1990", "unstructured": "Kaneko, Y. et al. Current urinary mass screening or catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J. Clin. Oncol. 8, 2005\u20132013 (1990).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR15", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.1056/NEJM198407263110405", "volume": "311", "author": "AT Look", "year": "1984", "unstructured": "Look, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B. & Green, A. A. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N. Engl. J. Med. 311, 231\u2013235 (1984). The first report to show the prognostic significance of tumour-cell DNA content in infants with neuroblastoma.", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR16", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1200/JCO.1991.9.4.581", "volume": "9", "author": "AT Look", "year": "1991", "unstructured": "Look, A. T. et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma. A Pediatric Oncology Group Study. J. Clin. Oncol. 9, 581\u2013591 (1991).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR17", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1002/1098-2264(2000)9999:9999<::AID-GCC1021>3.0.CO;2-Y", "volume": "29", "author": "Y Kaneko", "year": "2000", "unstructured": "Kaneko, Y. & Knudson, A. G. Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosom. Cancer 29, 89\u201395 (2000).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR18", "doi-asserted-by": "publisher", "first-page": "245", "DOI": "10.1038/305245a0", "volume": "305", "author": "M Schwab", "year": "1983", "unstructured": "Schwab, M. et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305, 245\u2013248 (1983). Reports the cloning of the  MYCN  proto-oncogene as the gene amplified in neuroblastoma cell lines and a primary tumour.", "journal-title": "Nature"}, {"key": "BFnrc1014_CR19", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1038/308288a0", "volume": "308", "author": "M Schwab", "year": "1984", "unstructured": "Schwab, M. et al. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 308, 288\u2013291 (1984).", "journal-title": "Nature"}, {"key": "BFnrc1014_CR20", "doi-asserted-by": "publisher", "first-page": "5523", "DOI": "10.1073/pnas.91.12.5523", "volume": "91", "author": "R Corvi", "year": "1994", "unstructured": "Corvi, R., Amler, L. C., Savelyeva, L., Gehring, M. & Schwab, M. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc. Natl Acad. Sci. USA 91, 5523\u20135527 (1994).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrc1014_CR21", "doi-asserted-by": "publisher", "first-page": "5563", "DOI": "10.1128/MCB.12.12.5563", "volume": "12", "author": "SS Schneider", "year": "1992", "unstructured": "Schneider, S. S. et al. Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma. Mol. Cell. Biol. 12, 5563\u20135570 (1992).", "journal-title": "Mol. Cell. Biol."}, {"key": "BFnrc1014_CR22", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1016/0165-4608(89)90243-4", "volume": "41", "author": "GM Brodeur", "year": "1989", "unstructured": "Brodeur, G. M. & Fong, C. T. Molecular biology and genetics of human neuroblastoma. Cancer Genet. Cytogenet. 41, 153\u2013174 (1989).", "journal-title": "Cancer Genet. Cytogenet."}, {"key": "BFnrc1014_CR23", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1006/geno.1996.0081", "volume": "32", "author": "JL Reiter", "year": "1996", "unstructured": "Reiter, J. L. & Brodeur, G. M. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Genomics 32, 97\u2013103 (1996).", "journal-title": "Genomics"}, {"key": "BFnrc1014_CR24", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1002/(SICI)1098-2264(199810)23:2<134::AID-GCC6>3.0.CO;2-3", "volume": "23", "author": "JL Reiter", "year": "1998", "unstructured": "Reiter, J. L. & Brodeur, G. M. MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas. Genes Chromosom. Cancer 23, 134\u2013140 (1998).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR25", "doi-asserted-by": "publisher", "first-page": "1121", "DOI": "10.1126/science.6719137", "volume": "224", "author": "GM Brodeur", "year": "1984", "unstructured": "Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. & Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121\u20131124 (1984). Amplification of the  MYCN  oncogene is strongly associated with advanced stages of disease in neuroblastoma.", "journal-title": "Science"}, {"key": "BFnrc1014_CR26", "doi-asserted-by": "publisher", "first-page": "1111", "DOI": "10.1056/NEJM198510313131802", "volume": "313", "author": "RC Seeger", "year": "1985", "unstructured": "Seeger, R. C. et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313, 1111\u20131116 (1985). The first report to show the adverse prognostic significance of  MYCN  amplification in neuroblastoma patients.", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR27", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1097/00043426-199703000-00001", "volume": "19", "author": "GM Brodeur", "year": "1997", "unstructured": "Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D. & White, P. S. Biology and genetics of human neuroblastomas. J. Pediatr. Hematol. Oncol. 19, 93\u2013101 (1997).", "journal-title": "J. Pediatr. Hematol. Oncol."}, {"key": "BFnrc1014_CR28", "author": "GM Brodeur", "first-page": "355", "year": "2000", "unstructured": "Brodeur, G. M. & Ambros, P. F. in Neuroblastoma (eds Brodeur, G. M., Sawada, T., Tsuchida, Y. & Vo\u00fbte, P. A.) 355\u2013369 (Elsevier Science B. V., Amsterdam, 2000).", "volume-title": "Neuroblastoma"}, {"key": "BFnrc1014_CR29", "author": "GM Brodeur", "first-page": "895", "year": "2002", "unstructured": "Brodeur, G. M. & Maris, J. M. in Principles and Practice of Pediatric Oncology (eds Pizzo, P. & Poplack, D.) 895\u2013937 (2002).", "volume-title": "Principles and Practice of Pediatric Oncology"}, {"key": "BFnrc1014_CR30", "author": "GM Brodeur", "first-page": "751", "year": "2002", "unstructured": "Brodeur, G. M. in The Genetic Basis of Human Cancer (eds Vogelstein, B. & Kinzler, K. W.) 751\u2013772 (McGraw\u2013Hill, Inc., New York, 2002).", "volume-title": "The Genetic Basis of Human Cancer"}, {"key": "BFnrc1014_CR31", "first-page": "4248", "volume": "47", "author": "GM Brodeur", "year": "1987", "unstructured": "Brodeur, G. M. et al. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res. 47, 4248\u20134253 (1987).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR32", "first-page": "41", "volume": "271", "author": "RC Seeger", "year": "1988", "unstructured": "Seeger, R. C. et al. Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. Prog. Clin. Biol. Res. 271, 41\u201349 (1988).", "journal-title": "Prog. Clin. Biol. Res."}, {"key": "BFnrc1014_CR33", "doi-asserted-by": "publisher", "first-page": "1911", "DOI": "10.1016/S0959-8049(97)00284-0", "volume": "33", "author": "MD Norris", "year": "1997", "unstructured": "Norris, M. D. et al. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma. Eur. J. Cancer 33, 1911\u20131916 (1997).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrc1014_CR34", "first-page": "1123", "volume": "62", "author": "JM Shohet", "year": "2002", "unstructured": "Shohet, J. M. et al. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res. 62, 1123\u20131128 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR35", "first-page": "1364", "volume": "52", "author": "A Nakagawara", "year": "1992", "unstructured": "Nakagawara, A., Arima, M., Azar, C. G., Scavarda, N. J. & Brodeur, G. M. Inverse relationship between TRK expression and N-MYC amplification in human neuroblastomas. Cancer Res. 52, 1364\u20131368 (1992).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR36", "doi-asserted-by": "publisher", "first-page": "3346", "DOI": "10.1002/1097-0142(19931201)72:11<3346::AID-CNCR2820721134>3.0.CO;2-E", "volume": "72", "author": "RK Wada", "year": "1993", "unstructured": "Wada, R. K. et al. Human neuroblastoma cell lines that express N-myc without gene amplification. Cancer 72, 3346\u20133354 (1993).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR37", "first-page": "21", "volume": "366", "author": "SL Cohn", "year": "1991", "unstructured": "Cohn, S. L. et al. High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification. Prog. Clin. Biol. Res. 366, 21\u201327 (1991).", "journal-title": "Prog. Clin. Biol. Res."}, {"key": "BFnrc1014_CR38", "doi-asserted-by": "publisher", "first-page": "1937", "DOI": "10.1038/sj.onc.1201363", "volume": "15", "author": "LE Sivak", "year": "1997", "unstructured": "Sivak, L. E. et al. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines. Oncogene 15, 1937\u20131946 (1997).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR39", "first-page": "1699", "volume": "3", "author": "HS Chan", "year": "1997", "unstructured": "Chan, H. S. et al. MYCN protein expression as a predictor of neuroblastoma prognosis. Clin. Cancer Res. 3, 1699\u20131706 (1997).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrc1014_CR40", "doi-asserted-by": "publisher", "first-page": "3286", "DOI": "10.1200/JCO.1998.16.10.3286", "volume": "16", "author": "SB Bordow", "year": "1998", "unstructured": "Bordow, S. B., Norris, M. D., Haber, P. S., Marshall, G. M. & Haber, M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J. Clin. Oncol. 16, 3286\u20133294 (1998).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR41", "doi-asserted-by": "publisher", "first-page": "3604", "DOI": "10.1200/JCO.2000.18.21.3604", "volume": "18", "author": "SL Cohn", "year": "2000", "unstructured": "Cohn, S. L. et al. MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCN. J. Clin. Oncol. 18, 3604\u20133613 (2000).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR42", "doi-asserted-by": "publisher", "first-page": "3753", "DOI": "10.1073/pnas.86.10.3753", "volume": "86", "author": "CT Fong", "year": "1989", "unstructured": "Fong, C. T. et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc. Natl Acad. Sci. USA 86, 3753\u20133757 (1989).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrc1014_CR43", "first-page": "5366", "volume": "55", "author": "M Gehring", "year": "1995", "unstructured": "Gehring, M., Berthold, F., Edler, L., Schwab, M. & Amler, L. C. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res. 55, 5366\u20135369 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR44", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1056/NEJM199601253340404", "volume": "334", "author": "H Caron", "year": "1996", "unstructured": "Caron, H. et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N. Engl. J. Med. 334, 225\u2013230 (1996).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR45", "doi-asserted-by": "publisher", "first-page": "1888", "DOI": "10.1200/JCO.2000.18.9.1888", "volume": "18", "author": "JM Maris", "year": "2000", "unstructured": "Maris, J. M. et al. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J. Clin. Oncol. 18, 1888\u20131899 (2000).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR46", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1111/j.1349-7006.1989.tb02309.x", "volume": "80", "author": "T Jinbo", "year": "1989", "unstructured": "Jinbo, T., Iwamura, Y., Kaneko, M. & Sawaguchi, S. Coamplification of the L-myc and N-myc oncogenes in a neuroblastoma cell line. Jpn. J. Cancer Res. 80, 299\u2013301 (1989).", "journal-title": "Jpn. J. Cancer Res."}, {"key": "BFnrc1014_CR47", "first-page": "1081", "volume": "10", "author": "R Corvi", "year": "1995", "unstructured": "Corvi, R. et al. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene 10, 1081\u20131086 (1995).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR48", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1016/0165-4608(95)00034-M", "volume": "82", "author": "N Van Roy", "year": "1995", "unstructured": "Van Roy, N. et al. Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet. Cytogenet. 82, 151\u2013154 (1995).", "journal-title": "Cancer Genet. Cytogenet."}, {"key": "BFnrc1014_CR49", "doi-asserted-by": "publisher", "first-page": "394", "DOI": "10.1002/(SICI)1096-9896(199704)181:4<394::AID-PATH800>3.0.CO;2-1", "volume": "181", "author": "C Brinkschmidt", "year": "1997", "unstructured": "Brinkschmidt, C. et al. Comparative genomic hybridization (CGH) analysis of neuroblastomas \u2014 an important methodological approach in paediatric tumour pathology. J. Pathol. 181, 394\u2013400 (1997).", "journal-title": "J. Pathol."}, {"key": "BFnrc1014_CR50", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1002/(SICI)1098-2264(199703)18:3<162::AID-GCC2>3.0.CO;2-#", "volume": "18", "author": "M Lastowska", "year": "1997", "unstructured": "Lastowska, M. et al. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Genes Chromosom. Cancer 18, 162\u2013169 (1997).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR51", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1002/(SICI)1098-2264(199810)23:2<141::AID-GCC7>3.0.CO;2-2", "volume": "23", "author": "J Vandesompele", "year": "1998", "unstructured": "Vandesompele, J. et al. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosom. Cancer 23, 141\u2013152 (1998).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR52", "doi-asserted-by": "publisher", "first-page": "215", "DOI": "10.1002/mpo.2950240402", "volume": "24", "author": "H Caron", "year": "1995", "unstructured": "Caron, H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med. Pediatr. Oncol. 24, 215\u2013221 (1995).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR53", "doi-asserted-by": "publisher", "first-page": "1954", "DOI": "10.1056/NEJM199906243402504", "volume": "340", "author": "N Bown", "year": "1999", "unstructured": "Bown, N. et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N. Engl. J. Med. 340, 1954\u20131961 (1999). Definitive report of the prevalence and clinical significance of unbalanced 17q gain in neuroblastomas.", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR54", "doi-asserted-by": "publisher", "first-page": "1974", "DOI": "10.1016/S0959-8049(97)00319-5", "volume": "33", "author": "N Van Roy", "year": "1997", "unstructured": "Van Roy, N. et al. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes. Eur. J. Cancer 33, 1974\u20131978 (1997).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrc1014_CR55", "doi-asserted-by": "publisher", "first-page": "428", "DOI": "10.1002/gcc.10089", "volume": "34", "author": "M Lastowska", "year": "2002", "unstructured": "Lastowska, M. et al. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors. Genes Chromosom. Cancer 34, 428\u2013436 (2002).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR56", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1038/sj.onc.1203358", "volume": "19", "author": "A Islam", "year": "2000", "unstructured": "Islam, A. et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19, 617\u2013623 (2000).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR57", "first-page": "5530", "volume": "49", "author": "CM Ireland", "year": "1989", "unstructured": "Ireland, C. M. Activated N-ras oncogenes in human neuroblastoma. Cancer Res. 49, 5530\u20135533 (1989).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR58", "first-page": "1596", "volume": "51", "author": "JF Moley", "year": "1991", "unstructured": "Moley, J. F. et al. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas and medullary thyroid cancers. Cancer Res. 51, 1596\u20131599 (1991).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR59", "first-page": "1030", "volume": "48", "author": "T Tanaka", "year": "1988", "unstructured": "Tanaka, T. et al. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis. Cancer Res. 48, 1030\u20131034 (1988).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR60", "first-page": "4678", "volume": "41", "author": "GM Brodeur", "year": "1981", "unstructured": "Brodeur, G. M. et al. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res. 41, 4678\u20134686 (1981). Definitive report of distal 1p deletions as a genetic change characteristic of neuroblastomas. The clinical significance of deletion of 1p was shown subsequently in large studies.", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR61", "doi-asserted-by": "publisher", "first-page": "5520", "DOI": "10.1073/pnas.92.12.5520", "volume": "92", "author": "PS White", "year": "1995", "unstructured": "White, P. S. et al. A region of consistent deletion in neuroblastoma maps within 1p36.2-3. Proc. Natl Acad. Sci. USA 92, 5520\u20135524 (1995).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrc1014_CR62", "first-page": "5681", "volume": "55", "author": "T Martinsson", "year": "1995", "unstructured": "Martinsson, T., Shoberg, P. -M., Hedborg, F. & Kogner, P. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res. 55, 5681\u20135686 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR63", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1002/1096-911X(20010101)36:1<61::AID-MPO1016>3.0.CO;2-0", "volume": "36", "author": "K Ejeskar", "year": "2001", "unstructured": "Ejeskar, K. et al. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. Med. Pediatr. Oncol. 36, 61\u201366 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR64", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1002/1098-2264(200102)30:2<168::AID-GCC1072>3.0.CO;2-E", "volume": "30", "author": "H Caron", "year": "2001", "unstructured": "Caron, H. et al. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosom. Cancer 30, 168\u2013174 (2001).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR65", "doi-asserted-by": "publisher", "first-page": "228", "DOI": "10.1002/gcc.1139", "volume": "31", "author": "A Bauer", "year": "2001", "unstructured": "Bauer, A. et al. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig. Genes Chromosom. Cancer 31, 228\u2013239 (2001).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR66", "doi-asserted-by": "publisher", "first-page": "512", "DOI": "10.1002/1096-911X(20001201)35:6<512::AID-MPO2>3.0.CO;2-D", "volume": "35", "author": "MD Hogarty", "year": "2000", "unstructured": "Hogarty, M. D. et al. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas. Med. Pediatr. Oncol. 35, 512\u2013515 (2000).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR67", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.1002/1096-911X(20010101)36:1<32::AID-MPO1009>3.0.CO;2-0", "volume": "36", "author": "JM Maris", "year": "2001", "unstructured": "Maris, J. M. et al. Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med. Pediatr. Oncol. 36, 32\u201336 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR68", "doi-asserted-by": "publisher", "first-page": "4302", "DOI": "10.1038/sj.onc.1203786", "volume": "19", "author": "M Ohira", "year": "2000", "unstructured": "Ohira, M. et al. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19, 4302\u20134307 (2000).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR69", "doi-asserted-by": "publisher", "first-page": "326", "DOI": "10.1002/gcc.1151", "volume": "31", "author": "YZ Chen", "year": "2001", "unstructured": "Chen, Y. Z. et al. Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36. Genes Chromosom. Cancer 31, 326\u2013332 (2001).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR70", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.1002/gcc.2870070106", "volume": "7", "author": "ES Srivatsan", "year": "1993", "unstructured": "Srivatsan, E. S., Ying, K. L. & Seeger, R. C. Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosom. Cancer 7, 32\u201337 (1993).", "journal-title": "Genes Chromosom. Cancer"}, {"key": "BFnrc1014_CR71", "doi-asserted-by": "publisher", "first-page": "680", "DOI": "10.1002/1097-0215(200002)9999:9999<::AID-IJC1114>3.0.CO;2-R", "volume": "91", "author": "D Plantaz", "year": "2001", "unstructured": "Plantaz, D. et al. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int. J. Cancer 91, 680\u2013686 (2001).", "journal-title": "Int. J. Cancer"}, {"key": "BFnrc1014_CR72", "doi-asserted-by": "publisher", "first-page": "4948", "DOI": "10.1038/sj.onc.1202887", "volume": "18", "author": "C Guo", "year": "1999", "unstructured": "Guo, C. et al. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18, 4948\u20134957 (1999).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR73", "first-page": "1095", "volume": "49", "author": "T Suzuki", "year": "1989", "unstructured": "Suzuki, T. et al. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res. 49, 1095\u20131098 (1989).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR74", "doi-asserted-by": "publisher", "first-page": "1801", "DOI": "10.1054/bjoc.2000.1108", "volume": "82", "author": "M Hoshi", "year": "2000", "unstructured": "Hoshi, M. et al. Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss. Br. J. Cancer 82, 1801\u20131807 (2000).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1014_CR75", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1002/1096-911X(20010101)36:1<28::AID-MPO1008>3.0.CO;2-0", "volume": "36", "author": "PM Thompson", "year": "2001", "unstructured": "Thompson, P. M. et al. Loss of heterozygosity for chromosome 14q in neuroblastoma. Med. Pediatr. Oncol. 36, 28\u201331 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR76", "first-page": "5269", "volume": "53", "author": "K Vogan", "year": "1993", "unstructured": "Vogan, K. et al. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res. 53, 5269\u20135273 (1993).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR77", "doi-asserted-by": "publisher", "first-page": "3087", "DOI": "10.1002/1097-0142(19940615)73:12<3087::AID-CNCR2820731230>3.0.CO;2-9", "volume": "73", "author": "G Hosoi", "year": "1994", "unstructured": "Hosoi, G. et al. Low frequency of the p53 gene mutations in neuroblastoma. Cancer 73, 3087\u20133093 (1994).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR78", "first-page": "6185", "volume": "61", "author": "N Keshelava", "year": "2001", "unstructured": "Keshelava, N. et al. Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res. 61, 6185\u20136193 (2001).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR79", "first-page": "8", "volume": "61", "author": "DA Tweddle", "year": "2001", "unstructured": "Tweddle, D. A., Malcolm, A. J., Bown, N., Pearson, A. D. & Lunec, J. Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line. Cancer Res. 61, 8\u201313 (2001).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR80", "doi-asserted-by": "publisher", "first-page": "4407", "DOI": "10.1073/pnas.92.10.4407", "volume": "92", "author": "UM Moll", "year": "1995", "unstructured": "Moll, U. M., LaQuaglia, M., Benard, J. & Riou, G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc. Natl Acad. Sci. USA 92, 4407\u20134411 (1995).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrc1014_CR81", "doi-asserted-by": "publisher", "first-page": "1126", "DOI": "10.1128/MCB.16.3.1126", "volume": "16", "author": "UM Moll", "year": "1996", "unstructured": "Moll, U. M. et al. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage. Mol. Cell. Biol. 16, 1126\u20131137 (1996).", "journal-title": "Mol. Cell. Biol."}, {"key": "BFnrc1014_CR82", "first-page": "1381", "volume": "148", "author": "SC Goldman", "year": "1996", "unstructured": "Goldman, S. C., Chen, C. Y., Lansing, T. J., Gilmer, T. M. & Kastan, M. B. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Am. J. Pathol. 148, 1381\u20131385 (1996).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrc1014_CR83", "first-page": "2053", "volume": "55", "author": "CP Beltinger", "year": "1995", "unstructured": "Beltinger, C. P., White, P. S., Sulman, E. P., Maris, J. M. & Brodeur, G. M. No CDKN2 mutations in neuroblastomas. Cancer Res. 55, 2053\u20132055 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR84", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1203/00006450-199801000-00021", "volume": "43", "author": "A Iolascon", "year": "1998", "unstructured": "Iolascon, A. et al. Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma. Pediatr. Res. 43, 139\u2013144 (1998).", "journal-title": "Pediatr. Res."}, {"key": "BFnrc1014_CR85", "doi-asserted-by": "publisher", "first-page": "570", "DOI": "10.1002/(SICI)1097-0142(19960201)77:3<570::AID-CNCR21>3.0.CO;2-0", "volume": "77", "author": "N Kawamata", "year": "1996", "unstructured": "Kawamata, N., Seriu, T., Koeffler, H. P. & Bartram, C. R. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas. Cancer 77, 570\u2013575 (1996).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR86", "first-page": "679", "volume": "61", "author": "PM Thompson", "year": "2001", "unstructured": "Thompson, P. M. et al. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma. Cancer Res. 61, 679\u2013686 (2001).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR87", "doi-asserted-by": "publisher", "first-page": "5539", "DOI": "10.1073/pnas.90.12.5539", "volume": "90", "author": "MR Johnson", "year": "1993", "unstructured": "Johnson, M. R., Look, A. T., DeClue, J. E., Valentine, M. B. & Lowy, D. R. Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP Ras. Proc. Natl Acad. Sci. USA 90, 5539\u20135543 (1993).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrc1014_CR88", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1038/ng0193-62", "volume": "3", "author": "I The", "year": "1993", "unstructured": "The, I. et al. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nature Genet. 3, 62\u201366 (1993).", "journal-title": "Nature Genet."}, {"key": "BFnrc1014_CR89", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1016/S0031-6865(99)00036-9", "volume": "74", "author": "H Yano", "year": "2000", "unstructured": "Yano, H. & Chao, M. V. Neurotrophin receptor structure and interactions. Pharm. Acta Helv. 74, 253\u2013260 (2000).", "journal-title": "Pharm. Acta Helv."}, {"key": "BFnrc1014_CR90", "doi-asserted-by": "publisher", "first-page": "272", "DOI": "10.1016/S0959-4388(00)00208-7", "volume": "11", "author": "A Patapoutian", "year": "2001", "unstructured": "Patapoutian, A. & Reichardt, L. F. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11, 272\u2013280 (2001).", "journal-title": "Curr. Opin. Neurobiol."}, {"key": "BFnrc1014_CR91", "doi-asserted-by": "publisher", "first-page": "847", "DOI": "10.1056/NEJM199303253281205", "volume": "328", "author": "A Nakagawara", "year": "1993", "unstructured": "Nakagawara, A. et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 328, 847\u2013854 (1993). The first report to show the favourable prognostic value of TrkA expression in neuroblastomas. Other reports were reported independently with similar results.", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR92", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1093/jnci/85.5.377", "volume": "85", "author": "T Suzuki", "year": "1993", "unstructured": "Suzuki, T., Bogenmann, E., Shimada, H., Stram, D. & Seeger, R. C. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl Cancer Inst. 85, 377\u2013384 (1993).", "journal-title": "J. Natl Cancer Inst."}, {"key": "BFnrc1014_CR93", "first-page": "2044", "volume": "53", "author": "P Kogner", "year": "1993", "unstructured": "Kogner, P. et al. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 53, 2044\u20132050 (1993).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR94", "doi-asserted-by": "publisher", "first-page": "1505", "DOI": "10.1056/NEJM199606063342304", "volume": "334", "author": "IM Ambros", "year": "1996", "unstructured": "Ambros, I. M. et al. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N. Engl. J. Med. 334, 1505\u20131511 (1996).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR95", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1002/1096-911X(20010101)36:1<163::AID-MPO1040>3.0.CO;2-2", "volume": "36", "author": "IM Ambros", "year": "2001", "unstructured": "Ambros, I. M. et al. Neuroblastoma cells provoke Schwann cell proliferation in vitro. Med. Pediatr. Oncol. 36, 163\u2013168 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR96", "doi-asserted-by": "publisher", "first-page": "2050", "DOI": "10.1016/S0959-8049(97)00280-3", "volume": "33", "author": "A Nakagawara", "year": "1997", "unstructured": "Nakagawara, A. & Brodeur, G. M. Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur. J. Cancer 33, 2050\u20132053 (1997).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrc1014_CR97", "doi-asserted-by": "publisher", "first-page": "759", "DOI": "10.1128/MCB.14.1.759", "volume": "14", "author": "A Nakagawara", "year": "1994", "unstructured": "Nakagawara, A., Azar, C. G., Scavarda, N. J. & Brodeur, G. M. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell. Biol. 14, 759\u2013767 (1994). The first report to associate TrkB and BDNF expression with high-risk neuroblastomas that have  MYCN  amplification.", "journal-title": "Mol. Cell. Biol."}, {"key": "BFnrc1014_CR98", "doi-asserted-by": "publisher", "first-page": "450", "DOI": "10.1038/374450a0", "volume": "374", "author": "A Acheson", "year": "1995", "unstructured": "Acheson, A. et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374, 450\u2013453 (1995).", "journal-title": "Nature"}, {"key": "BFnrc1014_CR99", "first-page": "1798", "volume": "55", "author": "K Matsumoto", "year": "1995", "unstructured": "Matsumoto, K., Wada, R. K., Yamashiro, J. M., Kaplan, D. R. & Thiele, C. J. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res. 55, 1798\u20131806 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR100", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1002/1096-911X(20001201)35:6<569::AID-MPO16>3.0.CO;2-A", "volume": "35", "author": "A Eggert", "year": "2000", "unstructured": "Eggert, A. et al. Expression of neurotrophin receptor TrkA inhibits angiogenesis in neuroblastoma. Med. Pediatr. Oncol. 35, 569\u2013572 (2000).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR101", "first-page": "6462", "volume": "62", "author": "R Ho", "year": "2002", "unstructured": "Ho, R. et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res. 62, 6462\u20136466 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR102", "first-page": "37", "volume": "12", "author": "DJ Yamashiro", "year": "1996", "unstructured": "Yamashiro, D. J., Nakagawara, A., Ikegaki, N., Liu, X. -G. & Brodeur, G. M. Expression of TrkC in favorable human neuroblastomas. Oncogene 12, 37\u201341 (1996).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR103", "doi-asserted-by": "publisher", "first-page": "773", "DOI": "10.1038/bjc.1996.435", "volume": "74", "author": "M Ryden", "year": "1996", "unstructured": "Ryden, M. et al. Expression of mRNA for the neurotrophin receptor TrkC in neuroblastomas with favourable tumour stage and good prognosis. Br. J. Cancer 74, 773\u2013779 (1996).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1014_CR104", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1007/978-1-4615-4685-6_22", "volume": "468", "author": "P Casaccia-Bonnefil", "year": "1999", "unstructured": "Casaccia-Bonnefil, P., Gu, C. & Chao, M. V. Neurotrophins in cell survival/death decisions. Adv. Exp. Med. Biol. 468, 275\u2013282 (1999).", "journal-title": "Adv. Exp. Med. Biol."}, {"key": "BFnrc1014_CR105", "doi-asserted-by": "publisher", "first-page": "260", "DOI": "10.1016/S0959-4388(02)00321-5", "volume": "12", "author": "BL Hempstead", "year": "2002", "unstructured": "Hempstead, B. L. The many faces of p75NTR. Curr. Opin. Neurobiol. 12, 260\u2013267 (2002).", "journal-title": "Curr. Opin. Neurobiol."}, {"key": "BFnrc1014_CR106", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1200/JCO.1990.8.1.128", "volume": "8", "author": "LJ Goldstein", "year": "1990", "unstructured": "Goldstein, L. J. et al. Expression of the multidrug resistance, MDR1, gene in neuroblastomas. J. Clin. Oncol. 8, 128\u2013136 (1990).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR107", "doi-asserted-by": "publisher", "first-page": "1608", "DOI": "10.1056/NEJM199112053252304", "volume": "325", "author": "HS Chan", "year": "1991", "unstructured": "Chan, H. S. et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med. 325, 1608\u20131614 (1991).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR108", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.1056/NEJM199601253340405", "volume": "334", "author": "MD Norris", "year": "1996", "unstructured": "Norris, M. D. et al. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engl. J. Med. 334, 231\u2013238 (1996).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR109", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1038/nm0395-249", "volume": "1", "author": "E Hiyama", "year": "1995", "unstructured": "Hiyama, E. et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med. 1, 249\u2013255 (1995).", "journal-title": "Nature Med."}, {"key": "BFnrc1014_CR110", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1038/nm0395-203", "volume": "1", "author": "GM Brodeur", "year": "1995", "unstructured": "Brodeur, G. M. Do the ends justify the means? Nature Med. 1, 203\u2013205 (1995).", "journal-title": "Nature Med."}, {"key": "BFnrc1014_CR111", "author": "GM Brodeur", "first-page": "305", "year": "1999", "unstructured": "Brodeur, G. M. & Castle, V. P. in Apoptosis and Cancer Chemotherapy (eds Hickman, J. A. & Dive, C.) 305\u2013318 (Humana, New Jersey, 1999).", "volume-title": "Apoptosis and Cancer Chemotherapy", "DOI": "10.1007/978-1-59259-720-8_20", "doi-asserted-by": "publisher"}, {"key": "BFnrc1014_CR112", "doi-asserted-by": "publisher", "first-page": "1463", "DOI": "10.1038/sj.onc.1200972", "volume": "14", "author": "G Bunone", "year": "1997", "unstructured": "Bunone, G., Mariotti, A., Compagni, A., Morandi, E. & Della Valle, G. Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene 14, 1463\u20131470 (1997).", "journal-title": "Oncogene"}, {"key": "BFnrc1014_CR113", "first-page": "3823", "volume": "57", "author": "S Fulda", "year": "1997", "unstructured": "Fulda, S., Sieverts, H., Friesen, C., Herr, I. & Debatin, K. M. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57, 3823\u20133829 (1997).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR114", "first-page": "1543", "volume": "143", "author": "VP Castle", "year": "1993", "unstructured": "Castle, V. P. et al. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am. J. Pathol. 143, 1543\u20131550 (1993).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrc1014_CR115", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1016/S0022-3468(96)90009-3", "volume": "31", "author": "T Oue", "year": "1996", "unstructured": "Oue, T. et al. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: relation to apoptosis and spontaneous regression. J. Pediatr. Surg. 31, 251\u2013257 (1996).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrc1014_CR116", "first-page": "3253", "volume": "54", "author": "M Dole", "year": "1994", "unstructured": "Dole, M. et al. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54, 3253\u20133259 (1994).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR117", "first-page": "2576", "volume": "55", "author": "MG Dole", "year": "1995", "unstructured": "Dole, M. G. et al. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55, 2576\u20132582 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR118", "first-page": "4578", "volume": "57", "author": "A Nakagawara", "year": "1997", "unstructured": "Nakagawara, A. et al. High levels of expression and nuclear localization of interleukin-1\u03b2 converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res. 57, 4578\u20134584 (1997).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR119", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1016/S0304-3835(02)00199-4", "volume": "184", "author": "F Westermann", "year": "2002", "unstructured": "Westermann, F. & Schwab, M. Genetic parameters of neuroblastomas. Cancer Lett. 184, 127\u2013147 (2002).", "journal-title": "Cancer Lett."}, {"key": "BFnrc1014_CR120", "doi-asserted-by": "publisher", "first-page": "1466", "DOI": "10.1200/JCO.1993.11.8.1466", "volume": "11", "author": "GM Brodeur", "year": "1993", "unstructured": "Brodeur, G. M. et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J. Clin. Oncol. 11, 1466\u20131477 (1993). A description of the International Neuroblastoma Staging System currently used throughout the world.", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR121", "first-page": "2843", "volume": "45", "author": "HWL Hann", "year": "1985", "unstructured": "Hann, H. W. L. et al. Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma. The Children's Cancer Study Group Experience. Cancer Res. 45, 2843\u20132848 (1985).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR122", "doi-asserted-by": "publisher", "first-page": "1230", "DOI": "10.1002/1097-0142(19860315)57:6<1230::AID-CNCR2820570628>3.0.CO;2-#", "volume": "57", "author": "PM Zeltzer", "year": "1986", "unstructured": "Zeltzer, P. M., Marangos, P. J., Evans, A. E. & Schneider, S. L. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 57, 1230\u20131234 (1986).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR123", "doi-asserted-by": "publisher", "first-page": "136", "DOI": "10.1016/S0140-6736(85)91906-3", "volume": "1", "author": "S Ladisch", "year": "1985", "unstructured": "Ladisch, S. & Wu, Z. L. Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma. Lancet 1, 136\u2013138 (1985).", "journal-title": "Lancet"}, {"key": "BFnrc1014_CR124", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1016/S0022-3476(80)80139-9", "volume": "97", "author": "JJ Quinn", "year": "1980", "unstructured": "Quinn, J. J., Altman, A. J. & Frantz, C. N. Serum lactic dehydrogenase, an indicator of tumor activity in neuroblastoma. J. Pediatr. 97, 89\u201391 (1980).", "journal-title": "J. Pediatr."}, {"key": "BFnrc1014_CR125", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1097/00000421-199208000-00004", "volume": "15", "author": "JJ Shuster", "year": "1992", "unstructured": "Shuster, J. J. et al. Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study. Am. J. Clin. Oncol. 15, 295\u2013303 (1992).", "journal-title": "Am. J. Clin. Oncol."}, {"key": "BFnrc1014_CR126", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1093/jnci/73.2.405", "volume": "73", "author": "H Shimada", "year": "1984", "unstructured": "Shimada, H. et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl Cancer Inst. 73, 405\u2013413 (1984). The original report of the popular histopathological classification for predicting outcome of neuroblastoma patients. This was subsequently revised into the International Neuroblastoma Pathology Classification.", "journal-title": "J. Natl Cancer Inst."}, {"key": "BFnrc1014_CR127", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y", "volume": "86", "author": "H Shimada", "year": "1999", "unstructured": "Shimada, H. et al. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86, 349\u2013363 (1999).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR128", "doi-asserted-by": "publisher", "first-page": "364", "DOI": "10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7", "volume": "86", "author": "H Shimada", "year": "1999", "unstructured": "Shimada, H. et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86, 364\u2013372 (1999).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR129", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1200/JCO.1996.14.1.25", "volume": "14", "author": "V Combaret", "year": "1996", "unstructured": "Combaret, V. et al. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J. Clin. Oncol. 14, 25\u201334 (1996).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR130", "doi-asserted-by": "publisher", "first-page": "2113", "DOI": "10.1016/S0959-8049(97)00202-5", "volume": "33", "author": "RP Castleberry", "year": "1997", "unstructured": "Castleberry, R. P. et al. The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur. J. Cancer 33, 2113\u20132116 (1997). First report of an international consensus on neuroblastoma risk groups using a combination of clinical and biological variables.", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrc1014_CR131", "first-page": "1089", "volume": "43", "author": "J Beckwith", "year": "1963", "unstructured": "Beckwith, J. & Perrin, E. In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am. J. Pathol. 43, 1089\u20131104 (1963).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrc1014_CR132", "first-page": "225", "volume": "76", "author": "SB Turkel", "year": "1975", "unstructured": "Turkel, S. B. & Itabashi, H. H. The natural history of neuroblastic cells in the fetal adrenal gland. Am. J. Pathol. 76, 225\u2013243 (1975).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrc1014_CR133", "doi-asserted-by": "publisher", "first-page": "636", "DOI": "10.1016/0022-3468(81)90019-1", "volume": "16", "author": "Y Ikeda", "year": "1981", "unstructured": "Ikeda, Y., Lister, J., Bouton, J. M. & Buyukpamukcu, M. Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal. J. Pediatr. Surg. 16, 636\u2013644 (1981).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrc1014_CR134", "first-page": "49", "volume": "44", "author": "AE Evans", "year": "1976", "unstructured": "Evans, A. E., Gerson, J. & Schnaufer, L. Spontaneous regression of neuroblastoma. Natl Cancer Inst. Monogr. 44, 49\u201354 (1976).", "journal-title": "Natl Cancer Inst. Monogr."}, {"key": "BFnrc1014_CR135", "doi-asserted-by": "publisher", "first-page": "2731", "DOI": "10.1002/1097-0142(19840615)53:12<2731::AID-CNCR2820531232>3.0.CO;2-D", "volume": "53", "author": "T Sawada", "year": "1984", "unstructured": "Sawada, T. et al. Neuroblastoma. Mass screening for early detection and its prognosis. Cancer 53, 2731\u20132735 (1984). A seminal paper that indicates the potential value of mass screening for early detection of disease to improve the prognosis of neuroblastoma. Subsequent reports from mass screening programmes in Quebec and Germany indicate that there is no impact on mortality.", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR136", "doi-asserted-by": "publisher", "first-page": "368", "DOI": "10.1002/mpo.2950170504", "volume": "17", "author": "T Takeda", "year": "1989", "unstructured": "Takeda, T. et al. Japanese experience of screening. Med. Pediatr. Oncol. 17, 368\u2013372 (1989).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR137", "doi-asserted-by": "publisher", "first-page": "1157", "DOI": "10.1016/S0140-6736(94)90665-3", "volume": "344", "author": "FH Schilling", "year": "1994", "unstructured": "Schilling, F. H. et al. Screening for neuroblastoma. Lancet 344, 1157\u20131158 (1994).", "journal-title": "Lancet"}, {"key": "BFnrc1014_CR138", "doi-asserted-by": "publisher", "first-page": "1682", "DOI": "10.1016/S0140-6736(96)06020-5", "volume": "348", "author": "WG Woods", "year": "1996", "unstructured": "Woods, W. G. et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 348, 1682\u20131687 (1996).", "journal-title": "Lancet"}, {"key": "BFnrc1014_CR139", "doi-asserted-by": "publisher", "first-page": "174", "DOI": "10.1016/S0140-6736(88)92739-0", "volume": "1", "author": "Y Kaneko", "year": "1988", "unstructured": "Kaneko, Y. et al. Chromosomes and screening for neuroblastoma. Lancet 1, 174\u2013175 (1988).", "journal-title": "Lancet"}, {"key": "BFnrc1014_CR140", "doi-asserted-by": "publisher", "first-page": "567", "DOI": "10.1016/S0022-3476(88)80168-9", "volume": "112", "author": "Y Hayashi", "year": "1988", "unstructured": "Hayashi, Y., Inaba, T., Hanada, R. & Yamamoto, K. Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening. J. Pediatr. 112, 567\u2013571 (1988).", "journal-title": "J. Pediatr."}, {"key": "BFnrc1014_CR141", "doi-asserted-by": "publisher", "first-page": "342", "DOI": "10.1097/00043426-199211000-00011", "volume": "14", "author": "Y Hayashi", "year": "1992", "unstructured": "Hayashi, Y., Hanada, R. & Yamamoto, K. Biology of neuroblastomas in Japan found by screening. Am. J. Pediatr. Hematol. Oncol. 14, 342\u2013347 (1992).", "journal-title": "Am. J. Pediatr. Hematol. Oncol."}, {"key": "BFnrc1014_CR142", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1002/1096-911X(20010101)36:1<157::AID-MPO1038>3.0.CO;2-F", "volume": "36", "author": "GM Brodeur", "year": "2001", "unstructured": "Brodeur, G. M. et al. Biological aspects of neuroblastomas identified by mass screening in Quebec. Med. Pediatr. Oncol. 36, 157\u2013159 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR143", "doi-asserted-by": "publisher", "first-page": "1041", "DOI": "10.1056/NEJMoa012387", "volume": "346", "author": "WG Woods", "year": "2002", "unstructured": "Woods, W. G. et al. Screening of infants and mortality due to neuroblastoma. N. Engl. J. Med. 346, 1041\u20131046 (2002).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR144", "doi-asserted-by": "publisher", "first-page": "1047", "DOI": "10.1056/NEJMoa012277", "volume": "346", "author": "FH Schilling", "year": "2002", "unstructured": "Schilling, F. H. et al. Neuroblastoma screening at one year of age. N. Engl. J. Med. 346, 1047\u20131053 (2002).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR145", "doi-asserted-by": "publisher", "first-page": "54", "DOI": "10.1002/(SICI)1097-0215(19990105)80:1<54::AID-IJC11>3.0.CO;2-G", "volume": "80", "author": "Y Kaneko", "year": "1999", "unstructured": "Kaneko, Y., Kobayashi, H., Maseki, N., Nakagawara, A. & Sakurai, M. Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants. Int. J. Cancer 80, 54\u201359 (1999).", "journal-title": "Int. J. Cancer"}, {"key": "BFnrc1014_CR146", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1002/1097-0142(20010715)92:2<349::AID-CNCR1329>3.0.CO;2-C", "volume": "92", "author": "T Tajiri", "year": "2001", "unstructured": "Tajiri, T. et al. Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan. Cancer 92, 349\u2013353 (2001).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR147", "doi-asserted-by": "publisher", "first-page": "554", "DOI": "10.1002/1096-911X(20001201)35:6<554::AID-MPO13>3.0.CO;2-R", "volume": "35", "author": "V van Limpt", "year": "2000", "unstructured": "van Limpt, V. et al. SAGE analysis of neuroblastoma reveals a high expression of the human homologue of the Drosophila Delta gene. Med. Pediatr. Oncol. 35, 554\u2013558 (2000).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR148", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1006/geno.2000.6408", "volume": "71", "author": "N Spieker", "year": "2001", "unstructured": "Spieker, N. et al. The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics 71, 214\u2013221 (2001).", "journal-title": "Genomics"}, {"key": "BFnrc1014_CR149", "doi-asserted-by": "publisher", "first-page": "673", "DOI": "10.1038/89044", "volume": "7", "author": "J Khan", "year": "2001", "unstructured": "Khan, J. et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nature Med. 7, 673\u2013679 (2001).", "journal-title": "Nature Med."}, {"key": "BFnrc1014_CR150", "first-page": "67", "volume": "18", "author": "ME Truckenmiller", "year": "2001", "unstructured": "Truckenmiller, M. E. et al. Gene expression profile in early stage of retinoic acid-induced differentiation of human SH-SY5Y neuroblastoma cells. Restor. Neurol. Neurosci. 18, 67\u201380 (2001).", "journal-title": "Restor. Neurol. Neurosci."}, {"key": "BFnrc1014_CR151", "doi-asserted-by": "publisher", "first-page": "2985", "DOI": "10.1093/emboj/16.11.2985", "volume": "16", "author": "WA Weiss", "year": "1997", "unstructured": "Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G. & Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985\u20132995 (1997). First report of a transgenic mouse that overexpresses the  MYCN  proto-oncogene under the control of a tyrosine kinase promoter and develops neuroblastoma with high frequency.", "journal-title": "EMBO J."}, {"key": "BFnrc1014_CR152", "first-page": "2483", "volume": "60", "author": "WA Weiss", "year": "2000", "unstructured": "Weiss, W. A., Godfrey, T., Francisco, C. & Bishop, J. M. Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma. Cancer Res. 60, 2483\u20132487 (2000).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR153", "doi-asserted-by": "publisher", "first-page": "585", "DOI": "10.1002/1096-911X(20001201)35:6<585::AID-MPO20>3.0.CO;2-P", "volume": "35", "author": "MD Norris", "year": "2000", "unstructured": "Norris, M. D., Burkhart, C. A., Marshall, G. M., Weiss, W. A. & Haber, M. Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. Med. Pediatr. Oncol. 35, 585\u2013589 (2000).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR154", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1016/0014-4827(83)90184-2", "volume": "148", "author": "N Sidell", "year": "1983", "unstructured": "Sidell, N., Altman, A., Haussler, M. R. & Seeger, R. C. Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp. Cell Res. 148, 21\u201330 (1983).", "journal-title": "Exp. Cell Res."}, {"key": "BFnrc1014_CR155", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1038/313404a0", "volume": "313", "author": "CJ Thiele", "year": "1985", "unstructured": "Thiele, C. J., Reynolds, C. P. & Israel, M. A. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313, 404\u2013406 (1985).", "journal-title": "Nature"}, {"key": "BFnrc1014_CR156", "first-page": "237", "volume": "385", "author": "CP Reynolds", "year": "1994", "unstructured": "Reynolds, C. P. et al. Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines. Prog. Clin. Biol. Res. 385, 237\u2013244 (1994).", "journal-title": "Prog. Clin. Biol. Res."}, {"key": "BFnrc1014_CR157", "doi-asserted-by": "publisher", "first-page": "1165", "DOI": "10.1056/NEJM199910143411601", "volume": "341", "author": "KK Matthay", "year": "1999", "unstructured": "Matthay, K. K. et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N. Engl. J. Med. 341, 1165\u20131173 (1999). First clinical trial indicating that a survival advantage exists for the treatment of neuroblastoma patients with retinoic acid following bone-marrow transplantation.", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrc1014_CR158", "doi-asserted-by": "publisher", "first-page": "50", "DOI": "10.1006/excr.2000.4988", "volume": "260", "author": "PE Lovat", "year": "2000", "unstructured": "Lovat, P. E. et al. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Exp. Cell Res. 260, 50\u201360 (2000).", "journal-title": "Exp. Cell Res."}, {"key": "BFnrc1014_CR159", "first-page": "853", "volume": "55", "author": "M Ponzoni", "year": "1995", "unstructured": "Ponzoni, M. et al. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res. 55, 853\u2013861 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR160", "doi-asserted-by": "publisher", "first-page": "511", "DOI": "10.1007/s11912-000-0104-y", "volume": "2", "author": "CP Reynolds", "year": "2000", "unstructured": "Reynolds, C. P. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. Curr. Oncol. Rep. 2, 511\u2013518 (2000).", "journal-title": "Curr. Oncol. Rep."}, {"key": "BFnrc1014_CR161", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D", "volume": "181", "author": "U Galderisi", "year": "1999", "unstructured": "Galderisi, U., Cascino, A. & Giordano, A. Antisense oligonucleotides as therapeutic agents. J. Cell Physiol. 181, 251\u2013257 (1999).", "journal-title": "J. Cell Physiol."}, {"key": "BFnrc1014_CR162", "first-page": "3594", "volume": "5", "author": "AE Evans", "year": "1999", "unstructured": "Evans, A. E. et al. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts. Clin. Cancer Res. 5, 3594\u20133602 (1999). First report of a tyrosine kinase inhibitor that is selective for Trk receptors with potential use in treating neuroblastomas.", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrc1014_CR163", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1200/JCO.1996.14.2.405", "volume": "14", "author": "D Meitar", "year": "1996", "unstructured": "Meitar, D., Crawford, S. E., Rademaker, A. W. & Cohn, S. L. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol. 14, 405\u2013414 (1996). Definitive report correlating tumour angiogenesis with high-risk features and outcome in neuroblastomas. This report serves as the rationale for anti-angiogenesis therapy in high-risk neuroblastomas.", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR164", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1203/00006450-199703000-00004", "volume": "41", "author": "E Wassberg", "year": "1997", "unstructured": "Wassberg, E., Pahlman, S., Westlin, J. E. & Christofferson, R. The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr. Res. 41, 327\u2013333 (1997).", "journal-title": "Pediatr. Res."}, {"key": "BFnrc1014_CR165", "first-page": "4273", "volume": "5", "author": "HM Katzenstein", "year": "1999", "unstructured": "Katzenstein, H. M. et al. Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burden. Clin. Cancer Res. 5, 4273\u20134278 (1999).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrc1014_CR166", "doi-asserted-by": "publisher", "first-page": "673", "DOI": "10.1002/1096-911X(20001201)35:6<673::AID-MPO41>3.0.CO;2-O", "volume": "35", "author": "S Shusterman", "year": "2000", "unstructured": "Shusterman, S., Grupp, S. A. & Maris, J. M. Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470. Med. Pediatr. Oncol. 35, 673\u2013676 (2000).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrc1014_CR167", "first-page": "712", "volume": "60", "author": "A Erdreich-Epstein", "year": "2000", "unstructured": "Erdreich-Epstein, A. et al. Integrins \u03b1(v)\u03b23 and \u03b1(v)\u03b25 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res. 60, 712\u2013721 (2000).", "journal-title": "Cancer Res."}, {"key": "BFnrc1014_CR168", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1023/A:1006420200626", "volume": "51", "author": "E Jouanneau", "year": "2001", "unstructured": "Jouanneau, E. et al. Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model. J. Neurooncol. 51, 11\u201318 (2001).", "journal-title": "J. Neurooncol."}, {"key": "BFnrc1014_CR169", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1053/jpsu.2002.30855", "volume": "37", "author": "ES Kim", "year": "2002", "unstructured": "Kim, E. S. et al. Distinct response of experimental neuroblastoma to combination antiangiogenic strategies. J. Pediatr. Surg. 37, 518\u2013522 (2002).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrc1014_CR170", "doi-asserted-by": "publisher", "first-page": "30", "DOI": "10.1053/Jpsu.2001.19998", "volume": "36", "author": "AM Davidoff", "year": "2001", "unstructured": "Davidoff, A. M., Leary, M. A., Ng, C. Y. & Vanin, E. F. Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo. J. Pediatr. Surg. 36, 30\u201336 (2001).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrc1014_CR171", "doi-asserted-by": "publisher", "first-page": "1045", "DOI": "10.1172/JCI9872", "volume": "105", "author": "D Hanahan", "year": "2000", "unstructured": "Hanahan, D., Bergers, G. & Bergsland, E. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J. Clin. Invest. 105, 1045\u20131047 (2000).", "journal-title": "J. Clin. Invest."}, {"key": "BFnrc1014_CR172", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1002/(SICI)1097-0142(19970715)80:2<317::AID-CNCR21>3.0.CO;2-W", "volume": "80", "author": "JD Frost", "year": "1997", "unstructured": "Frost, J. D. et al. A phase I/IB trial of murine monoclonal anti-GD2 antibody 14. G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer 80, 317\u2013333 (1997).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR173", "doi-asserted-by": "publisher", "first-page": "2169", "DOI": "10.1200/JCO.1998.16.6.2169", "volume": "16", "author": "AL Yu", "year": "1998", "unstructured": "Yu, A. L. et al. Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. J. Clin. Oncol. 16, 2169\u20132180 (1998).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR174", "first-page": "1299", "volume": "12", "author": "NK Cheung", "year": "1998", "unstructured": "Cheung, N. K., Kushner, B. H., Yeh, S. D. & Larson, S. M. 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study. Int. J. Oncol. 12, 1299\u20131306 (1998).", "journal-title": "Int. J. Oncol."}, {"key": "BFnrc1014_CR175", "doi-asserted-by": "publisher", "first-page": "600", "DOI": "10.1016/0959-8049(95)00063-O", "volume": "31A", "author": "J De Kraker", "year": "1995", "unstructured": "De Kraker, J. et al. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma. Eur. J. Cancer 31A, 600\u2013602 (1995).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrc1014_CR176", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1200/JCO.1998.16.1.229", "volume": "16", "author": "KK Matthay", "year": "1998", "unstructured": "Matthay, K. K. et al. Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J. Clin. Oncol. 16, 229\u2013236 (1998).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR177", "doi-asserted-by": "publisher", "first-page": "2142", "DOI": "10.1200/JCO.2002.08.124", "volume": "20", "author": "GA Yanik", "year": "2002", "unstructured": "Yanik, G. A. et al. Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma. J. Clin. Oncol. 20, 2142\u20132149 (2002).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1014_CR178", "doi-asserted-by": "publisher", "first-page": "2623", "DOI": "10.1002/cncr.10537", "volume": "94", "author": "MM Fitzek", "year": "2002", "unstructured": "Fitzek, M. M. et al. Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 94, 2623\u20132634 (2002).", "journal-title": "Cancer"}, {"key": "BFnrc1014_CR179", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1054/bjoc.2001.1960", "volume": "85", "author": "ME Luttikhuis", "year": "2001", "unstructured": "Luttikhuis, M. E. et al. Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. Br. J. Cancer 85, 531\u2013537 (2001).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1014_CR180", "doi-asserted-by": "publisher", "first-page": "34", "DOI": "10.1001/archotol.1997.01900010038005", "volume": "123", "author": "N Bhattacharyya", "year": "1997", "unstructured": "Bhattacharyya, N., Thornton, A. F., Joseph, M. P., Goodman, M. L. & Amrein, P. C. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Arch. Otolaryngol. Head Neck Surg. 123, 34\u201340 (1997).", "journal-title": "Arch. Otolaryngol. Head Neck Surg."}, {"key": "BFnrc1014_CR181", "doi-asserted-by": "publisher", "first-page": "428", "DOI": "10.1097/00043426-199709000-00004", "volume": "19", "author": "JG Gurney", "year": "1997", "unstructured": "Gurney, J. G. et al. Infant cancer in the US: histology-specific incidence and trends, 1973 to 1992. J. Pediatr. Hematol. Oncol. 19, 428\u2013432 (1997).", "journal-title": "J. Pediatr. Hematol. Oncol."}, {"key": "BFnrc1014_CR182", "doi-asserted-by": "publisher", "first-page": "1260", "DOI": "10.1200/JCO.2000.18.6.1260", "volume": "18", "author": "ML Schmidt", "year": "2000", "unstructured": "Schmidt, M. L. et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective Children's Cancer Group study. J. Clin. Oncol. 18, 1260\u20131268 (2000).", "journal-title": "J. Clin. Oncol."}], "container-title": ["Nature Reviews Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/nrc1014.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrc1014", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrc1014.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T15:18:07Z", "timestamp": 1555600687000}, "score": 61.411507, "issued": {"date-parts": [[2003, 3]]}, "references-count": 182, "journal-issue": {"published-print": {"date-parts": [[2003, 3]]}, "issue": "3"}, "alternative-id": ["BFnrc1014"], "URL": "http://dx.doi.org/10.1038/nrc1014", "relation": {"cites": []}, "ISSN": ["1474-175X", "1474-1768"], "issn-type": [{"value": "1474-175X", "type": "print"}, {"value": "1474-1768", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T14:41:50Z", "timestamp": 1574347310349}, "reference-count": 60, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 9131, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Brain Pathology"], "published-print": {"date-parts": [[1990, 9]]}, "DOI": "10.1111/j.1750-3639.1990.tb00638.x", "type": "journal-article", "created": {"date-parts": [[2008, 1, 29]], "date-time": "2008-01-29T05:23:20Z", "timestamp": 1201584200000}, "page": "47-54", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Neuroblastoma -Clinical Applications of Molecular Parameters"], "prefix": "10.1111", "volume": "1", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "b1_259", "DOI": "10.1016/0165-4608(89)90243-4", "doi-asserted-by": "publisher"}, {"key": "b2_260", "DOI": "10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7", "doi-asserted-by": "publisher"}, {"key": "b3_261", "DOI": "10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1", "doi-asserted-by": "publisher"}, {"key": "b4_262", "author": "Biedler JL", "volume": "12", "first-page": "81", "year": "1980", "journal-title": "Progr Cancer Res Trier"}, {"key": "b5_263", "author": "Brodeur GM", "volume": "41", "first-page": "4678", "year": "1981", "journal-title": "Cancer Res"}, {"key": "b6_264", "author": "Gilbert F.", "volume": "44", "first-page": "5444", "year": "1984", "journal-title": "Cancer Res"}, {"key": "b7_265", "author": "Brodeur GM", "volume": "271", "first-page": "3", "year": "1988", "journal-title": "Progr Clin Biol Res"}, {"key": "b8_266", "DOI": "10.1007/BF00389243", "doi-asserted-by": "publisher"}, {"key": "b9_267", "DOI": "10.1016/0165-4608(87)90047-1", "doi-asserted-by": "publisher"}, {"key": "b10_268", "author": "Kaneko Y.", "volume": "47", "first-page": "311", "year": "1987", "journal-title": "Cancer Res"}, {"key": "b11_269", "author": "Christiansen H.", "volume": "57", "first-page": "121", "year": "1988", "journal-title": "Br J Cancer", "DOI": "10.1038/bjc.1988.24", "doi-asserted-by": "crossref"}, {"key": "b12_270", "DOI": "10.1016/S0022-3476(88)80125-2", "doi-asserted-by": "publisher"}, {"key": "b13_271", "DOI": "10.1016/S0140-6736(65)90131-5", "doi-asserted-by": "publisher"}, {"key": "b14_272", "DOI": "10.1126/science.942798", "doi-asserted-by": "publisher"}, {"key": "b15_273", "author": "Biedler JL", "volume": "57", "first-page": "683", "year": "1976", "journal-title": "J Natl Cancer Inst", "DOI": "10.1093/jnci/57.3.683", "doi-asserted-by": "crossref"}, {"key": "b16_274", "author": "Balaban-Malenbaum G.", "volume": "12", "first-page": "97", "year": "1980", "journal-title": "Progr Cancer Res Ther"}, {"key": "b17_275", "author": "Look AT", "volume": "311", "first-page": "231", "year": "1984", "journal-title": "New Engl J Med", "DOI": "10.1056/NEJM198407263110405", "doi-asserted-by": "crossref"}, {"key": "b18_276", "DOI": "10.1002/1097-0142(19861201)58:11<2453::AID-CNCR2820581117>3.0.CO;2-I", "doi-asserted-by": "publisher"}, {"key": "b19_277", "DOI": "10.1002/1097-0142(19880815)62:4<749::AID-CNCR2820620418>3.0.CO;2-W", "doi-asserted-by": "publisher"}, {"key": "b20_278", "DOI": "10.1002/1097-0142(19880815)62:4<772::AID-CNCR2820620422>3.0.CO;2-U", "doi-asserted-by": "publisher"}, {"key": "b21_279", "DOI": "10.1038/305245a0", "doi-asserted-by": "publisher"}, {"key": "b22_280", "DOI": "10.1016/0092-8674(83)90169-1", "doi-asserted-by": "publisher"}, {"key": "b23_281", "DOI": "10.1073/pnas.80.18.5724", "doi-asserted-by": "publisher"}, {"key": "b24_282", "DOI": "10.1038/308288a0", "doi-asserted-by": "publisher"}, {"key": "b25_283", "DOI": "10.1016/0165-4608(86)90377-8", "doi-asserted-by": "publisher"}, {"key": "b26_284", "DOI": "10.1073/pnas.83.4.1031", "doi-asserted-by": "publisher"}, {"key": "b27_285", "author": "Shiloh Y.", "volume": "46", "first-page": "5297", "year": "1986", "journal-title": "Cancer Res"}, {"key": "b28_286", "author": "Zehnbauer BA", "volume": "8", "first-page": "522", "year": "1988", "journal-title": "Molec Cell Biol", "DOI": "10.1128/MCB.8.2.522", "doi-asserted-by": "crossref"}, {"key": "b29_287", "author": "Amler LC", "volume": "9", "first-page": "4903", "year": "1989", "journal-title": "Molec Cell Biol", "DOI": "10.1128/MCB.9.11.4903", "doi-asserted-by": "crossref"}, {"key": "b30_288", "DOI": "10.1126/science.6719137", "doi-asserted-by": "publisher"}, {"key": "b31_289", "author": "Seeger RC", "volume": "313", "first-page": "1111", "year": "1985", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM198510313131802", "doi-asserted-by": "crossref"}, {"key": "b32_290", "DOI": "10.1002/1097-0142(19860715)58:2+<541::AID-CNCR2820581322>3.0.CO;2-2", "doi-asserted-by": "publisher"}, {"key": "b33_291", "DOI": "10.1002/1097-0142(19870815)60:4<820::AID-CNCR2820600418>3.0.CO;2-Y", "doi-asserted-by": "publisher"}, {"key": "b34_292", "DOI": "10.1016/S0022-3468(87)80260-9", "doi-asserted-by": "publisher"}, {"key": "b35_293", "DOI": "10.1007/BF02343225", "doi-asserted-by": "publisher"}, {"key": "b36_294", "author": "Brodeur GM", "volume": "47", "first-page": "4248", "year": "1987", "journal-title": "Cancer Res"}, {"key": "b37_295", "author": "Grady-Leopardi EF", "volume": "46", "first-page": "3196", "year": "1986", "journal-title": "Cancer Res"}, {"key": "b38_296", "author": "Seeger RC", "volume": "271", "first-page": "41", "year": "1988", "journal-title": "Progr Clin Biol Res"}, {"key": "b39_297", "DOI": "10.1093/jnci/80.20.1633", "doi-asserted-by": "publisher"}, {"key": "b40_298", "author": "Slave I.", "volume": "50", "first-page": "1459", "year": "1990", "journal-title": "Cancer Res"}, {"key": "b41_299", "DOI": "10.1126/science.6505694", "doi-asserted-by": "publisher"}, {"key": "b42_300", "author": "Thiele CJ", "volume": "80", "first-page": "804", "year": "1987", "journal-title": "J Clin Invest", "DOI": "10.1172/JCI113137", "doi-asserted-by": "crossref"}, {"key": "b43_301", "DOI": "10.1038/316160a0", "doi-asserted-by": "publisher"}, {"key": "b44_302", "DOI": "10.1073/pnas.82.16.5455", "doi-asserted-by": "publisher"}, {"key": "b45_303", "author": "Small MB", "volume": "7", "first-page": "1638", "year": "1987", "journal-title": "Molec Cell Biol", "DOI": "10.1128/MCB.7.5.1638", "doi-asserted-by": "crossref"}, {"key": "b46_304", "DOI": "10.1073/pnas.80.2.383", "doi-asserted-by": "publisher"}, {"key": "b47_305", "DOI": "10.1016/0092-8674(83)90390-2", "doi-asserted-by": "publisher"}, {"key": "b48_306", "DOI": "10.1007/BF00442704", "doi-asserted-by": "publisher"}, {"key": "b49_307", "author": "Ireland CM", "volume": "49", "first-page": "5530", "year": "1989", "journal-title": "Cancer Res"}, {"key": "b50_308", "author": "Tanaka T.", "volume": "48", "first-page": "1030", "year": "1988", "journal-title": "Cancer Res"}, {"key": "b51_309", "author": "Douglass EC", "volume": "75", "first-page": "51", "year": "1985", "journal-title": "J Natl Cancer Inst"}, {"key": "b52_310", "DOI": "10.1016/0165-4608(86)90206-2", "doi-asserted-by": "publisher"}, {"key": "b53_311", "DOI": "10.1073/pnas.86.10.3753", "doi-asserted-by": "publisher"}, {"key": "b54_312", "DOI": "10.1002/gcc.2870010209", "doi-asserted-by": "publisher"}, {"key": "b55_313", "DOI": "10.1038/328524a0", "doi-asserted-by": "publisher"}, {"key": "b56_314", "DOI": "10.1073/pnas.86.12.4614", "doi-asserted-by": "publisher"}, {"key": "b57_315", "DOI": "10.1093/jnci/81.5.367", "doi-asserted-by": "publisher"}, {"key": "b58_316", "DOI": "10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z", "doi-asserted-by": "publisher"}, {"key": "b59_317", "author": "Suzuki T.", "volume": "49", "first-page": "1095", "year": "1989", "journal-title": "Cancer Res"}, {"key": "b60_318", "author": "Brodeur GM", "volume": "6", "first-page": "1874", "year": "1988", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.1988.6.12.1874", "doi-asserted-by": "crossref"}], "container-title": ["Brain Pathology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1750-3639.1990.tb00638.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 7]], "date-time": "2019-02-07T15:32:20Z", "timestamp": 1549553540000}, "score": 39.141327, "issued": {"date-parts": [[1990, 9]]}, "references-count": 60, "journal-issue": {"published-print": {"date-parts": [[1990, 9]]}, "issue": "1"}, "alternative-id": ["10.1111/j.1750-3639.1990.tb00638.x"], "URL": "http://dx.doi.org/10.1111/j.1750-3639.1990.tb00638.x", "relation": {"cites": []}, "ISSN": ["1015-6305", "1750-3639"], "issn-type": [{"value": "1015-6305", "type": "print"}, {"value": "1750-3639", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T00:10:20Z", "timestamp": 1574554220587}, "reference-count": 173, "publisher": "Springer Science and Business Media LLC", "issue": "12", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2014, 10, 21]], "date-time": "2014-10-21T00:00:00Z", "timestamp": 1413849600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Nat Rev Clin Oncol"], "published-print": {"date-parts": [[2014, 12]]}, "DOI": "10.1038/nrclinonc.2014.168", "type": "journal-article", "created": {"date-parts": [[2014, 10, 21]], "date-time": "2014-10-21T09:35:46Z", "timestamp": 1413884146000}, "page": "704-713", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 96, "title": ["Mechanisms of neuroblastoma regression"], "prefix": "10.1038", "volume": "11", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}, {"given": "Rochelle", "family": "Bagatell", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2014, 10, 21]]}, "reference": [{"key": "BFnrclinonc2014168_CR1", "author": "GM Brodeur", "first-page": "786", "year": "2010", "unstructured": "Brodeur, G. M. & Maris, J. M. in Principles and Practice of Pediatric Oncology (eds Pizzo, P. A. & Poplack, D. G.) 786\u2013822 (Lippincott, Williams and Wilkins, Philadelphia, 2010).", "volume-title": "Principles and Practice of Pediatric Oncology"}, {"key": "BFnrclinonc2014168_CR2", "doi-asserted-by": "publisher", "first-page": "2106", "DOI": "10.1016/S0140-6736(07)60983-0", "volume": "369", "author": "JM Maris", "year": "2007", "unstructured": "Maris, J. M., Hogarty, M. D., Bagatell, R. & Cohn, S. L. Neuroblastoma. Lancet 369, 2106\u20132120 (2007).", "journal-title": "Lancet"}, {"key": "BFnrclinonc2014168_CR3", "doi-asserted-by": "publisher", "first-page": "2625", "DOI": "10.1200/JCO.2009.27.0421", "volume": "28", "author": "MA Smith", "year": "2010", "unstructured": "Smith, M. A.  et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J. Clin. Oncol. 28, 2625\u20132634 (2010).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR4", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1016/S1470-2045(13)70548-5", "volume": "15", "author": "G Gatta", "year": "2014", "unstructured": "Gatta, G.  et al. Childhood cancer survival in Europe 1999\u20132007: results of EUROCARE-5\u2014a population-based study. Lancet Oncol. 15, 35\u201347 (2014).", "journal-title": "Lancet Oncol."}, {"key": "BFnrclinonc2014168_CR5", "doi-asserted-by": "publisher", "first-page": "999", "DOI": "10.1016/S1470-2045(13)70309-7", "volume": "14", "author": "SG Kreissman", "year": "2013", "unstructured": "Kreissman, S. G.  et al. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial. Lancet Oncol. 14, 999\u20131008 (2013).", "journal-title": "Lancet Oncol."}, {"key": "BFnrclinonc2014168_CR6", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1038/nrc3656", "volume": "14", "author": "SJ Diede", "year": "2014", "unstructured": "Diede, S. J. Spontaneous regression of metastatic cancer: learning from neuroblastoma. Nat. Rev. Cancer 14, 71\u201372 (2014).", "journal-title": "Nat. Rev. Cancer"}, {"key": "BFnrclinonc2014168_CR7", "doi-asserted-by": "publisher", "first-page": "2003", "DOI": "10.1200/JCO.1998.16.6.2003", "volume": "16", "author": "KK Matthay", "year": "1998", "unstructured": "Matthay, K. K. Stage 4S neuroblastoma: what makes it special? J. Clin. Oncol. 16, 2003\u20132006 (1998).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR8", "first-page": "115", "volume": "11", "author": "A Nakagawara", "year": "1998", "unstructured": "Nakagawara, A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum. Cell 11, 115\u2013124 (1998).", "journal-title": "Hum. Cell"}, {"key": "BFnrclinonc2014168_CR9", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1200/JCO.2000.18.3.477", "volume": "18", "author": "HJ Nickerson", "year": "2000", "unstructured": "Nickerson, H. J.  et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J. Clin. Oncol. 18, 477\u2013486 (2000).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR10", "doi-asserted-by": "publisher", "first-page": "869", "DOI": "10.1016/S0140-6736(94)92834-7", "volume": "344", "author": "J Pritchard", "year": "1994", "unstructured": "Pritchard, J. & Hickman, J. A. Why does stage 4s neuroblastoma regress spontaneously? Lancet 344, 869\u2013870 (1994).", "journal-title": "Lancet"}, {"key": "BFnrclinonc2014168_CR11", "doi-asserted-by": "publisher", "first-page": "1209", "DOI": "10.1200/JCO.2002.20.5.1209", "volume": "20", "author": "K Yamamoto", "year": "2002", "unstructured": "Yamamoto, K.  et al. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J. Clin. Oncol. 20, 1209\u20131214 (2002).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR12", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.3109/08880019109033437", "volume": "8", "author": "T Sawada", "year": "1991", "unstructured": "Sawada, T.  et al. Mass screening for neuroblastoma in Japan. Pediatr. Hematol. Oncol. 8, 93\u2013109 (1991).", "journal-title": "Pediatr. Hematol. Oncol."}, {"key": "BFnrclinonc2014168_CR13", "doi-asserted-by": "publisher", "first-page": "1391", "DOI": "10.1016/S0959-8049(98)00135-X", "volume": "34", "author": "R Erttmann", "year": "1998", "unstructured": "Erttmann, R.  et al. 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE). Eur. J. Cancer 34, 1391\u20131397 (1998).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrclinonc2014168_CR14", "doi-asserted-by": "publisher", "first-page": "1682", "DOI": "10.1016/S0140-6736(96)06020-5", "volume": "348", "author": "WG Woods", "year": "1996", "unstructured": "Woods, W. G.  et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 348, 1682\u20131687 (1996).", "journal-title": "Lancet"}, {"key": "BFnrclinonc2014168_CR15", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1038/nrc1014", "volume": "3", "author": "GM Brodeur", "year": "2003", "unstructured": "Brodeur, G. M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3, 203\u2013216 (2003).", "journal-title": "Nat. Rev. Cancer"}, {"key": "BFnrclinonc2014168_CR16", "first-page": "102", "volume": "147", "author": "JC Hoehner", "year": "1995", "unstructured": "Hoehner, J. C., Olsen, L., Sandstedt, B., Kaplan, D. R. & Pahlman, S. Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am. J. Pathol. 147, 102\u2013113 (1995).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrclinonc2014168_CR17", "doi-asserted-by": "publisher", "first-page": "818", "DOI": "10.1002/1097-0142(19880815)62:4<818::AID-CNCR2820620430>3.0.CO;2-K", "volume": "62", "author": "D Haas", "year": "1988", "unstructured": "Haas, D., Ablin, A. R., Miller, C., Zoger, S. & Matthay, K. K. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 62, 818\u2013825 (1988).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR18", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1002/1097-0142(19840715)54:2<357::AID-CNCR2820540230>3.0.CO;2-4", "volume": "54", "author": "JH Garvin Jr", "year": "1984", "unstructured": "Garvin, J. H. Jr, Lack, E. E., Berenberg, W. & Frantz, C. N. Ganglioneuroma presenting with differentiated skeletal metastases. Report of a case. Cancer 54, 357\u2013360 (1984).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR19", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y", "volume": "86", "author": "H Shimada", "year": "1999", "unstructured": "Shimada, H.  et al. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86, 349\u2013363 (1999).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR20", "doi-asserted-by": "publisher", "first-page": "930", "DOI": "10.1038/nature07261", "volume": "455", "author": "YP Mosse", "year": "2008", "unstructured": "Mosse, Y. P.  et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455, 930\u2013935 (2008).", "journal-title": "Nature"}, {"key": "BFnrclinonc2014168_CR21", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1002/pbc.10381", "volume": "42", "author": "T Shojaei-Brosseau", "year": "2004", "unstructured": "Shojaei-Brosseau, T.  et al. Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France. Pediatr. Blood Cancer 42, 99\u2013105 (2004).", "journal-title": "Pediatr. Blood Cancer"}, {"key": "BFnrclinonc2014168_CR22", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1086/424530", "volume": "75", "author": "YP Mosse", "year": "2004", "unstructured": "Mosse, Y. P.  et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am. J. Hum. Genet. 75, 727\u2013730 (2004).", "journal-title": "Am. J. Hum. Genet."}, {"key": "BFnrclinonc2014168_CR23", "first-page": "6651", "volume": "62", "author": "JM Maris", "year": "2002", "unstructured": "Maris, J. M.  et al. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12\u201313 Cancer Res. 62, 6651\u20136658 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR24", "doi-asserted-by": "publisher", "first-page": "971", "DOI": "10.1038/nature07399", "volume": "455", "author": "Y Chen", "year": "2008", "unstructured": "Chen, Y.  et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455, 971\u2013974 (2008).", "journal-title": "Nature"}, {"key": "BFnrclinonc2014168_CR25", "doi-asserted-by": "publisher", "first-page": "975", "DOI": "10.1038/nature07397", "volume": "455", "author": "RE George", "year": "2008", "unstructured": "George, R. E.  et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 455, 975\u2013978 (2008).", "journal-title": "Nature"}, {"key": "BFnrclinonc2014168_CR26", "doi-asserted-by": "publisher", "first-page": "967", "DOI": "10.1038/nature07398", "volume": "455", "author": "I Janoueix-Lerosey", "year": "2008", "unstructured": "Janoueix-Lerosey, I.  et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455, 967\u2013970 (2008).", "journal-title": "Nature"}, {"key": "BFnrclinonc2014168_CR27", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1038/sj.onc.1210659", "volume": "27", "author": "EH Raabe", "year": "2008", "unstructured": "Raabe, E. H.  et al. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene 27, 469\u2013476 (2008).", "journal-title": "Oncogene"}, {"key": "BFnrclinonc2014168_CR28", "doi-asserted-by": "publisher", "first-page": "761", "DOI": "10.1086/383253", "volume": "74", "author": "D Trochet", "year": "2004", "unstructured": "Trochet, D.  et al. Germline mutations of the paired-like homeoBox 2B (PHOX2B) gene in neuroblastoma. Am. J. Hum. Genet. 74, 761\u2013764 (2004).", "journal-title": "Am. J. Hum. Genet."}, {"key": "BFnrclinonc2014168_CR29", "doi-asserted-by": "publisher", "first-page": "2068", "DOI": "10.1158/0008-5472.CAN-11-3703", "volume": "72", "author": "KR Bosse", "year": "2012", "unstructured": "Bosse, K. R.  et al. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Cancer Res. 72, 2068\u20132078 (2012).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR30", "doi-asserted-by": "publisher", "first-page": "718", "DOI": "10.1038/ng.374", "volume": "41", "author": "M Capasso", "year": "2009", "unstructured": "Capasso, M.  et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat. Genet. 41, 718\u2013723 (2009).", "journal-title": "Nat. Genet."}, {"key": "BFnrclinonc2014168_CR31", "doi-asserted-by": "publisher", "first-page": "1126", "DOI": "10.1038/ng.2387", "volume": "44", "author": "SJ Diskin", "year": "2012", "unstructured": "Diskin, S. J.  et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat. Genet. 44, 1126\u20131130 (2012).", "journal-title": "Nat. Genet."}, {"key": "BFnrclinonc2014168_CR32", "doi-asserted-by": "publisher", "first-page": "e1002026", "DOI": "10.1371/journal.pgen.1002026", "volume": "7", "author": "B Nguyen le", "year": "2011", "unstructured": "Nguyen le, B.  et al. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci. PLoS Genet. 7, e1002026 (2011).", "journal-title": "PLoS Genet."}, {"key": "BFnrclinonc2014168_CR33", "doi-asserted-by": "publisher", "first-page": "216", "DOI": "10.1038/nature09609", "volume": "469", "author": "K Wang", "year": "2011", "unstructured": "Wang, K.  et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469, 216\u2013220 (2011).", "journal-title": "Nature"}, {"key": "BFnrclinonc2014168_CR34", "doi-asserted-by": "publisher", "first-page": "2985", "DOI": "10.1093/emboj/16.11.2985", "volume": "16", "author": "WA Weiss", "year": "1997", "unstructured": "Weiss, W. A., Aldape, K., Mohapatra, G., Feuerstein, B. G. & Bishop, J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 16, 2985\u20132995 (1997).", "journal-title": "EMBO J."}, {"key": "BFnrclinonc2014168_CR35", "doi-asserted-by": "publisher", "first-page": "753", "DOI": "10.1593/neo.09466", "volume": "11", "author": "Z Chen", "year": "2009", "unstructured": "Chen, Z.  et al. Mdm2 deficiency suppresses MYCN-driven neuroblastoma tumorigenesis in vivo. Neoplasia 11, 753\u2013762 (2009).", "journal-title": "Neoplasia"}, {"key": "BFnrclinonc2014168_CR36", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1016/j.ccr.2012.06.001", "volume": "22", "author": "T Berry", "year": "2012", "unstructured": "Berry, T.  et al. The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer Cell 22, 117\u2013130 (2012).", "journal-title": "Cancer Cell"}, {"key": "BFnrclinonc2014168_CR37", "doi-asserted-by": "publisher", "first-page": "141ra91", "DOI": "10.1126/scitranslmed.3003967", "volume": "4", "author": "LC Heukamp", "year": "2012", "unstructured": "Heukamp, L. C.  et al. Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. Sci. Transl. Med. 4, 141ra91 (2012).", "journal-title": "Sci. Transl. Med."}, {"key": "BFnrclinonc2014168_CR38", "doi-asserted-by": "publisher", "first-page": "1199", "DOI": "10.1038/ng.2436", "volume": "44", "author": "JJ Molenaar", "year": "2012", "unstructured": "Molenaar, J. J.  et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat. Genet. 44, 1199\u20131206 (2012).", "journal-title": "Nat. Genet."}, {"key": "BFnrclinonc2014168_CR39", "doi-asserted-by": "publisher", "first-page": "936", "DOI": "10.1002/gcc.20477", "volume": "46", "author": "YP Mosse", "year": "2007", "unstructured": "Mosse, Y. P.  et al. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression. Genes Chromosomes Cancer 46, 936\u2013949 (2007).", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BFnrclinonc2014168_CR40", "doi-asserted-by": "publisher", "first-page": "1418", "DOI": "10.1038/bjc.2012.375", "volume": "107", "author": "G Schleiermacher", "year": "2012", "unstructured": "Schleiermacher, G.  et al. Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br. J. Cancer 107, 1418\u20131422 (2012).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrclinonc2014168_CR41", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1038/ng.2529", "volume": "45", "author": "TJ Pugh", "year": "2013", "unstructured": "Pugh, T. J.  et al. The genetic landscape of high-risk neuroblastoma. Nat. Genet. 45, 279\u2013284 (2013).", "journal-title": "Nat. Genet."}, {"key": "BFnrclinonc2014168_CR42", "doi-asserted-by": "publisher", "first-page": "1062", "DOI": "10.1001/jama.2012.228", "volume": "307", "author": "NK Cheung", "year": "2012", "unstructured": "Cheung, N. K.  et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA 307, 1062\u20131071 (2012).", "journal-title": "JAMA"}, {"key": "BFnrclinonc2014168_CR43", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1038/ng.2493", "volume": "45", "author": "M Sausen", "year": "2013", "unstructured": "Sausen, M.  et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 45, 12\u201317 (2013).", "journal-title": "Nat. Genet."}, {"key": "BFnrclinonc2014168_CR44", "doi-asserted-by": "publisher", "first-page": "589", "DOI": "10.1038/nature10910", "volume": "483", "author": "JJ Molenaar", "year": "2012", "unstructured": "Molenaar, J. J.  et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589\u2013593 (2012).", "journal-title": "Nature"}, {"key": "BFnrclinonc2014168_CR45", "doi-asserted-by": "publisher", "first-page": "1571", "DOI": "10.1038/onc.2011.344", "volume": "31", "author": "EE Santo", "year": "2012", "unstructured": "Santo, E. E.  et al. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma. Oncogene 31, 1571\u20131581 (2012).", "journal-title": "Oncogene"}, {"key": "BFnrclinonc2014168_CR46", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1016/j.molonc.2008.07.002", "volume": "2", "author": "J Benard", "year": "2008", "unstructured": "Benard, J.  et al. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S. Mol. Oncol. 2, 261\u2013271 (2008).", "journal-title": "Mol. Oncol."}, {"key": "BFnrclinonc2014168_CR47", "author": "SJ Diskin", "first-page": "POB083", "year": "2014", "unstructured": "Diskin, S. J.  et al. Integrative genomic and epigenomic characterization of stage 4S neuroblastoma gene expression [abstract]. Advances in Neuroblastoma Research, POB083 (Cologne, 2014).", "volume-title": "Advances in Neuroblastoma Research"}, {"key": "BFnrclinonc2014168_CR48", "doi-asserted-by": "publisher", "first-page": "4358", "DOI": "10.1200/JCO.2011.35.9570", "volume": "29", "author": "DR Taggart", "year": "2011", "unstructured": "Taggart, D. R.  et al. Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age. J. Clin. Oncol. 29, 4358\u20134364 (2011).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR49", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.3109/02841869009090048", "volume": "29", "author": "GB Challis", "year": "1990", "unstructured": "Challis, G. B. & Stam, H. J. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol. 29, 545\u2013550 (1990).", "journal-title": "Acta Oncol."}, {"key": "BFnrclinonc2014168_CR50", "doi-asserted-by": "publisher", "first-page": "721", "DOI": "10.1111/j.1749-6632.1964.tb40991.x", "volume": "114", "author": "TC Everson", "year": "1964", "unstructured": "Everson, T. C. Spontaneous regression of cancer. Ann. N.Y. Acad. Sci. 114, 721\u2013735 (1964).", "journal-title": "Ann. N.Y. Acad. Sci."}, {"key": "BFnrclinonc2014168_CR51", "author": "TC Everson", "year": "1966", "unstructured": "Everson, T. C. & Cole, W. H. Spontaneous regression of cancer (W. B. Saunders & Co., Philadelphia, 1966).", "volume-title": "Spontaneous regression of cancer"}, {"key": "BFnrclinonc2014168_CR52", "first-page": "571", "volume": "12", "author": "RJ Papac", "year": "1998", "unstructured": "Papac, R. J. Spontaneous regression of cancer: possible mechanisms. In Vivo 12, 571\u2013578 (1998).", "journal-title": "In Vivo"}, {"key": "BFnrclinonc2014168_CR53", "first-page": "1089", "volume": "43", "author": "JB Beckwith", "year": "1963", "unstructured": "Beckwith, J. B. & Perrin, E. V. In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am. J. Pathol. 43, 1089\u20131104 (1963).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrclinonc2014168_CR54", "doi-asserted-by": "publisher", "first-page": "636", "DOI": "10.1016/0022-3468(81)90019-1", "volume": "16", "author": "Y Ikeda", "year": "1981", "unstructured": "Ikeda, Y., Lister, J., Bouton, J. M. & Buyukpamukcu, M. Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal. J. Pediatr. Surg. 16, 636\u2013644 (1981).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrclinonc2014168_CR55", "first-page": "225", "volume": "76", "author": "SB Turkel", "year": "1974", "unstructured": "Turkel, S. B. & Itabashi, H. H. The natural history of neuroblastic cells in the fetal adrenal gland. Am. J. Pathol. 76, 225\u2013244 (1974).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrclinonc2014168_CR56", "doi-asserted-by": "publisher", "first-page": "1046", "DOI": "10.1016/S0140-6736(71)91606-0", "volume": "1", "author": "GJ D'Angio", "year": "1971", "unstructured": "D'Angio, G. J., Evans, A. E. & Koop, C. E. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1, 1046\u20131049 (1971).", "journal-title": "Lancet"}, {"key": "BFnrclinonc2014168_CR57", "doi-asserted-by": "publisher", "first-page": "374", "DOI": "10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G", "volume": "27", "author": "AE Evans", "year": "1971", "unstructured": "Evans, A. E., D'Angio, G. J. & Randolph, J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer 27, 374\u2013378 (1971).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR58", "doi-asserted-by": "publisher", "first-page": "2891", "DOI": "10.1200/JCO.2006.05.6986", "volume": "24", "author": "RE George", "year": "2006", "unstructured": "George, R. E.  et al. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J. Clin. Oncol. 24, 2891\u20132896 (2006).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR59", "doi-asserted-by": "publisher", "first-page": "1165", "DOI": "10.1056/NEJM199910143411601", "volume": "341", "author": "KK Matthay", "year": "1999", "unstructured": "Matthay, K. K.  et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N. Engl. J. Med. 341, 1165\u20131173 (1999).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR60", "doi-asserted-by": "publisher", "first-page": "1466", "DOI": "10.1200/JCO.1993.11.8.1466", "volume": "11", "author": "GM Brodeur", "year": "1993", "unstructured": "Brodeur, G. M.  et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 11, 1466\u20131477 (1993).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR61", "doi-asserted-by": "publisher", "first-page": "1874", "DOI": "10.1200/JCO.1988.6.12.1874", "volume": "6", "author": "GM Brodeur", "year": "1988", "unstructured": "Brodeur, G. M.  et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol. 6, 1874\u20131881 (1988).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR62", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1200/JCO.2008.16.6876", "volume": "27", "author": "T Monclair", "year": "2009", "unstructured": "Monclair, T.  et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J. Clin. Oncol. 27, 298\u2013303 (2009).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR63", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1007/s00268-012-1837-0", "volume": "37", "author": "DA Cozzi", "year": "2013", "unstructured": "Cozzi, D. A.  et al. Long-term follow-up of the \u201cwait and see\u201d approach to localized perinatal adrenal neuroblastoma. World J. Surg. 37, 459\u2013465 (2013).", "journal-title": "World J. Surg."}, {"key": "BFnrclinonc2014168_CR64", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1016/j.siny.2012.05.002", "volume": "17", "author": "JP Fisher", "year": "2012", "unstructured": "Fisher, J. P. & Tweddle, D. A. Neonatal neuroblastoma. Semin. Fetal Neonatal Med. 17, 207\u2013215 (2012).", "journal-title": "Semin. Fetal Neonatal Med."}, {"key": "BFnrclinonc2014168_CR65", "doi-asserted-by": "publisher", "first-page": "373", "DOI": "10.1200/JCO.1996.14.2.373", "volume": "14", "author": "BH Kushner", "year": "1996", "unstructured": "Kushner, B. H.  et al. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J. Clin. Oncol. 14, 373\u2013381 (1996).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR66", "doi-asserted-by": "publisher", "first-page": "44", "DOI": "10.1186/1471-2407-9-44", "volume": "9", "author": "C Lavarino", "year": "2009", "unstructured": "Lavarino, C.  et al. Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma. BMC Cancer 9, 44 (2009).", "journal-title": "BMC Cancer"}, {"key": "BFnrclinonc2014168_CR67", "doi-asserted-by": "publisher", "first-page": "1948", "DOI": "10.1016/j.jpedsurg.2011.06.024", "volume": "46", "author": "F Yu", "year": "2011", "unstructured": "Yu, F.  et al. Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma. J. Pediatr. Surg. 46, 1948\u20131955 (2011).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrclinonc2014168_CR68", "doi-asserted-by": "publisher", "first-page": "1254", "DOI": "10.1056/NEJM198005293022210", "volume": "302", "author": "AG Knudson Jr", "year": "1980", "unstructured": "Knudson, A. G. Jr & Meadows, A. T. Regression of neuroblastoma IV-S: a genetic hypothesis. N. Engl. J. Med. 302, 1254\u20131256 (1980).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR69", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1016/S1470-2045(12)70012-8", "volume": "13", "author": "MM van Noesel", "year": "2012", "unstructured": "van Noesel, M. M. Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest. Lancet Oncol. 13, 229\u2013230 (2012).", "journal-title": "Lancet Oncol."}, {"key": "BFnrclinonc2014168_CR70", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1016/j.cancergencyto.2005.09.001", "volume": "167", "author": "R Spitz", "year": "2006", "unstructured": "Spitz, R.  et al. Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma. Cancer Genet. Cytogenet. 167, 51\u201356 (2006).", "journal-title": "Cancer Genet. Cytogenet."}, {"key": "BFnrclinonc2014168_CR71", "doi-asserted-by": "publisher", "first-page": "510", "DOI": "10.1016/0959-8049(95)00044-J", "volume": "31A", "author": "PF Ambros", "year": "1995", "unstructured": "Ambros, P. F.  et al. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour? Eur. J. Cancer 31A, 510\u2013515 (1995).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrclinonc2014168_CR72", "doi-asserted-by": "publisher", "first-page": "633", "DOI": "10.1093/jnci/57.3.633", "volume": "57", "author": "EH LaBrosse", "year": "1976", "unstructured": "LaBrosse, E. H., Comoy, E., Bohuon, C., Zucker, J. M. & Schweisguth, O. Catecholamine metabolism in neuroblastoma. J. Natl Cancer Inst. 57, 633\u2013638 (1976).", "journal-title": "J. Natl Cancer Inst."}, {"key": "BFnrclinonc2014168_CR73", "doi-asserted-by": "publisher", "first-page": "404", "DOI": "10.1111/j.1651-2227.1999.tb01130.x", "volume": "88", "author": "F Bessho", "year": "1999", "unstructured": "Bessho, F. Comparison of the incidences of neuroblastoma for screened and unscreened cohorts. Acta Paediatr. 88, 404\u2013406 (1999).", "journal-title": "Acta Paediatr."}, {"key": "BFnrclinonc2014168_CR74", "doi-asserted-by": "publisher", "first-page": "1047", "DOI": "10.1056/NEJMoa012277", "volume": "346", "author": "FH Schilling", "year": "2002", "unstructured": "Schilling, F. H.  et al. Neuroblastoma screening at one year of age. N. Engl. J. Med. 346, 1047\u20131053 (2002).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR75", "doi-asserted-by": "publisher", "first-page": "1041", "DOI": "10.1056/NEJMoa012387", "volume": "346", "author": "WG Woods", "year": "2002", "unstructured": "Woods, W. G.  et al. Screening of infants and mortality due to neuroblastoma. N. Engl. J. Med. 346, 1041\u20131046 (2002).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR76", "doi-asserted-by": "publisher", "first-page": "1209", "DOI": "10.1200/JCO.2002.20.5.1209", "volume": "20", "author": "K Yamamoto", "year": "2002", "unstructured": "Yamamoto, K.  et al. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J. Clin. Oncol. 20, 1209\u20131214 (2002).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR77", "doi-asserted-by": "publisher", "first-page": "394", "DOI": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I", "volume": "31", "author": "GM Brodeur", "year": "1998", "unstructured": "Brodeur, G. M., Ambros, P. F. & Favrot, M. C. Biological aspects of neuroblastoma screening. Med. Ped. Oncol. 31, 394\u2013400 (1998).", "journal-title": "Med. Ped. Oncol."}, {"key": "BFnrclinonc2014168_CR78", "doi-asserted-by": "publisher", "first-page": "342", "DOI": "10.1097/00043426-199211000-00011", "volume": "14", "author": "Y Hayashi", "year": "1992", "unstructured": "Hayashi, Y., Hanada, R. & Yamamoto, K. Biology of neuroblastomas in Japan found by screening. Am. J. Pediatr. Hematol. Oncol. 14, 342\u2013347 (1992).", "journal-title": "Am. J. Pediatr. Hematol. Oncol."}, {"key": "BFnrclinonc2014168_CR79", "doi-asserted-by": "publisher", "first-page": "2005", "DOI": "10.1200/JCO.1990.8.12.2005", "volume": "8", "author": "Y Kaneko", "year": "1990", "unstructured": "Kaneko, Y.  et al. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: A chromosome and N-myc amplification study. J. Clin. Oncol. 8, 2005\u20132013 (1990).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR80", "doi-asserted-by": "publisher", "first-page": "304", "DOI": "10.1002/(SICI)1097-0142(19970715)80:2<304::AID-CNCR19>3.0.CO;2-Y", "volume": "80", "author": "S Acharya", "year": "1997", "unstructured": "Acharya, S.  et al. Prenatally diagnosed neuroblastoma. Cancer 80, 304\u2013310 (1997).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR81", "first-page": "358", "volume": "92", "author": "PT Ho", "year": "1993", "unstructured": "Ho, P. T.  et al. Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children's Hospital. Pediatrics 92, 358\u2013364 (1993).", "journal-title": "Pediatrics"}, {"key": "BFnrclinonc2014168_CR82", "first-page": "356", "volume": "16", "author": "RL Saylors 3rd", "year": "1994", "unstructured": "Saylors, R. L. 3rd, Cohn, S. L., Morgan, E. R. & Brodeur, G. M. Prenatal detection of neuroblastoma by fetal ultrasonography. Am. J. Pediatr. Hematol. Oncol. 16, 356\u2013360 (1994).", "journal-title": "Am. J. Pediatr. Hematol. Oncol."}, {"key": "BFnrclinonc2014168_CR83", "doi-asserted-by": "publisher", "first-page": "1246", "DOI": "10.1016/S0022-3468(98)90160-9", "volume": "33", "author": "H Ikeda", "year": "1998", "unstructured": "Ikeda, H.  et al. Surgical treatment of neuroblastomas in infants under 12 months of age. J. Pediatr. Surg. 33, 1246\u20131250 (1998).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrclinonc2014168_CR84", "doi-asserted-by": "publisher", "first-page": "1504", "DOI": "10.1200/JCO.2007.12.3349", "volume": "26", "author": "B Hero", "year": "2008", "unstructured": "Hero, B.  et al. Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J. Clin. Oncol. 26, 1504\u20131510 (2008).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR85", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1016/j.jpedsurg.2004.10.062", "volume": "40", "author": "T Oue", "year": "2005", "unstructured": "Oue, T.  et al. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study. J. Pediatr. Surg. 40, 359\u2013363 (2005).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrclinonc2014168_CR86", "doi-asserted-by": "publisher", "first-page": "3012", "DOI": "10.1200/JCO.2000.18.16.3012", "volume": "18", "author": "H Nishihira", "year": "2000", "unstructured": "Nishihira, H.  et al. Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J. Clin. Oncol. 18, 3012\u20133017 (2000).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR87", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1097/SLA.0b013e31826cbbbd", "volume": "256", "author": "JG Nuchtern", "year": "2012", "unstructured": "Nuchtern, J. G.  et al. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study. Ann. Surg. 256, 573\u2013580 (2012).", "journal-title": "Ann. Surg."}, {"key": "BFnrclinonc2014168_CR88", "doi-asserted-by": "publisher", "first-page": "3244", "DOI": "10.1158/1078-0432.CCR-08-1815", "volume": "15", "author": "GM Brodeur", "year": "2009", "unstructured": "Brodeur, G. M.  et al. Trk receptor expression and inhibition in neuroblastomas. Clin. Cancer Res. 15, 3244\u20133250 (2009).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrclinonc2014168_CR89", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1023/A:1005729329526", "volume": "31", "author": "GM Brodeur", "year": "1997", "unstructured": "Brodeur, G. M.  et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J. Neurooncol. 31, 49\u201355 (1997).", "journal-title": "J. Neurooncol."}, {"key": "BFnrclinonc2014168_CR90", "doi-asserted-by": "publisher", "first-page": "5962", "DOI": "10.1158/1078-0432.CCR-08-0651", "volume": "15", "author": "CJ Thiele", "year": "2009", "unstructured": "Thiele, C. J., Li, Z. & McKee, A. E. On Trk\u2014the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin. Cancer Res. 15, 5962\u20135967 (2009).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrclinonc2014168_CR91", "first-page": "2044", "volume": "53", "author": "P Kogner", "year": "1993", "unstructured": "Kogner, P.  et al. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 53, 2044\u20132050 (1993).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR92", "first-page": "1364", "volume": "52", "author": "A Nakagawara", "year": "1992", "unstructured": "Nakagawara, A., Arima, M., Azar, C. G., Scavarda, N. J. & Brodeur, G. M. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res. 52, 1364\u20131368 (1992).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR93", "doi-asserted-by": "publisher", "first-page": "847", "DOI": "10.1056/NEJM199303253281205", "volume": "328", "author": "A Nakagawara", "year": "1993", "unstructured": "Nakagawara, A.  et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 328, 847\u2013854 (1993).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR94", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1093/jnci/85.5.377", "volume": "85", "author": "D Stram", "year": "1993", "unstructured": "Stram, D. & Seeger, R. C. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J. Natl Cancer Inst. 85, 377\u2013384 (1993).", "journal-title": "J. Natl Cancer Inst."}, {"key": "BFnrclinonc2014168_CR95", "doi-asserted-by": "publisher", "first-page": "759", "DOI": "10.1128/MCB.14.1.759", "volume": "14", "author": "A Nakagawara", "year": "1994", "unstructured": "Nakagawara, A., Azar, C. G., Scavarda, N. J. & Brodeur, G. M. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol. Cell Biol. 14, 759\u2013767 (1994).", "journal-title": "Mol. Cell Biol."}, {"key": "BFnrclinonc2014168_CR96", "doi-asserted-by": "publisher", "first-page": "450", "DOI": "10.1038/374450a0", "volume": "374", "author": "A Acheson", "year": "1995", "unstructured": "Acheson, A.  et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374, 450\u2013453 (1995).", "journal-title": "Nature"}, {"key": "BFnrclinonc2014168_CR97", "first-page": "6756", "volume": "62", "author": "J Jaboin", "year": "2002", "unstructured": "Jaboin, J., Kim, C. J., Kaplan, D. R. & Thiele, C. J. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3\u2032-kinase pathway. Cancer Res. 62, 6756\u20136763 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR98", "first-page": "1798", "volume": "55", "author": "K Matsumoto", "year": "1995", "unstructured": "Matsumoto, K., Wada, R. K., Yamashiro, J. M., Kaplan, D. R. & Thiele, C. J. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res. 55, 1798\u20131806 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR99", "doi-asserted-by": "publisher", "first-page": "4249", "DOI": "10.1158/0008-5472.CAN-05-2789", "volume": "66", "author": "K Nakamura", "year": "2006", "unstructured": "Nakamura, K.  et al. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res. 66, 4249\u20134255 (2006).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR100", "doi-asserted-by": "publisher", "first-page": "1865", "DOI": "10.1038/onc.2010.13", "volume": "29", "author": "D Goldschneider", "year": "2010", "unstructured": "Goldschneider, D. & Mehlen, P. Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29, 1865\u20131882 (2010).", "journal-title": "Oncogene"}, {"key": "BFnrclinonc2014168_CR101", "doi-asserted-by": "publisher", "first-page": "1222", "DOI": "10.1038/sj.cdd.4400614", "volume": "6", "author": "S Rabizadeh", "year": "1999", "unstructured": "Rabizadeh, S., Ye, X., Wang, J. J. & Bredesen, D. E. Neurotrophin dependence mediated by p75NTR: contrast between rescue by BDNF and NGF. Cell Death Differ. 6, 1222\u20131227 (1999).", "journal-title": "Cell Death Differ."}, {"key": "BFnrclinonc2014168_CR102", "doi-asserted-by": "publisher", "first-page": "187", "DOI": "10.1016/0896-6273(94)90469-3", "volume": "13", "author": "PA Hantzopoulos", "year": "1994", "unstructured": "Hantzopoulos, P. A., Suri, C., Glass, D. J., Goldfarb, M. P. & Yancopoulos, G. D. The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron 13, 187\u2013201 (1994).", "journal-title": "Neuron"}, {"key": "BFnrclinonc2014168_CR103", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1016/j.canlet.2011.02.029", "volume": "305", "author": "R Ho", "year": "2011", "unstructured": "Ho, R.  et al. The effect of P75 on Trk receptors in neuroblastomas. Cancer Lett. 305, 76\u201385 (2011).", "journal-title": "Cancer Lett."}, {"key": "BFnrclinonc2014168_CR104", "doi-asserted-by": "publisher", "first-page": "911", "DOI": "10.1083/jcb.140.4.911", "volume": "140", "author": "SX Bamji", "year": "1998", "unstructured": "Bamji, S. X.  et al. The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140, 911\u2013923 (1998).", "journal-title": "J. Cell Biol."}, {"key": "BFnrclinonc2014168_CR105", "doi-asserted-by": "publisher", "first-page": "2050", "DOI": "10.1016/S0959-8049(97)00280-3", "volume": "33", "author": "A Nakagawara", "year": "1997", "unstructured": "Nakagawara, A. & Brodeur, G. M. Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur. J. Cancer 33, 2050\u20132053 (1997).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrclinonc2014168_CR106", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1016/j.ccr.2004.09.011", "volume": "6", "author": "A Tacconelli", "year": "2004", "unstructured": "Tacconelli, A.  et al. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6, 347\u2013360 (2004).", "journal-title": "Cancer Cell"}, {"key": "BFnrclinonc2014168_CR107", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.2217/14796694.1.5.689", "volume": "1", "author": "A Tacconelli", "year": "2005", "unstructured": "Tacconelli, A., Farina, A. R., Cappabianca, L., Gulino, A. & Mackay, A. R. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma. Future Oncol. 1, 689\u2013698 (2005).", "journal-title": "Future Oncol."}, {"key": "BFnrclinonc2014168_CR108", "doi-asserted-by": "publisher", "first-page": "571", "DOI": "10.1002/neu.480250509", "volume": "25", "author": "N Kahane", "year": "1994", "unstructured": "Kahane, N. & Kalcheim, C. Expression of trkC receptor mRNA during development of the avian nervous system. J. Neurobiol. 25, 571\u2013584 (1994).", "journal-title": "J. Neurobiol."}, {"key": "BFnrclinonc2014168_CR109", "first-page": "1005", "volume": "119", "author": "V Pachnis", "year": "1993", "unstructured": "Pachnis, V., Mankoo, B. & Costantini, F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119, 1005\u20131017 (1993).", "journal-title": "Development"}, {"key": "BFnrclinonc2014168_CR110", "first-page": "191", "volume": "10", "author": "T Tsuzuki", "year": "1995", "unstructured": "Tsuzuki, T.  et al. Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10, 191\u2013198 (1995).", "journal-title": "Oncogene"}, {"key": "BFnrclinonc2014168_CR111", "doi-asserted-by": "publisher", "first-page": "4328", "DOI": "10.4049/jimmunol.0800471", "volume": "182", "author": "R Salcedo", "year": "2009", "unstructured": "Salcedo, R.  et al. Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J. Immunol. 182, 4328\u20134338 (2009).", "journal-title": "J. Immunol."}, {"key": "BFnrclinonc2014168_CR112", "doi-asserted-by": "publisher", "first-page": "7170", "DOI": "10.4049/jimmunol.173.12.7170", "volume": "173", "author": "R Salcedo", "year": "2004", "unstructured": "Salcedo, R.  et al. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J. Immunol. 173, 7170\u20137182 (2004).", "journal-title": "J. Immunol."}, {"key": "BFnrclinonc2014168_CR113", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1097/00043426-200007000-00007", "volume": "22", "author": "NL Antunes", "year": "2000", "unstructured": "Antunes, N. L.  et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J. Pediatr. Hematol. Oncol. 22, 315\u2013320 (2000).", "journal-title": "J. Pediatr. Hematol. Oncol."}, {"key": "BFnrclinonc2014168_CR114", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1016/0304-3835(93)90182-9", "volume": "73", "author": "Y Kataoka", "year": "1993", "unstructured": "Kataoka, Y., Matsumura, T., Yamamoto, S., Sugimoto, T. & Sawada, T. Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma. Cancer Lett. 73, 11\u201321 (1993).", "journal-title": "Cancer Lett."}, {"key": "BFnrclinonc2014168_CR115", "first-page": "362", "volume": "56", "author": "D Valteau", "year": "1996", "unstructured": "Valteau, D.  et al. T-cell receptor repertoire in neuroblastoma patients. Cancer Res. 56, 362\u2013369 (1996).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR116", "doi-asserted-by": "publisher", "first-page": "623", "DOI": "10.1002/mpo.1139", "volume": "36", "author": "R Cooper", "year": "2001", "unstructured": "Cooper, R.  et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med. Pediatr. Oncol. 36, 623\u2013629 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrclinonc2014168_CR117", "doi-asserted-by": "publisher", "first-page": "1526", "DOI": "10.1212/WNL.62.9.1526", "volume": "62", "author": "MR Pranzatelli", "year": "2004", "unstructured": "Pranzatelli, M. R.  et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62, 1526\u20131532 (2004).", "journal-title": "Neurology"}, {"key": "BFnrclinonc2014168_CR118", "doi-asserted-by": "publisher", "first-page": "612", "DOI": "10.1002/mpo.1138", "volume": "36", "author": "E Rudnick", "year": "2001", "unstructured": "Rudnick, E.  et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study. Med. Pediatr. Oncol. 36, 612\u2013622 (2001).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrclinonc2014168_CR119", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.1002/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E", "volume": "28", "author": "C Russo", "year": "1997", "unstructured": "Russo, C., Cohn, S. L., Petruzzi, M. J. & de Alarcon, P. A. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med. Pediatr. Oncol. 28, 284\u2013288 (1997).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrclinonc2014168_CR120", "doi-asserted-by": "publisher", "first-page": "4634", "DOI": "10.1038/sj.onc.1208594", "volume": "24", "author": "L Raffaghello", "year": "2005", "unstructured": "Raffaghello, L.  et al. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene 24, 4634\u20134644 (2005).", "journal-title": "Oncogene"}, {"key": "BFnrclinonc2014168_CR121", "doi-asserted-by": "publisher", "first-page": "381", "DOI": "10.1016/0022-3468(90)90375-J", "volume": "25", "author": "R Squire", "year": "1990", "unstructured": "Squire, R., Fowler, C. L., Brooks, S. P., Rich, G. A. & Cooney, D. R. The relationship of class I MHC antigen expression to stage IV-S disease and survival in neuroblastoma. J. Pediatr. Surg. 25, 381\u2013386 (1990).", "journal-title": "J. Pediatr. Surg."}, {"key": "BFnrclinonc2014168_CR122", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1159/000064028", "volume": "23", "author": "Q Bin", "year": "2002", "unstructured": "Bin, Q., Johnson, B. D., Schauer, D. W., Casper, J. T. & Orentas, R. J. Production of macrophage migration inhibitory factor by human and murine neuroblastoma. Tumour Biol. 23, 123\u2013129 (2002).", "journal-title": "Tumour Biol."}, {"key": "BFnrclinonc2014168_CR123", "doi-asserted-by": "publisher", "first-page": "9180", "DOI": "10.1158/0008-5472.CAN-04-2682", "volume": "64", "author": "R Castriconi", "year": "2004", "unstructured": "Castriconi, R.  et al. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction. Cancer Res. 64, 9180\u20139184 (2004).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR124", "doi-asserted-by": "publisher", "first-page": "558", "DOI": "10.1593/neo.04316", "volume": "6", "author": "L Raffaghello", "year": "2004", "unstructured": "Raffaghello, L.  et al. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia 6, 558\u2013568 (2004).", "journal-title": "Neoplasia"}, {"key": "BFnrclinonc2014168_CR125", "doi-asserted-by": "publisher", "first-page": "3501", "DOI": "10.1038/sj.onc.1209395", "volume": "25", "author": "Y Ren", "year": "2006", "unstructured": "Ren, Y.  et al. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma. Oncogene 25, 3501\u20133508 (2006).", "journal-title": "Oncogene"}, {"key": "BFnrclinonc2014168_CR126", "doi-asserted-by": "publisher", "first-page": "3525", "DOI": "10.1200/JCO.2011.40.9169", "volume": "30", "author": "S Asgharzadeh", "year": "2012", "unstructured": "Asgharzadeh, S.  et al. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J. Clin. Oncol. 30, 3525\u20133532 (2012).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR127", "doi-asserted-by": "publisher", "first-page": "2011", "DOI": "10.1126/science.7605428", "volume": "266", "author": "NW Kim", "year": "1994", "unstructured": "Kim, N. W.  et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011\u20132015 (1994).", "journal-title": "Science"}, {"key": "BFnrclinonc2014168_CR128", "doi-asserted-by": "publisher", "first-page": "249", "DOI": "10.1038/nm0395-249", "volume": "1", "author": "E Hiyama", "year": "1995", "unstructured": "Hiyama, E.  et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat. Med. 1, 249\u2013255 (1995).", "journal-title": "Nat. Med."}, {"key": "BFnrclinonc2014168_CR129", "doi-asserted-by": "publisher", "first-page": "2384", "DOI": "10.1158/1535-7163.MCT-12-0281", "volume": "11", "author": "M Samy", "year": "2012", "unstructured": "Samy, M.  et al. Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant. Mol. Cancer Ther. 11, 2384\u20132393 (2012).", "journal-title": "Mol. Cancer Ther."}, {"key": "BFnrclinonc2014168_CR130", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1038/nm0395-203", "volume": "1", "author": "GM Brodeur", "year": "1995", "unstructured": "Brodeur, G. M. Do the ends justify the means? Nat. Med. 1, 203\u2013205 (1995).", "journal-title": "Nat. Med."}, {"key": "BFnrclinonc2014168_CR131", "doi-asserted-by": "publisher", "first-page": "1019", "DOI": "10.1016/S0002-9440(10)63896-5", "volume": "162", "author": "M Krams", "year": "2003", "unstructured": "Krams, M.  et al. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am. J. Pathol. 162, 1019\u20131026 (2003).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrclinonc2014168_CR132", "doi-asserted-by": "publisher", "first-page": "1391", "DOI": "10.1002/cncr.22132", "volume": "107", "author": "A Ohali", "year": "2006", "unstructured": "Ohali, A.  et al. Telomere length is a prognostic factor in neuroblastoma. Cancer 107, 1391\u20131399 (2006).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR133", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1007/s100240010108", "volume": "4", "author": "CJ Streutker", "year": "2001", "unstructured": "Streutker, C. J., Thorner, P., Fabricius, N., Weitzman, S. & Zielenska, M. Telomerase activity as a prognostic factor in neuroblastomas. Pediatr. Dev. Pathol. 4, 62\u201367 (2001).", "journal-title": "Pediatr. Dev. Pathol."}, {"key": "BFnrclinonc2014168_CR134", "doi-asserted-by": "publisher", "first-page": "7573", "DOI": "10.1038/sj.onc.1204968", "volume": "20", "author": "D Astuti", "year": "2001", "unstructured": "Astuti, D.  et al. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 20, 7573\u20137577 (2001).", "journal-title": "Oncogene"}, {"key": "BFnrclinonc2014168_CR135", "doi-asserted-by": "publisher", "first-page": "541", "DOI": "10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T", "volume": "35", "author": "J Takita", "year": "2000", "unstructured": "Takita, J.  et al. Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med. Pediatr. Oncol. 35, 541\u2013543 (2000).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrclinonc2014168_CR136", "doi-asserted-by": "publisher", "first-page": "765", "DOI": "10.1158/0008-5472.CAN-13-1315", "volume": "74", "author": "E Barbieri", "year": "2014", "unstructured": "Barbieri, E.  et al. Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma. Cancer Res. 74, 765\u2013774 (2014).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR137", "doi-asserted-by": "publisher", "first-page": "1415", "DOI": "10.1007/s00432-010-0796-9", "volume": "136", "author": "E Grau", "year": "2010", "unstructured": "Grau, E.  et al. Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients. J. Cancer Res. Clin. Oncol. 136, 1415\u20131421 (2010).", "journal-title": "J. Cancer Res. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR138", "doi-asserted-by": "publisher", "first-page": "3191", "DOI": "10.1158/1078-0432.CCR-06-2846", "volume": "13", "author": "Q Yang", "year": "2007", "unstructured": "Yang, Q.  et al. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin. Cancer Res. 13, 3191\u20133197 (2007).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrclinonc2014168_CR139", "doi-asserted-by": "publisher", "first-page": "962", "DOI": "10.4161/epi.6.8.16516", "volume": "6", "author": "A Decock", "year": "2011", "unstructured": "Decock, A., Ongenaert, M., Vandesompele, J. & Speleman, F. Neuroblastoma epigenetics: from candidate gene approaches to genome-wide screenings. Epigenetics 6, 962\u2013970 (2011).", "journal-title": "Epigenetics"}, {"key": "BFnrclinonc2014168_CR140", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1016/j.neuroscience.2013.07.030", "volume": "264", "author": "NV Batora", "year": "2014", "unstructured": "Batora, N. V.  et al. Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics. Neuroscience 264, 171\u2013185 (2014).", "journal-title": "Neuroscience"}, {"key": "BFnrclinonc2014168_CR141", "doi-asserted-by": "publisher", "first-page": "427", "DOI": "10.1016/j.semcancer.2004.06.005", "volume": "14", "author": "AP Feinberg", "year": "2004", "unstructured": "Feinberg, A. P. The epigenetics of cancer etiology. Semin. Cancer Biol. 14, 427\u2013432 (2004).", "journal-title": "Semin. Cancer Biol."}, {"key": "BFnrclinonc2014168_CR142", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1038/nrc1279", "volume": "4", "author": "AP Feinberg", "year": "2004", "unstructured": "Feinberg, A. P. & Tycko, B. The history of cancer epigenetics. Nat. Rev. Cancer 4, 143\u2013153 (2004).", "journal-title": "Nat. Rev. Cancer"}, {"issue": "Suppl. 1", "key": "BFnrclinonc2014168_CR143", "doi-asserted-by": "publisher", "first-page": "S4", "DOI": "10.1038/ncponc0354", "volume": "2", "author": "SB Baylin", "year": "2005", "unstructured": "Baylin, S. B. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol. 2 (Suppl. 1), S4\u2013S11 (2005).", "journal-title": "Nat. Clin. Pract. Oncol."}, {"key": "BFnrclinonc2014168_CR144", "doi-asserted-by": "publisher", "first-page": "2280", "DOI": "10.1016/j.biochi.2012.07.025", "volume": "94", "author": "C Gros", "year": "2012", "unstructured": "Gros, C.  et al. DNA methylation inhibitors in cancer: recent and future approaches. Biochimie 94, 2280\u20132296 (2012).", "journal-title": "Biochimie"}, {"key": "BFnrclinonc2014168_CR145", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.2217/epi.14.23", "volume": "6", "author": "MT McCabe", "year": "2014", "unstructured": "McCabe, M. T. & Creasy, C. L. EZH2 as a potential target in cancer therapy. Epigenomics 6, 341\u2013351 (2014).", "journal-title": "Epigenomics"}, {"key": "BFnrclinonc2014168_CR146", "doi-asserted-by": "publisher", "first-page": "181", "DOI": "10.1002/1096-911X(20010101)36:1<181::AID-MPO1043>3.0.CO;2-Q", "volume": "36", "author": "AE Evans", "year": "2001", "unstructured": "Evans, A. E.  et al. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB. Med. Ped. Oncol. 36, 181\u2013184 (2001).", "journal-title": "Med. Ped. Oncol."}, {"key": "BFnrclinonc2014168_CR147", "first-page": "3594", "volume": "5", "author": "AE Evans", "year": "1999", "unstructured": "Evans, A. E.  et al. Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts. Clin. Cancer Res. 5, 3594\u20133602 (1999).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrclinonc2014168_CR148", "first-page": "6462", "volume": "62", "author": "R Ho", "year": "2002", "unstructured": "Ho, R.  et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res. 62, 6462\u20136466 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrclinonc2014168_CR149", "doi-asserted-by": "publisher", "first-page": "1478", "DOI": "10.1158/1078-0432.CCR-09-1531", "volume": "16", "author": "R Iyer", "year": "2010", "unstructured": "Iyer, R.  et al. Lestaurtinib enhances the antitumor efficacy of chemotherapy in murine xenograft models of neuroblastoma. Clin. Cancer Res. 16, 1478\u20131485 (2010).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrclinonc2014168_CR150", "doi-asserted-by": "publisher", "first-page": "1057", "DOI": "10.1007/s00280-011-1581-4", "volume": "68", "author": "JE Minturn", "year": "2011", "unstructured": "Minturn, J. E.  et al. Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study. Cancer Chemother. Pharmacol. 68, 1057\u20131065 (2011).", "journal-title": "Cancer Chemother. Pharmacol."}, {"issue": "Suppl.", "key": "BFnrclinonc2014168_CR151", "doi-asserted-by": "publisher", "first-page": "a2502", "DOI": "10.1200/jco.2014.32.15_suppl.2502", "volume": "32", "author": "FG De Braud", "year": "2014", "unstructured": "De Braud, F. G.  et al. Phase 1 open label, dose escalation study of RXDX101, an oral pan-trk, ROS1, and ALK inhibitor, in patients with advanced solid tumors with relevant molecular alterations [abstract]. J. Clin. Oncol. 32 (Suppl.), a2502 (2014).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR152", "unstructured": "US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."}, {"key": "BFnrclinonc2014168_CR153", "unstructured": "US National Library of Medicine.ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."}, {"key": "BFnrclinonc2014168_CR154", "unstructured": "US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2014)."}, {"key": "BFnrclinonc2014168_CR155", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1002/(SICI)1096-911X(199612)27:6<521::AID-MPO3>3.0.CO;2-N", "volume": "27", "author": "LL Hsu", "year": "1996", "unstructured": "Hsu, L. L., Evans, A. E. & D'Angio, G. J. Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate. Med. Pediatr. Oncol. 27, 521\u2013528 (1996).", "journal-title": "Med. Pediatr. Oncol."}, {"key": "BFnrclinonc2014168_CR156", "doi-asserted-by": "publisher", "first-page": "278", "DOI": "10.1002/pbc.20564", "volume": "46", "author": "BH Kushner", "year": "2006", "unstructured": "Kushner, B. H., Kramer, K., LaQuaglia, M. P., Modak, S. & Cheung, N. K. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients. Pediatr. Blood Cancer 46, 278\u2013284 (2006).", "journal-title": "Pediatr. Blood Cancer"}, {"key": "BFnrclinonc2014168_CR157", "doi-asserted-by": "publisher", "first-page": "1324", "DOI": "10.1056/NEJMoa0911123", "volume": "363", "author": "AL Yu", "year": "2010", "unstructured": "Yu, A. L.  et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N. Engl. J. Med. 363, 1324\u20131334 (2010).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR158", "doi-asserted-by": "publisher", "first-page": "6050", "DOI": "10.1182/blood-2011-05-354449", "volume": "118", "author": "CU Louis", "year": "2011", "unstructured": "Louis, C. U.  et al. Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood 118, 6050\u20136056 (2011).", "journal-title": "Blood"}, {"key": "BFnrclinonc2014168_CR159", "doi-asserted-by": "publisher", "first-page": "1313", "DOI": "10.1056/NEJMoa1001527", "volume": "363", "author": "DL Baker", "year": "2010", "unstructured": "Baker, D. L.  et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N. Engl. J. Med. 363, 1313\u20131323 (2010).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR160", "doi-asserted-by": "publisher", "first-page": "715", "DOI": "10.1097/00043426-200309000-00008", "volume": "25", "author": "Y Yuza", "year": "2003", "unstructured": "Yuza, Y., Agawa, M., Matsuzaki, M., Yamada, H. & Urashima, M. Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid. J. Pediatr. Hematol. Oncol. 25, 715\u2013720 (2003).", "journal-title": "J. Pediatr. Hematol. Oncol."}, {"key": "BFnrclinonc2014168_CR161", "doi-asserted-by": "publisher", "first-page": "364", "DOI": "10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7", "volume": "86", "author": "H Shimada", "year": "1999", "unstructured": "Shimada, H.  et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86, 364\u2013372 (1999).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR162", "doi-asserted-by": "publisher", "first-page": "3623", "DOI": "10.1200/JCO.2009.25.9119", "volume": "28", "author": "M Fouladi", "year": "2010", "unstructured": "Fouladi, M.  et al. Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report. J. Clin. Oncol. 28, 3623\u20133629 (2010).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrclinonc2014168_CR163", "author": "JR Park", "first-page": "OR070", "year": "2014", "unstructured": "Park, J. R.  et al. A phase I study of vorinostat in combination with isotretinoin (RA) in patients with refractory/recurrent neuroblastoma (NB): a new approaches to neuroblastoma therapy consortium trial [abstract]. Advances in Neuroblastoma Research, OR070 (Cologne, 2014).", "volume-title": "Advances in Neuroblastoma Research"}, {"key": "BFnrclinonc2014168_CR164", "doi-asserted-by": "publisher", "first-page": "1069", "DOI": "10.1101/gr.157586.113", "volume": "23", "author": "M Simoes-Costa", "year": "2013", "unstructured": "Simoes-Costa, M. & Bronner, M. E. Insights into neural crest development and evolution from genomic analysis. Genome Res. 23, 1069\u20131080 (2013).", "journal-title": "Genome Res."}, {"key": "BFnrclinonc2014168_CR165", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1146/annurev.cellbio.042308.113245", "volume": "26", "author": "P Betancur", "year": "2010", "unstructured": "Betancur, P., Bronner-Fraser, M. & Sauka-Spengler, T. Assembling neural crest regulatory circuits into a gene regulatory network. Annu. Rev. Cell. Dev. Biol. 26, 581\u2013603 (2010).", "journal-title": "Annu. Rev. Cell. Dev. Biol."}, {"key": "BFnrclinonc2014168_CR166", "doi-asserted-by": "publisher", "first-page": "R84", "DOI": "10.1186/gb-2006-7-9-r84", "volume": "7", "author": "K De Preter", "year": "2006", "unstructured": "De Preter, K.  et al. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol. 7, R84 (2006).", "journal-title": "Genome Biol."}, {"key": "BFnrclinonc2014168_CR167", "doi-asserted-by": "publisher", "first-page": "4775", "DOI": "10.1242/dev.01370", "volume": "131", "author": "K Tsarovina", "year": "2004", "unstructured": "Tsarovina, K.  et al. Essential role of GATA transcription factors in sympathetic neuron development. Development 131, 4775\u20134786 (2004).", "journal-title": "Development"}, {"key": "BFnrclinonc2014168_CR168", "doi-asserted-by": "publisher", "first-page": "324", "DOI": "10.1016/j.mod.2012.11.004", "volume": "130", "author": "K Unsicker", "year": "2013", "unstructured": "Unsicker, K., Huber, K., Schober, A. & Kalcheim, C. Resolved and open issues in chromaffin cell development. Mech. Dev. 130, 324\u2013329 (2013).", "journal-title": "Mech. Dev."}, {"key": "BFnrclinonc2014168_CR169", "doi-asserted-by": "publisher", "first-page": "e1003533", "DOI": "10.1371/journal.pgen.1003533", "volume": "9", "author": "D Pei", "year": "2013", "unstructured": "Pei, D.  et al. Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models. PLoS Genet. 9, e1003533 (2013).", "journal-title": "PLoS Genet."}, {"key": "BFnrclinonc2014168_CR170", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1093/jnci/73.2.405", "volume": "73", "author": "H Shimada", "year": "1984", "unstructured": "Shimada, H.  et al. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J. Natl Cancer Inst. 73, 405\u2013413 (1984).", "journal-title": "J. Natl Cancer Inst."}, {"key": "BFnrclinonc2014168_CR171", "doi-asserted-by": "publisher", "first-page": "2451", "DOI": "10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S", "volume": "92", "author": "H Shimada", "year": "2001", "unstructured": "Shimada, H.  et al. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92, 2451\u20132461 (2001).", "journal-title": "Cancer"}, {"key": "BFnrclinonc2014168_CR172", "doi-asserted-by": "publisher", "first-page": "1505", "DOI": "10.1056/NEJM199606063342304", "volume": "334", "author": "IM Ambros", "year": "1996", "unstructured": "Ambros, I. M.  et al. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N. Engl. J. Med. 334, 1505\u20131511 (1996).", "journal-title": "N. Engl. J. Med."}, {"key": "BFnrclinonc2014168_CR173", "doi-asserted-by": "publisher", "first-page": "1537", "DOI": "10.1056/NEJM199606063342311", "volume": "334", "author": "GM Brodeur", "year": "1996", "unstructured": "Brodeur, G. M. Schwann cells as antineuroblastoma agents. N. Engl. J. Med. 334, 1537\u20131539 (1996).", "journal-title": "N. Engl. J. Med."}], "container-title": ["Nature Reviews Clinical Oncology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/nrclinonc.2014.168", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrclinonc.2014.168.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrclinonc.2014.168.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 2]], "date-time": "2019-10-02T01:14:08Z", "timestamp": 1569978848000}, "score": 37.213013, "issued": {"date-parts": [[2014, 10, 21]]}, "references-count": 173, "journal-issue": {"published-print": {"date-parts": [[2014, 12]]}, "issue": "12"}, "alternative-id": ["BFnrclinonc2014168"], "URL": "http://dx.doi.org/10.1038/nrclinonc.2014.168", "relation": {"cites": []}, "ISSN": ["1759-4774", "1759-4782"], "issn-type": [{"value": "1759-4774", "type": "print"}, {"value": "1759-4782", "type": "electronic"}], "assertion": [{"value": "21 October 2014", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no competing financial interests.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T00:43:20Z", "timestamp": 1576802600993}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Pediatric Hematology/Oncology"], "published-print": {"date-parts": [[1992, 5]]}, "DOI": "10.1097/00043426-199205000-00004", "type": "journal-article", "created": {"date-parts": [[2006, 10, 31]], "date-time": "2006-10-31T10:46:29Z", "timestamp": 1162291589000}, "page": "111-116", "source": "Crossref", "is-referenced-by-count": 104, "title": ["Molecular Basis of Clinical Heterogeneity in Neuroblastoma"], "prefix": "10.1097", "volume": "14", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}, {"given": "Akira", "family": "Nakagawara", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Journal of Pediatric Hematology/Oncology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T11:33:52Z", "timestamp": 1518176032000}, "score": 35.351788, "subtitle": [""], "issued": {"date-parts": [[1992, 5]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1097/00043426-199205000-00004", "ISSN": ["1077-4114"], "issn-type": [{"value": "1077-4114", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T16:26:07Z", "timestamp": 1575044767859}, "reference-count": 0, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 5722, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Med. Pediatr. Oncol."], "published-print": {"date-parts": [[2000, 12, 1]]}, "DOI": "10.1002/1096-911x(20001201)35:6<727::aid-mpo54>3.0.co;2-o", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T18:17:21Z", "timestamp": 1030299441000}, "page": "727-728", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Meeting summary for Advances in Neuroblastoma Research-2000"], "prefix": "10.1002", "volume": "35", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2000]]}, "container-title": ["Medical and Pediatric Oncology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1096-911X(20001201)35:6%3C727::AID-MPO54%3E3.0.CO;2-O", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/1096-911X(20001201)35:6%3C727::AID-MPO54%3E3.0.CO;2-O", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 31]], "date-time": "2018-07-31T10:37:59Z", "timestamp": 1533033479000}, "score": 35.209732, "issued": {"date-parts": [[2000]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 12, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/1096-911x(20001201)35:6<727::aid-mpo54>3.0.co;2-o", "ISSN": ["0098-1532", "1096-911X"], "issn-type": [{"value": "0098-1532", "type": "print"}, {"value": "1096-911X", "type": "electronic"}], "subject": ["Pediatrics, Perinatology, and Child Health", "Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T23:35:24Z", "timestamp": 1575156924010}, "reference-count": 33, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 10, 1]], "date-time": "1992-10-01T00:00:00Z", "timestamp": 717897600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Screening"], "published-print": {"date-parts": [[1992, 10]]}, "DOI": "10.1016/0925-6164(92)90044-6", "type": "journal-article", "created": {"date-parts": [[2005, 6, 20]], "date-time": "2005-06-20T13:02:34Z", "timestamp": 1119272554000}, "page": "281-284", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Commentary on review by Sawada on screening for neuroblastoma in Japan"], "prefix": "10.1016", "volume": "1", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Screening"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0925616492900446?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0925616492900446?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 25]], "date-time": "2019-01-25T07:55:55Z", "timestamp": 1548402955000}, "score": 35.209732, "issued": {"date-parts": [[1992, 10]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[1992, 10]]}, "issue": "4"}, "alternative-id": ["0925616492900446"], "URL": "http://dx.doi.org/10.1016/0925-6164(92)90044-6", "ISSN": ["0925-6164"], "issn-type": [{"value": "0925-6164", "type": "print"}], "subject": ["Pediatrics, Perinatology, and Child Health"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T17:13:37Z", "timestamp": 1575220417286}, "reference-count": 119, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 1, 5]], "date-time": "2018-01-05T00:00:00Z", "timestamp": 1515110400000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/100000054", "name": "National Cancer Institute", "doi-asserted-by": "publisher", "award": ["CA094194"]}, {"DOI": "10.13039/100001445", "name": "Alex's Lemonade Stand Foundation for Childhood Cancer", "doi-asserted-by": "publisher", "award": []}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Cell Tissue Res"], "published-print": {"date-parts": [[2018, 5]]}, "DOI": "10.1007/s00441-017-2761-2", "type": "journal-article", "created": {"date-parts": [[2018, 1, 5]], "date-time": "2018-01-05T05:09:15Z", "timestamp": 1515128955000}, "page": "277-286", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Spontaneous regression of neuroblastoma"], "prefix": "10.1007", "volume": "372", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 1, 5]]}, "reference": [{"key": "2761_CR1", "doi-asserted-by": "crossref", "first-page": "304", "DOI": "10.1002/(SICI)1097-0142(19970715)80:2<304::AID-CNCR19>3.0.CO;2-Y", "volume": "80", "author": "S Acharya", "year": "1997", "unstructured": "Acharya S, Jayabose S, Kogan SJ, Tugal O, Beneck D, Leslie D, Slim M (1997) Prenatally diagnosed neuroblastoma. Cancer 80:304\u2013310", "journal-title": "Cancer"}, {"key": "2761_CR2", "doi-asserted-by": "crossref", "first-page": "450", "DOI": "10.1038/374450a0", "volume": "374", "author": "A Acheson", "year": "1995", "unstructured": "Acheson A, Conover JC, Fandi JP, DeChiara TM, Russell M, Thadani A, Squinto SP, Yancopoulos GD, Lindsay RM (1995) A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374:450\u2013453", "journal-title": "Nature"}, {"key": "2761_CR3", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1097/00043426-200007000-00007", "volume": "22", "author": "NL Antunes", "year": "2000", "unstructured": "Antunes NL, Khakoo Y, Matthay KK, Seeger RC, Stram DO, Gerstner E, Abrey LE, Dalmau J (2000) Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 22:315\u2013320", "journal-title": "J Pediatr Hematol Oncol"}, {"key": "2761_CR4", "doi-asserted-by": "crossref", "first-page": "3525", "DOI": "10.1200/JCO.2011.40.9169", "volume": "30", "author": "S Asgharzadeh", "year": "2012", "unstructured": "Asgharzadeh S, Salo JA, Ji L, Oberthuer A, Fischer M, Berthold F, Hadjidaniel M, Liu CW, Metelitsa LS, Pique-Regi R, Wakamatsu P, Villablanca JG, Kreissman SG, Matthay KK, Shimada H, London WB, Sposto R, Seeger RC (2012) Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol 30:3525\u20133532", "journal-title": "J Clin Oncol"}, {"key": "2761_CR5", "doi-asserted-by": "crossref", "first-page": "7573", "DOI": "10.1038/sj.onc.1204968", "volume": "20", "author": "D Astuti", "year": "2001", "unstructured": "Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F (2001) RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 20:7573\u20137577", "journal-title": "Oncogene"}, {"key": "2761_CR6", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1056/NEJMoa1001527", "volume": "363", "author": "DL Baker", "year": "2010", "unstructured": "Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK, Children's Oncology G (2010) Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med 363:1313\u20131323", "journal-title": "N Engl J Med"}, {"key": "2761_CR7", "doi-asserted-by": "crossref", "first-page": "911", "DOI": "10.1083/jcb.140.4.911", "volume": "140", "author": "SX Bamji", "year": "1998", "unstructured": "Bamji SX, Majdan M, Pozniak CD, Belliveau DJ, Aloyz R, Kohn J, Causing CG, Miller FD (1998) The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J Cell Biol 140:911\u2013923", "journal-title": "J Cell Biol"}, {"key": "2761_CR8", "doi-asserted-by": "crossref", "first-page": "765", "DOI": "10.1158/0008-5472.CAN-13-1315", "volume": "74", "author": "E Barbieri", "year": "2014", "unstructured": "Barbieri E, De Preter K, Capasso M, Chen Z, Hsu DM, Tonini GP, Lefever S, Hicks J, Versteeg R, Pession A, Speleman F, Kim ES, Shohet JM (2014) Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma. Cancer Res 74:765\u2013774", "journal-title": "Cancer Res"}, {"issue": "Suppl 1", "key": "2761_CR9", "doi-asserted-by": "crossref", "first-page": "S4", "DOI": "10.1038/ncponc0354", "volume": "2", "author": "SB Baylin", "year": "2005", "unstructured": "Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2(Suppl 1):S4\u201311", "journal-title": "Nat Clin Pract Oncol"}, {"key": "2761_CR10", "first-page": "1089", "volume": "43", "author": "JB Beckwith", "year": "1963", "unstructured": "Beckwith JB, Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol 43:1089\u20131104", "journal-title": "Am J Pathol"}, {"key": "2761_CR11", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/j.molonc.2008.07.002", "volume": "2", "author": "J Benard", "year": "2008", "unstructured": "Benard J, Raguenez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D (2008) MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S. Mol Oncol 2:261\u2013271", "journal-title": "Mol Oncol"}, {"key": "2761_CR12", "doi-asserted-by": "crossref", "first-page": "404", "DOI": "10.1111/j.1651-2227.1999.tb01130.x", "volume": "88", "author": "F Bessho", "year": "1999", "unstructured": "Bessho F (1999) Comparison of the incidences of neuroblastoma for screened and unscreened cohorts. Acta Paediatr 88:404\u2013406", "journal-title": "Acta Paediatr"}, {"key": "2761_CR13", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1038/nrc1014", "volume": "3", "author": "GM Brodeur", "year": "2003", "unstructured": "Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203\u2013216", "journal-title": "Nat Rev Cancer"}, {"key": "2761_CR14", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I", "volume": "31", "author": "GM Brodeur", "year": "1998", "unstructured": "Brodeur GM, Ambros PF, Favrot MC (1998) Biological aspects of neuroblastoma screening. Med Pediatr Oncol 31:394\u2013400", "journal-title": "Med Pediatr Oncol"}, {"key": "2761_CR15", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1038/nrclinonc.2014.168", "volume": "11", "author": "GM Brodeur", "year": "2014", "unstructured": "Brodeur GM, Bagatell R (2014) Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol 11:704\u2013713", "journal-title": "Nat Rev Clin Oncol"}, {"key": "2761_CR16", "doi-asserted-by": "crossref", "first-page": "3244", "DOI": "10.1158/1078-0432.CCR-08-1815", "volume": "15", "author": "GM Brodeur", "year": "2009", "unstructured": "Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, Kolla V, Evans AE (2009) Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res 15:3244\u20133250", "journal-title": "Clin Cancer Res"}, {"key": "2761_CR17", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1023/A:1005729329526", "volume": "31", "author": "GM Brodeur", "year": "1997", "unstructured": "Brodeur GM, Nakagawara A, Yamashiro DJ, Ikegaki N, Liu XG, Azar CG, Lee CP, Evans AE (1997) Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neuro-Oncol 31:49\u201355", "journal-title": "J Neuro-Oncol"}, {"key": "2761_CR18", "doi-asserted-by": "crossref", "first-page": "1466", "DOI": "10.1200/JCO.1993.11.8.1466", "volume": "11", "author": "GM Brodeur", "year": "1993", "unstructured": "Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncolo 11:1466\u20131477", "journal-title": "J Clin Oncolo"}, {"key": "2761_CR19", "doi-asserted-by": "crossref", "first-page": "1874", "DOI": "10.1200/JCO.1988.6.12.1874", "volume": "6", "author": "GM Brodeur", "year": "1988", "unstructured": "Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI et al (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874\u20131881", "journal-title": "J Clin Oncol"}, {"key": "2761_CR20", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.3109/02841869009090048", "volume": "29", "author": "GB Challis", "year": "1990", "unstructured": "Challis GB, Stam HJ (1990) The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 29:545\u2013550", "journal-title": "Acta Oncol"}, {"key": "2761_CR21", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1002/mpo.1139", "volume": "36", "author": "R Cooper", "year": "2001", "unstructured": "Cooper R, Khakoo Y, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Nakagawa A, Shimada H (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's cancer group. Med Pediatr Oncol 36:623\u2013629", "journal-title": "Med Pediatr Oncol"}, {"key": "2761_CR22", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1007/s00268-012-1837-0", "volume": "37", "author": "DA Cozzi", "year": "2013", "unstructured": "Cozzi DA, Mele E, Ceccanti S, Natale F, Clerico A, Schiavetti A, Dominici C (2013) Long-term follow-up of the \"wait and see\" approach to localized perinatal adrenal neuroblastoma. World J Surg 37:459\u2013465", "journal-title": "World J Surg"}, {"key": "2761_CR23", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1007/s00280-014-2627-1", "volume": "75", "author": "JL Croucher", "year": "2015", "unstructured": "Croucher JL, Iyer R, Li N, Molteni V, Loren J, Gordon WP, Tuntland T, Liu B, Brodeur GM (2015) TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts. Cancer Chemother Pharmacol 75:131\u2013141", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "2761_CR24", "doi-asserted-by": "crossref", "first-page": "1046", "DOI": "10.1016/S0140-6736(71)91606-0", "volume": "1", "author": "GJ D'Angio", "year": "1971", "unstructured": "D'Angio GJ, Evans AE, Koop CE (1971) Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1:1046\u20131049", "journal-title": "Lancet"}, {"key": "2761_CR25", "doi-asserted-by": "crossref", "first-page": "962", "DOI": "10.4161/epi.6.8.16516", "volume": "6", "author": "A Decock", "year": "2011", "unstructured": "Decock A, Ongenaert M, Vandesompele J, Speleman F (2011) Neuroblastoma epigenetics: from candidate gene approaches to genome-wide screenings. Epigenetics 6:962\u2013970", "journal-title": "Epigenetics"}, {"key": "2761_CR26", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1038/nrc3656", "volume": "14", "author": "SJ Diede", "year": "2014", "unstructured": "Diede SJ (2014) Spontaneous regression of metastatic cancer: learning from neuroblastoma. Nat Rev Cancer 14:71\u201372", "journal-title": "Nat Rev Cancer"}, {"key": "2761_CR27", "unstructured": "Diskin SJ, McDaniel L, Oldridge DA, Attiyeh E, Asgharzadeh S, Weisenberger DJ, Shen H, Diamond M, Auvil AG, Smith MA, Gerhard DS, Hogarty MD, London WB, Khan J, Seeger RC, Laird PW, Maris JM (2014) Integrative genomic and epigenomic characterization of stage4S neuroblastoma. Advances in neuroblastoma research\u20132014, Cologne, Germany"}, {"key": "2761_CR28", "doi-asserted-by": "crossref", "first-page": "1049", "DOI": "10.1158/2159-8290.CD-15-0443", "volume": "5", "author": "RC Doebele", "year": "2015", "unstructured": "Doebele RC, Davis LE, Vaishnavi A, Le AT, Estrada-Bernal A, Keysar S, Jimeno A, Varella-Garcia M, Aisner DL, Li Y, Stephens PJ, Morosini D, Tuch BB, Fernandes M, Nanda N, Low JA (2015) An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor LOXO-101. Cancer Discov 5:1049\u20131057", "journal-title": "Cancer Discov"}, {"key": "2761_CR29", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1158/2159-8290.CD-16-1237", "volume": "7", "author": "A Drilon", "year": "2017", "unstructured": "Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG (2017) Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor Entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1). Cancer Discov 7:400\u2013409", "journal-title": "Cancer Discov"}, {"key": "2761_CR30", "doi-asserted-by": "crossref", "first-page": "1391", "DOI": "10.1016/S0959-8049(98)00135-X", "volume": "34", "author": "R Erttmann", "year": "1998", "unstructured": "Erttmann R, Tafese T, Berthold F, Kerbl R, Mann J, Parker L, Schilling F, Ambros P, Christiansen H, Favrot M, Kabisch H, Hero B, Philip T (1998) 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the study Group for Evaluation of neuroblastoma screening in Europe (SENSE). Eur J Cancer 34:1391\u20131397", "journal-title": "Eur J Cancer"}, {"key": "2761_CR31", "doi-asserted-by": "crossref", "first-page": "1717", "DOI": "10.1083/jcb.127.6.1717", "volume": "127", "author": "S Estus", "year": "1994", "unstructured": "Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM Jr (1994) Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127:1717\u20131727", "journal-title": "J Cell Biol"}, {"key": "2761_CR32", "first-page": "374", "volume": "27", "author": "AE Evans", "year": "1971", "unstructured": "Evans AE, D'Angio GJ, Randolph J (1971) A proposed staging for children with neuroblastoma. Child Cancer Stud Group A 27:374\u2013378", "journal-title": "Child Cancer Stud Group A"}, {"key": "2761_CR33", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1002/1096-911X(20010101)36:1<181::AID-MPO1043>3.0.CO;2-Q", "volume": "36", "author": "AE Evans", "year": "2001", "unstructured": "Evans AE, Kisselbach KD, Liu X, Eggert A, Ikegaki N, Camoratto AM, Dionne C, Brodeur GM (2001) Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB. Med Pediat Oncol 36:181\u2013184", "journal-title": "Med Pediat Oncol"}, {"key": "2761_CR34", "first-page": "3594", "volume": "5", "author": "AE Evans", "year": "1999", "unstructured": "Evans AE, Kisselbach KD, Yamashiro DJ, Ikegaki N, Camoratto AM, Dionne CA, Brodeur GM (1999) Antitumor activity of CEP-751 (KT-6587) on human neuroblastoma and medulloblastoma xenografts. Clin Cancer Res 5:3594\u20133602", "journal-title": "Clin Cancer Res"}, {"key": "2761_CR35", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1111/j.1749-6632.1964.tb40991.x", "volume": "114", "author": "TC Everson", "year": "1964", "unstructured": "Everson TC (1964) Spontaneous regression of cancer. Ann N Y Acad Sci 114:721\u2013735", "journal-title": "Ann N Y Acad Sci"}, {"key": "2761_CR36", "author": "TC Everson", "year": "1966", "unstructured": "Everson TC, Cole WH (1966) Spontaneous regression of cancer. Saunders, Philadelphia", "volume-title": "Spontaneous regression of cancer"}, {"key": "2761_CR37", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/j.siny.2012.05.002", "volume": "17", "author": "JP Fisher", "year": "2012", "unstructured": "Fisher JP, Tweddle DA (2012) Neonatal neuroblastoma. Sem Fetal Neon Med 17:207\u2013215", "journal-title": "Sem Fetal Neon Med"}, {"key": "2761_CR38", "first-page": "357", "volume": "54", "author": "JH Garvin Jr", "year": "1984", "unstructured": "Garvin JH Jr, Lack EE, Berenberg W, Frantz CN (1984) Ganglioneuroma presenting with differentiated skeletal metastases. Rep Case Cancer 54:357\u2013360", "journal-title": "Rep Case Cancer"}, {"key": "2761_CR39", "doi-asserted-by": "crossref", "first-page": "2891", "DOI": "10.1200/JCO.2006.05.6986", "volume": "24", "author": "RE George", "year": "2006", "unstructured": "George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, Pulsipher M, Grupp SA, Diller L (2006) High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 24:2891\u20132896", "journal-title": "J Clin Oncol"}, {"key": "2761_CR40", "doi-asserted-by": "crossref", "first-page": "6466", "DOI": "10.1200/JCO.2005.05.582", "volume": "23", "author": "RE George", "year": "2005", "unstructured": "George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT (2005) Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a pediatric oncology group study. J Clin Oncol 23:6466\u20136473", "journal-title": "J Clin Oncol"}, {"key": "2761_CR41", "doi-asserted-by": "crossref", "first-page": "1865", "DOI": "10.1038/onc.2010.13", "volume": "29", "author": "D Goldschneider", "year": "2010", "unstructured": "Goldschneider D, Mehlen P (2010) Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29:1865\u20131882", "journal-title": "Oncogene"}, {"key": "2761_CR42", "doi-asserted-by": "crossref", "first-page": "1415", "DOI": "10.1007/s00432-010-0796-9", "volume": "136", "author": "E Grau", "year": "2010", "unstructured": "Grau E, Martinez F, Orellana C, Canete A, Yanez Y, Oltra S, Noguera R, Hernandez M, Bermudez JD, Castel V (2010) Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients. J Cancer Res Clin Oncol 136:1415\u20131421", "journal-title": "J Cancer Res Clin Oncol"}, {"key": "2761_CR43", "doi-asserted-by": "crossref", "first-page": "2280", "DOI": "10.1016/j.biochi.2012.07.025", "volume": "94", "author": "C Gros", "year": "2012", "unstructured": "Gros C, Fahy J, Halby L, Dufau I, Erdmann A, Gregoire JM, Ausseil F, Vispe S, Arimondo PB (2012) DNA methylation inhibitors in cancer: recent and future approaches. Biochimie 94:2280\u20132296", "journal-title": "Biochimie"}, {"key": "2761_CR44", "doi-asserted-by": "crossref", "first-page": "818", "DOI": "10.1002/1097-0142(19880815)62:4<818::AID-CNCR2820620430>3.0.CO;2-K", "volume": "62", "author": "D Haas", "year": "1988", "unstructured": "Haas D, Ablin AR, Miller C, Zoger S, Matthay KK (1988) Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 62:818\u2013825", "journal-title": "Cancer"}, {"key": "2761_CR45", "doi-asserted-by": "crossref", "first-page": "927", "DOI": "10.1016/0896-6273(95)90331-3", "volume": "14", "author": "J Ham", "year": "1995", "unstructured": "Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL (1995) A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927\u2013939", "journal-title": "Neuron"}, {"key": "2761_CR46", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1016/0896-6273(94)90469-3", "volume": "13", "author": "PA Hantzopoulos", "year": "1994", "unstructured": "Hantzopoulos PA, Suri C, Glass DJ, Goldfarb MP, Yancopoulos GD (1994) The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron 13:187\u2013201", "journal-title": "Neuron"}, {"key": "2761_CR47", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1097/00043426-199211000-00011", "volume": "14", "author": "Y Hayashi", "year": "1992", "unstructured": "Hayashi Y, Hanada R, Yamamoto K (1992) Biology of neuroblastomas in Japan found by screening. Am J Pediatr Hematol Oncol 14:342\u2013347", "journal-title": "Am J Pediatr Hematol Oncol"}, {"key": "2761_CR48", "doi-asserted-by": "crossref", "first-page": "1504", "DOI": "10.1200/JCO.2007.12.3349", "volume": "26", "author": "B Hero", "year": "2008", "unstructured": "Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG, Schwabe D, Schilling FH, Benz-Bohm G, Berthold F (2008) Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol 26:1504\u20131510", "journal-title": "J Clin Oncol"}, {"key": "2761_CR49", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1038/nm0395-249", "volume": "1", "author": "E Hiyama", "year": "1995", "unstructured": "Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW (1995) Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1:249\u2013255", "journal-title": "Nat Med"}, {"key": "2761_CR50", "first-page": "358", "volume": "92", "author": "PT Ho", "year": "1993", "unstructured": "Ho PT, Estroff JA, Kozakewich H, Shamberger RC, Lillehei CW, Grier HE, Diller L (1993) Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children's hospital. Pediatrics 92:358\u2013364", "journal-title": "Pediatrics"}, {"key": "2761_CR51", "first-page": "6462", "volume": "62", "author": "R Ho", "year": "2002", "unstructured": "Ho R, Eggert A, Hishiki T, Minturn JE, Ikegaki N, Foster P, Camoratto AM, Evans AE, Brodeur GM (2002) Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 62:6462\u20136466", "journal-title": "Cancer Res"}, {"key": "2761_CR52", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1016/j.canlet.2011.02.029", "volume": "305", "author": "R Ho", "year": "2011", "unstructured": "Ho R, Minturn JE, Simpson AM, Iyer R, Light JE, Evans AE, Brodeur GM (2011) The effect of P75 on Trk receptors in neuroblastomas. Cancer Lett 305:76\u201385", "journal-title": "Cancer Lett"}, {"key": "2761_CR53", "first-page": "102", "volume": "147", "author": "JC Hoehner", "year": "1995", "unstructured": "Hoehner JC, Olsen L, Sandstedt B, Kaplan DR, Pahlman S (1995) Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am J Pathol 147:102\u2013113", "journal-title": "Am J Pathol"}, {"key": "2761_CR54", "doi-asserted-by": "crossref", "first-page": "636", "DOI": "10.1016/0022-3468(81)90019-1", "volume": "16", "author": "Y Ikeda", "year": "1981", "unstructured": "Ikeda Y, Lister J, Bouton JM, Buyukpamukcu M (1981) Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal. J Pediatr Surg 16:636\u2013644", "journal-title": "J Pediatr Surg"}, {"key": "2761_CR55", "doi-asserted-by": "crossref", "first-page": "1478", "DOI": "10.1158/1078-0432.CCR-09-1531", "volume": "16", "author": "R Iyer", "year": "2010", "unstructured": "Iyer R, Evans AE, Qi X, Ho R, Minturn JE, Zhao H, Balamuth N, Maris JM, Brodeur GM (2010) Lestaurtinib enhances the antitumor efficacy of chemotherapy in murine xenograft models of neuroblastoma. Clin Cancer Res 16:1478\u20131485", "journal-title": "Clin Cancer Res"}, {"key": "2761_CR56", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1007/s00280-012-1879-x", "volume": "70", "author": "R Iyer", "year": "2012", "unstructured": "Iyer R, Varela CR, Minturn JE, Ho R, Simpson AM, Light JE, Evans AE, Zhao H, Thress K, Brown JL, Brodeur GM (2012) AZ64 inhibits TrkB and enhances the efficacy of chemotherapy and local radiation in neuroblastoma xenografts. Cancer Chemother Pharmacol 70:477\u2013486", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "2761_CR57", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/j.canlet.2016.01.018", "volume": "372", "author": "R Iyer", "year": "2016", "unstructured": "Iyer R, Wehrmann L, Golden RL, Naraparaju K, Croucher JL, MacFarland SP, Guan P, Kolla V, Wei G, Cam N, Li G, Hornby Z, Brodeur GM (2016) Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model. Cancer Lett 372:179\u2013186", "journal-title": "Cancer Lett"}, {"key": "2761_CR58", "first-page": "6756", "volume": "62", "author": "J Jaboin", "year": "2002", "unstructured": "Jaboin J, Kim CJ, Kaplan DR, Thiele CJ (2002) Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3\u2032-kinase pathway. Cancer Res 62:6756\u20136763", "journal-title": "Cancer Res"}, {"key": "2761_CR59", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1002/neu.480250509", "volume": "25", "author": "N Kahane", "year": "1994", "unstructured": "Kahane N, Kalcheim C (1994) Expression of trkC receptor mRNA during development of the avian nervous system. J Neurobiol 25:571\u2013584", "journal-title": "J Neurobiol"}, {"key": "2761_CR60", "doi-asserted-by": "crossref", "first-page": "2005", "DOI": "10.1200/JCO.1990.8.12.2005", "volume": "8", "author": "Y Kaneko", "year": "1990", "unstructured": "Kaneko Y, Kanda N, Maseki N, Nakachi K, Takeda T, Okabe I, Sakurai M (1990) Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J Clin Oncol 8:2005\u20132013", "journal-title": "J Clin Oncol"}, {"key": "2761_CR61", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/0304-3835(93)90182-9", "volume": "73", "author": "Y Kataoka", "year": "1993", "unstructured": "Kataoka Y, Matsumura T, Yamamoto S, Sugimoto T, Sawada T (1993) Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma. Cancer Lett 73:11\u201321", "journal-title": "Cancer Lett"}, {"key": "2761_CR62", "doi-asserted-by": "crossref", "first-page": "2011", "DOI": "10.1126/science.7605428", "volume": "266", "author": "NW Kim", "year": "1994", "unstructured": "Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011\u20132015", "journal-title": "Science"}, {"key": "2761_CR63", "first-page": "2044", "volume": "53", "author": "P Kogner", "year": "1993", "unstructured": "Kogner P, Barbany G, Dominici C, Castello MA, Raschella G, Persson H (1993) Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res 53:2044\u20132050", "journal-title": "Cancer Res"}, {"key": "2761_CR64", "doi-asserted-by": "crossref", "first-page": "1019", "DOI": "10.1016/S0002-9440(10)63896-5", "volume": "162", "author": "M Krams", "year": "2003", "unstructured": "Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P (2003) Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol 162:1019\u20131026", "journal-title": "Am J Pathol"}, {"key": "2761_CR65", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1200/JCO.1996.14.2.373", "volume": "14", "author": "BH Kushner", "year": "1996", "unstructured": "Kushner BH, Cheung NK, LaQuaglia MP, Ambros PF, Ambros IM, Bonilla MA, Gerald WL, Ladanyi M, Gilbert F, Rosenfield NS, Yeh SD (1996) Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373\u2013381", "journal-title": "J Clin Oncol"}, {"key": "2761_CR66", "doi-asserted-by": "crossref", "first-page": "44", "DOI": "10.1186/1471-2407-9-44", "volume": "9", "author": "C Lavarino", "year": "2009", "unstructured": "Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, Alaminos M, Rios J, Gerald WL, Kushner B, LaQuaglia M, Mora J (2009) Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma. BMC Cancer 9:44", "journal-title": "BMC Cancer"}, {"key": "2761_CR67", "doi-asserted-by": "crossref", "first-page": "6459", "DOI": "10.1200/JCO.2005.05.571", "volume": "23", "author": "WB London", "year": "2005", "unstructured": "London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's oncology group. J Clin Oncol 23:6459\u20136465", "journal-title": "J Clin Oncol"}, {"key": "2761_CR68", "doi-asserted-by": "crossref", "first-page": "6050", "DOI": "10.1182/blood-2011-05-354449", "volume": "118", "author": "CU Louis", "year": "2011", "unstructured": "Louis CU, Savoldo B, Dotti G, Pule M, Yvon E, Myers GD, Rossig C, Russell HV, Diouf O, Liu E, Liu H, Wu MF, Gee AP, Mei Z, Rooney CM, Heslop HE, Brenner MK (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood 118:6050\u20136056", "journal-title": "Blood"}, {"key": "2761_CR69", "first-page": "1798", "volume": "55", "author": "K Matsumoto", "year": "1995", "unstructured": "Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55:1798\u20131806", "journal-title": "Cancer Res"}, {"key": "2761_CR70", "doi-asserted-by": "crossref", "first-page": "2003", "DOI": "10.1200/JCO.1998.16.6.2003", "volume": "16", "author": "KK Matthay", "year": "1998", "unstructured": "Matthay KK (1998) Stage 4S neuroblastoma: what makes it special? J Clin Oncol 16:2003\u20132006", "journal-title": "J Clin Oncol"}, {"key": "2761_CR71", "doi-asserted-by": "crossref", "first-page": "1165", "DOI": "10.1056/NEJM199910143411601", "volume": "341", "author": "KK Matthay", "year": "1999", "unstructured": "Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Child Cancer Group New Eng J Med 341:1165\u20131173", "journal-title": "Child Cancer Group New Eng J Med"}, {"key": "2761_CR72", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.2217/epi.14.23", "volume": "6", "author": "MT McCabe", "year": "2014", "unstructured": "McCabe MT, Creasy CL (2014) EZH2 as a potential target in cancer therapy. Epigenomics 6:341\u2013351", "journal-title": "Epigenomics"}, {"key": "2761_CR73", "doi-asserted-by": "crossref", "first-page": "1057", "DOI": "10.1007/s00280-011-1581-4", "volume": "68", "author": "JE Minturn", "year": "2011", "unstructured": "Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, Groshen S, Hellriegel ET, Bensen-Kennedy D, Matthay KK, Brodeur GM, Maris JM (2011) Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study. Cancer Chemother Pharmacol 68:1057\u20131065", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "2761_CR74", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1200/JCO.2008.16.6876", "volume": "27", "author": "T Monclair", "year": "2009", "unstructured": "Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD, Force IT (2009) The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol 27:298\u2013303", "journal-title": "J Clin Oncol"}, {"key": "2761_CR75", "doi-asserted-by": "crossref", "first-page": "1468", "DOI": "10.1002/pbc.26026", "volume": "63", "author": "R Nagasubramanian", "year": "2016", "unstructured": "Nagasubramanian R, Wei J, Gordon P, Rastatter JC, Cox MC, Pappo A (2016) Infantile Fibrosarcoma with NTRK3-ETV6 fusion successfully treated with the tropomyosin-related kinase inhibitor LOXO-101. Pediatr Blood Cancer 63:1468\u20131470", "journal-title": "Pediatr Blood Cancer"}, {"key": "2761_CR76", "first-page": "115", "volume": "11", "author": "A Nakagawara", "year": "1998", "unstructured": "Nakagawara A (1998) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11:115\u2013124", "journal-title": "Hum Cell"}, {"key": "2761_CR77", "first-page": "1364", "volume": "52", "author": "A Nakagawara", "year": "1992", "unstructured": "Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM (1992) Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res 52:1364\u20131368", "journal-title": "Cancer Res"}, {"key": "2761_CR78", "doi-asserted-by": "crossref", "first-page": "847", "DOI": "10.1056/NEJM199303253281205", "volume": "328", "author": "A Nakagawara", "year": "1993", "unstructured": "Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328:847\u2013854", "journal-title": "N Engl J Med"}, {"key": "2761_CR79", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1128/MCB.14.1.759", "volume": "14", "author": "A Nakagawara", "year": "1994", "unstructured": "Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14:759\u2013767", "journal-title": "Mol Cell Biol"}, {"key": "2761_CR80", "doi-asserted-by": "crossref", "first-page": "2050", "DOI": "10.1016/S0959-8049(97)00280-3", "volume": "33", "author": "A Nakagawara", "year": "1997", "unstructured": "Nakagawara A, Brodeur GM (1997) Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur J Cancer 33:2050\u20132053", "journal-title": "Eur J Cancer"}, {"key": "2761_CR81", "doi-asserted-by": "crossref", "first-page": "4249", "DOI": "10.1158/0008-5472.CAN-05-2789", "volume": "66", "author": "K Nakamura", "year": "2006", "unstructured": "Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ (2006) Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res 66:4249\u20134255", "journal-title": "Cancer Res"}, {"key": "2761_CR82", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1200/JCO.2000.18.3.477", "volume": "18", "author": "HJ Nickerson", "year": "2000", "unstructured": "Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens J (2000) Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's cancer group study. J Clin Oncol 18:477\u2013486", "journal-title": "J Clin Oncol"}, {"key": "2761_CR83", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1038/nature09336", "volume": "467", "author": "V Nikoletopoulou", "year": "2010", "unstructured": "Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, Zhang L, Bibel M, Barde YA (2010) Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 467:59\u201363", "journal-title": "Nature"}, {"key": "2761_CR84", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1097/SLA.0b013e31826cbbbd", "volume": "256", "author": "JG Nuchtern", "year": "2012", "unstructured": "Nuchtern JG, London WB, Barnewolt CE, Naranjo A, McGrady PW, Geiger JD, Diller L, Schmidt ML, Maris JM, Cohn SL, Shamberger RC (2012) A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's oncology group study. Ann Surg 256:573\u2013580", "journal-title": "Ann Surg"}, {"key": "2761_CR85", "doi-asserted-by": "crossref", "first-page": "1391", "DOI": "10.1002/cncr.22132", "volume": "107", "author": "A Ohali", "year": "2006", "unstructured": "Ohali A, Avigad S, Ash S, Goshen Y, Luria D, Feinmesser M, Zaizov R, Yaniv I (2006) Telomere length is a prognostic factor in neuroblastoma. Cancer 107:1391\u20131399", "journal-title": "Cancer"}, {"key": "2761_CR86", "first-page": "1005", "volume": "119", "author": "V Pachnis", "year": "1993", "unstructured": "Pachnis V, Mankoo B, Costantini F (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119:1005\u20131017", "journal-title": "Development"}, {"key": "2761_CR87", "first-page": "571", "volume": "12", "author": "RJ Papac", "year": "1998", "unstructured": "Papac RJ (1998) Spontaneous regression of cancer: possible mechanisms. In vivo 12:571\u2013578", "journal-title": "In vivo"}, {"key": "2761_CR88", "doi-asserted-by": "crossref", "first-page": "700", "DOI": "10.1038/nature14980", "volume": "526", "author": "M Peifer", "year": "2015", "unstructured": "Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Kramer A, Roncaioli JL, Sand F, Heuckmann JM, Ikram F, Schmidt R, Ackermann S, Engesser A, Kahlert Y, Vogel W, Altmuller J, Nurnberg P, Thierry-Mieg J, Thierry-Mieg D, Mariappan A, Heynck S, Mariotti E, Henrich KO, Gloeckner C, Bosco G, Leuschner I, Schweiger MR, Savelyeva L, Watkins SC, Shao C, Bell E, Hofer T, Achter V, Lang U, Theissen J, Volland R, Saadati M, Eggert A, de Wilde B, Berthold F, Peng Z, Zhao C, Shi L, Ortmann M, Buttner R, Perner S, Hero B, Schramm A, Schulte JH, Herrmann C, O'Sullivan RJ, Westermann F, Thomas RK, Fischer M (2015) Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 526:700\u2013704", "journal-title": "Nature"}, {"key": "2761_CR89", "doi-asserted-by": "crossref", "first-page": "1526", "DOI": "10.1212/WNL.62.9.1526", "volume": "62", "author": "MR Pranzatelli", "year": "2004", "unstructured": "Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Moticka EJ, Franz DN, Nigro MA, Parke JT, Stumpf DA, Verhulst SJ (2004) B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62:1526\u20131532", "journal-title": "Neurology"}, {"key": "2761_CR90", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1016/S0140-6736(94)92834-7", "volume": "344", "author": "J Pritchard", "year": "1994", "unstructured": "Pritchard J, Hickman JA (1994) Why does stage 4s neuroblastoma regress spontaneously? Lancet 344:869\u2013870", "journal-title": "Lancet"}, {"key": "2761_CR91", "doi-asserted-by": "crossref", "first-page": "1222", "DOI": "10.1038/sj.cdd.4400614", "volume": "6", "author": "S Rabizadeh", "year": "1999", "unstructured": "Rabizadeh S, Ye X, Wang JJ, Bredesen DE (1999) Neurotrophin dependence mediated by p75NTR: contrast between rescue by BDNF and NGF. Cell Death Dif 6:1222\u20131227", "journal-title": "Cell Death Dif"}, {"key": "2761_CR92", "doi-asserted-by": "crossref", "first-page": "4634", "DOI": "10.1038/sj.onc.1208594", "volume": "24", "author": "L Raffaghello", "year": "2005", "unstructured": "Raffaghello L, Prigione I, Bocca P, Morandi F, Camoriano M, Gambini C, Wang X, Ferrone S, Pistoia V (2005) Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications. Oncogene 24:4634\u20134644", "journal-title": "Oncogene"}, {"key": "2761_CR93", "first-page": "813", "volume": "112", "author": "A Rodriguez-Tebar", "year": "1991", "unstructured": "Rodriguez-Tebar A, Rohrer H (1991) Retinoic acid induces NGF-dependent survival response and high-affinity NGF receptors in immature chick sympathetic neurons. Development 112:813\u2013820", "journal-title": "Development"}, {"key": "2761_CR94", "doi-asserted-by": "crossref", "first-page": "612", "DOI": "10.1002/mpo.1138", "volume": "36", "author": "E Rudnick", "year": "2001", "unstructured": "Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's cancer group study. Med Pediatr Oncol 36:612\u2013622", "journal-title": "Med Pediatr Oncol"}, {"key": "2761_CR95", "doi-asserted-by": "crossref", "first-page": "284", "DOI": "10.1002/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E", "volume": "28", "author": "C Russo", "year": "1997", "unstructured": "Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA (1997) Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the pediatric oncology group. Med Pediatr Oncol 28:284\u2013288", "journal-title": "Med Pediatr Oncol"}, {"key": "2761_CR96", "doi-asserted-by": "crossref", "first-page": "2384", "DOI": "10.1158/1535-7163.MCT-12-0281", "volume": "11", "author": "M Samy", "year": "2012", "unstructured": "Samy M, Gattolliat CH, Pendino F, Hillion J, Nguyen E, Bombard S, Douc-Rasy S, Benard J, Segal-Bendirdjian E (2012) Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant. Mol Cancer Ther 11:2384\u20132393", "journal-title": "Mol Cancer Ther"}, {"key": "2761_CR97", "first-page": "2731", "volume": "53", "author": "T Sawada", "year": "1984", "unstructured": "Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T (1984) Neuroblastoma. Mass Screen Detect Prognos Cancer 53:2731\u20132735", "journal-title": "Mass Screen Detect Prognos Cancer"}, {"key": "2761_CR98", "first-page": "356", "volume": "16", "author": "RL Saylors 3rd", "year": "1994", "unstructured": "Saylors RL 3rd, Cohn SL, Morgan ER, Brodeur GM (1994) Prenatal detection of neuroblastoma by fetal ultrasonography. Am J Pediat Hematol/Oncol 16:356\u2013360", "journal-title": "Am J Pediat Hematol/Oncol"}, {"key": "2761_CR99", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1056/NEJMoa012277", "volume": "346", "author": "FH Schilling", "year": "2002", "unstructured": "Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J (2002) Neuroblastoma screening at one year of age. N Engl J Med 346:1047\u20131053", "journal-title": "N Engl J Med"}, {"key": "2761_CR100", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.0.CO;2-Y", "volume": "86", "author": "H Shimada", "year": "1999", "unstructured": "Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999a) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the international neuroblastoma pathology committee. Cancer 86:349\u2013363", "journal-title": "Cancer"}, {"key": "2761_CR101", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7", "volume": "86", "author": "H Shimada", "year": "1999", "unstructured": "Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP (1999b) The international neuroblastoma pathology classification (the Shimada system). Cancer 86:364\u2013372", "journal-title": "Cancer"}, {"key": "2761_CR102", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/0022-3468(90)90375-J", "volume": "25", "author": "R Squire", "year": "1990", "unstructured": "Squire R, Fowler CL, Brooks SP, Rich GA, Cooney DR (1990) The relationship of class I MHC antigen expression to stage IV-S disease and survival in neuroblastoma. J Pediatr Surg 25:381\u2013386", "journal-title": "J Pediatr Surg"}, {"key": "2761_CR103", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1007/s100240010108", "volume": "4", "author": "CJ Streutker", "year": "2001", "unstructured": "Streutker CJ, Thorner P, Fabricius N, Weitzman S, Zielenska M (2001) Telomerase activity as a prognostic factor in neuroblastomas. Pediatr Dev Pathol 4:62\u201367", "journal-title": "Pediatr Dev Pathol"}, {"key": "2761_CR104", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1093/jnci/85.5.377", "volume": "85", "author": "T Suzuki", "year": "1993", "unstructured": "Suzuki T, Bogenmann E, Shimada H, Stram D, Seeger RC (1993) Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 85:377\u2013384", "journal-title": "J Natl Cancer Inst"}, {"key": "2761_CR105", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/j.ccr.2004.09.011", "volume": "6", "author": "A Tacconelli", "year": "2004", "unstructured": "Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, Vetuschi A, Sferra R, Rucci N, Argenti B, Screpanti I, Gulino A, Mackay AR (2004) TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6:347\u2013360", "journal-title": "Cancer Cell"}, {"key": "2761_CR106", "doi-asserted-by": "crossref", "first-page": "689", "DOI": "10.2217/14796694.1.5.689", "volume": "1", "author": "A Tacconelli", "year": "2005", "unstructured": "Tacconelli A, Farina AR, Cappabianca L, Gulino A, Mackay AR (2005) Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma. Future Oncol 1:689\u2013698", "journal-title": "Future Oncol"}, {"key": "2761_CR107", "doi-asserted-by": "crossref", "first-page": "4358", "DOI": "10.1200/JCO.2011.35.9570", "volume": "29", "author": "DR Taggart", "year": "2011", "unstructured": "Taggart DR, London WB, Schmidt ML, DuBois SG, Monclair TF, Nakagawara A, De Bernardi B, Ambros PF, Pearson AD, Cohn SL, Matthay KK (2011) Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of age. J Clin Oncol 29:4358\u20134364", "journal-title": "J Clin Oncol"}, {"key": "2761_CR108", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1002/1096-911X(20001201)35:6<541::AID-MPO9>3.0.CO;2-T", "volume": "35", "author": "J Takita", "year": "2000", "unstructured": "Takita J, Yang HW, Bessho F, Hanada R, Yamamoto K, Kidd V, Teitz T, Wei T, Hayashi Y (2000) Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med Pediatr Oncol 35:541\u2013543", "journal-title": "Med Pediatr Oncol"}, {"key": "2761_CR109", "doi-asserted-by": "crossref", "first-page": "5962", "DOI": "10.1158/1078-0432.CCR-08-0651", "volume": "15", "author": "CJ Thiele", "year": "2009", "unstructured": "Thiele CJ, Li Z, McKee AE (2009) On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 15:5962\u20135967", "journal-title": "Clin Cancer Res"}, {"key": "2761_CR110", "first-page": "191", "volume": "10", "author": "T Tsuzuki", "year": "1995", "unstructured": "Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J (1995) Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10:191\u2013198", "journal-title": "Oncogene"}, {"key": "2761_CR111", "first-page": "225", "volume": "76", "author": "SB Turkel", "year": "1974", "unstructured": "Turkel SB, Itabashi HH (1974) The natural history of neuroblastic cells in the fetal adrenal gland. Am J Pathol 76:225\u2013244", "journal-title": "Am J Pathol"}, {"key": "2761_CR112", "first-page": "362", "volume": "56", "author": "D Valteau", "year": "1996", "unstructured": "Valteau D, Scott V, Carcelain G, Hartmann O, Escudier B, Hercend T, Triebel F (1996) T-cell receptor repertoire in neuroblastoma patients. Cancer Res 56:362\u2013369", "journal-title": "Cancer Res"}, {"key": "2761_CR113", "doi-asserted-by": "crossref", "first-page": "1041", "DOI": "10.1056/NEJMoa012387", "volume": "346", "author": "WG Woods", "year": "2002", "unstructured": "Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B (2002) Screening of infants and mortality due to neuroblastoma. N Engl J Med 346:1041\u20131046", "journal-title": "N Engl J Med"}, {"key": "2761_CR114", "doi-asserted-by": "crossref", "first-page": "1682", "DOI": "10.1016/S0140-6736(96)06020-5", "volume": "348", "author": "WG Woods", "year": "1996", "unstructured": "Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc J-M, Brisson LC, Brossard J, Hill G, Shuster J, Luepker R, Weitzman S, Bunin G, Lemieux B (1996) A population-based study of the usefulness of screening for neuroblastoma. Lancet 348:1682\u20131687", "journal-title": "Lancet"}, {"key": "2761_CR115", "doi-asserted-by": "crossref", "first-page": "1209", "DOI": "10.1200/JCO.2002.20.5.1209", "volume": "20", "author": "K Yamamoto", "year": "2002", "unstructured": "Yamamoto K, Ohta S, Ito E, Hayashi Y, Asami T, Mabuchi O, Higashigawa M, Tanimura M (2002) Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan. J Clin Oncol 20:1209\u20131214", "journal-title": "J Clin Oncol"}, {"key": "2761_CR116", "doi-asserted-by": "crossref", "first-page": "3191", "DOI": "10.1158/1078-0432.CCR-06-2846", "volume": "13", "author": "Q Yang", "year": "2007", "unstructured": "Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB, Cohn SL (2007) Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome. Clin Cancer Res 13:3191\u20133197", "journal-title": "Clin Cancer Res"}, {"key": "2761_CR117", "doi-asserted-by": "crossref", "first-page": "1324", "DOI": "10.1056/NEJMoa0911123", "volume": "363", "author": "AL Yu", "year": "2010", "unstructured": "Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM, Children's Oncology G (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363:1324\u20131334", "journal-title": "N Engl J Med"}, {"key": "2761_CR118", "doi-asserted-by": "crossref", "first-page": "1948", "DOI": "10.1016/j.jpedsurg.2011.06.024", "volume": "46", "author": "F Yu", "year": "2011", "unstructured": "Yu F, Zhu X, Feng C, Wang T, Hong Q, Liu Z, Tang S (2011) Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma. J Pediatr Surg 46:1948\u20131955", "journal-title": "J Pediatr Surg"}, {"key": "2761_CR119", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1097/00043426-200309000-00008", "volume": "25", "author": "Y Yuza", "year": "2003", "unstructured": "Yuza Y, Agawa M, Matsuzaki M, Yamada H, Urashima M (2003) Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid. J Pediatr Hematol Oncol 25:715\u2013720", "journal-title": "J Pediatr Hematol Oncol"}], "container-title": ["Cell and Tissue Research"], "language": "en", "link": [{"URL": "http://link.springer.com/article/10.1007/s00441-017-2761-2/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00441-017-2761-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00441-017-2761-2.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 4, 24]], "date-time": "2018-04-24T06:49:44Z", "timestamp": 1524552584000}, "score": 35.209732, "issued": {"date-parts": [[2018, 1, 5]]}, "references-count": 119, "journal-issue": {"published-print": {"date-parts": [[2018, 5]]}, "issue": "2"}, "alternative-id": ["2761"], "URL": "http://dx.doi.org/10.1007/s00441-017-2761-2", "relation": {"cites": []}, "ISSN": ["0302-766X", "1432-0878"], "issn-type": [{"value": "0302-766X", "type": "print"}, {"value": "1432-0878", "type": "electronic"}], "subject": ["Pathology and Forensic Medicine", "Cell Biology", "Histology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T08:32:01Z", "timestamp": 1574411521043}, "publisher-location": "Abingdon, UK", "reference-count": 0, "publisher": "Taylor & Francis", "isbn-type": [{"value": "9780203450383", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4324/9780203450383_chapter_15", "type": "book-chapter", "created": {"date-parts": [[2010, 2, 16]], "date-time": "2010-02-16T15:56:23Z", "timestamp": 1266335783000}, "page": "335-362", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Genetics of neuroblastoma"], "prefix": "10.4324", "author": [{"given": "John M", "family": "Maris", "sequence": "first", "affiliation": []}, {"given": "Garrett M", "family": "Brodeur", "sequence": "additional", "affiliation": []}], "member": "301", "container-title": ["Molecular Genetics of Cancer"], "deposited": {"date-parts": [[2017, 10, 30]], "date-time": "2017-10-30T18:57:40Z", "timestamp": 1509389860000}, "score": 33.41509, "issued": {"date-parts": [[null]]}, "ISBN": ["9780203450383"], "references-count": 0, "URL": "http://dx.doi.org/10.4324/9780203450383_chapter_15"}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T06:49:32Z", "timestamp": 1575182972586}, "publisher-location": "Berlin/Heidelberg", "reference-count": 24, "publisher": "Springer-Verlag", "isbn-type": [{"value": "354040841X", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/3-540-26616-x_3", "type": "book-chapter", "created": {"date-parts": [[2005, 10, 21]], "date-time": "2005-10-21T03:44:23Z", "timestamp": 1129866263000}, "page": "21-26", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Genetics"], "prefix": "10.1007", "author": [{"given": "John M.", "family": "Maris", "sequence": "first", "affiliation": []}, {"given": "Garrett M.", "family": "Brodeur", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "3_CR1", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1038/ng1130", "volume": "33", "author": "J. Amiel", "year": "2003", "unstructured": "Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, Gener B et al. (2003) Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459\u2013461", "journal-title": "Nat Genet"}, {"key": "3_CR2", "doi-asserted-by": "crossref", "first-page": "666", "DOI": "10.1016/S0022-3476(97)70090-8", "volume": "131", "author": "J. Blatt", "year": "1997", "unstructured": "Blatt J, Olshan AF, Lee PA, Ross JL (1997) Neuroblastoma and related tumors in Turner's syndrome (published erratum appears in J Pediatr 1998, 133:312). J Pediatr 131:666\u2013670", "journal-title": "J Pediatr"}, {"key": "3_CR3", "first-page": "35", "volume": "42", "author": "H.J. Dodge", "year": "1945", "unstructured": "Dodge HJ, Benner MC (1945) Neuroblastoma of the adrenal medulla in siblings. Rocky Mt Med 42:35\u201338", "journal-title": "Rocky Mt Med"}, {"key": "3_CR4", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1002/1096-911X(20001201)35:6<531::AID-MPO6>3.0.CO;2-2", "volume": "35", "author": "S. Furuta", "year": "2000", "unstructured": "Furuta S, Ohira M, Machida T, Hamano S, Nakagawara A (2000) Analysis of loss of heterozygosity at 16p12\u2013p13 (familial neuroblastoma locus) in 470 neuroblastomas including both sporadic and mass screening tumors. Med Pediatr Oncol 35:531\u2013533", "journal-title": "Med Pediatr Oncol"}, {"key": "3_CR5", "first-page": "514", "volume": "24", "author": "A.G. Knudson Jr", "year": "1972", "unstructured": "Knudson AG Jr, Strong LC (1972) Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 24:514\u2013532", "journal-title": "Am J Hum Genet"}, {"key": "3_CR6", "doi-asserted-by": "crossref", "first-page": "1887", "DOI": "10.1002/1097-0142(19860501)57:9<1887::AID-CNCR2820570931>3.0.CO;2-7", "volume": "57", "author": "B.H. Kushner", "year": "1986", "unstructured": "Kushner BH, Gilbert F, Helson L (1986) Familial neuroblastoma. Case reports, literature review, and etiologic considerations. Cancer 57:1887\u20131893", "journal-title": "Cancer"}, {"key": "3_CR7", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1097/00043426-199809000-00017", "volume": "20", "author": "E.G. Lemire", "year": "1998", "unstructured": "Lemire EG, Chodirker BN, Williams GJ, Seargeant LE, Israels SJ, Phillips SM et al (1998) Familial neuroblastoma: report of a kindred with later age at presentation. J Pediatr Hematol Oncol 20:489\u2013493", "journal-title": "J Pediatr Hematol Oncol"}, {"key": "3_CR8", "first-page": "335", "volume-title": "Molecular genetics of cancer", "author": "J.M. Maris", "year": "2001", "unstructured": "Maris JM, Brodeur GM (2001) Genetics of neuroblastoma. In: Cowell JK (ed) Molecular genetics of cancer, 2nd edn. BIOS, Oxford, pp 335\u2013361", "edition": "2nd edn."}, {"key": "3_CR9", "first-page": "3421", "volume": "56", "author": "J.M. Maris", "year": "1996", "unstructured": "Maris JM, Kyemba SM, Rebbeck TR, White PS, Sulman EP, Jensen SJ et al. (1996) Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res 56:3421\u20133425", "journal-title": "Cancer Res"}, {"key": "3_CR10", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1002/(SICI)1096-911X(199701)28:1<1::AID-MPO1>3.0.CO;2-P", "volume": "28", "author": "J.M. Maris", "year": "1997", "unstructured": "Maris JM, Chatten J, Meadows AT, Biegel JA, Brodeur GM (1997) Familial neuroblastoma: a three generation pedigree and a further association with Hirschsprung disease. Med Pediatr Oncol 28:1\u20135", "journal-title": "Med Pediatr Oncol"}, {"key": "3_CR11", "first-page": "6651", "volume": "62", "author": "J.M. Maris", "year": "2002", "unstructured": "Maris JM, Weiss MJ, Mosse Y, Hii G, Guo C, White PS et al. (2002) Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12\u201313. Cancer Res 62:6651\u20136658", "journal-title": "Cancer Res"}, {"key": "3_CR12", "first-page": "293", "volume": "41", "author": "J.M. Maris", "year": "2003", "unstructured": "Maris JM, Mosse Y, Hii G, Dahia P (2003) Familial neuroblastoma: Further evidence for linkage to 16p13 and refinement of the HNB1 locus. Med Pediatr Oncol 41:293", "journal-title": "Med Pediatr Oncol"}, {"key": "3_CR13", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1016/S0165-4608(96)00259-2", "volume": "95", "author": "T. Martinsson", "year": "1997", "unstructured": "Martinsson T, Sjoberg RM, Hedborg F, Kogner P (1997) Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma. Cancer Genet Cytogenet 95:183\u2013189", "journal-title": "Cancer Genet Cytogenet"}, {"key": "3_CR14", "doi-asserted-by": "publisher", "first-page": "769", "DOI": "10.1016/S1470-2045(03)01283-X", "volume": "4", "author": "Y. Mosse", "year": "2003", "unstructured": "Mosse Y, Greshock J, King A, Khazi D, Weber BL, Maris JM (2003) Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma. Lancet Oncol 4:769\u2013771", "journal-title": "Lancet Oncol"}, {"key": "3_CR15", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1002/ajmg.a.10167", "volume": "118A", "author": "P. Origone", "year": "2003", "unstructured": "Origone P, Defferrari R, Mazzocco K, Lo Cunsolo C, Bernardi B de, Tonini GP (2003) Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma. Am J Med Genet 118A:309\u2013313", "journal-title": "Am J Med Genet"}, {"key": "3_CR16", "doi-asserted-by": "publisher", "first-page": "8356", "DOI": "10.1038/sj.onc.1206009", "volume": "21", "author": "P. Perri", "year": "2002", "unstructured": "Perri P, Longo L, Cusano R, McConville CM, Rees SA, Devoto M et al. (2002) Weak linkage at 4p16 to predisposition for human neuroblastoma. Oncogene 21:8356\u20138360", "journal-title": "Oncogene"}, {"key": "3_CR17", "doi-asserted-by": "publisher", "first-page": "3855", "DOI": "10.1242/jcs.00786", "volume": "116", "author": "H. Sariola", "year": "2003", "unstructured": "Sariola H, Saarma M (2003) Novel functions and signalling pathways for GDNF. J Cell Sci 116:3855\u20133862", "journal-title": "J Cell Sci"}, {"key": "3_CR18", "first-page": "448", "volume": "58", "author": "D. Satge", "year": "1998", "unstructured": "Satge D, Sasco AJ, Carlsen NL, Stiller CA, Rubie H, Hero B et al. (1998) A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res 58:448\u2013452", "journal-title": "Cancer Res"}, {"key": "3_CR19", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1016/S0165-4608(03)00203-6", "volume": "147", "author": "D. Satge", "year": "2003", "unstructured": "Satge D, Moore SW, Stiller CA, Niggli FK, Pritchard-Jones K, Bown N et al.(2003) Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature. Cancer Genet Cytogenet 147:89\u201398", "journal-title": "Cancer Genet Cytogenet"}, {"key": "3_CR20", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1002/pbc.10381", "volume": "42", "author": "T. Shojaei-Brosseau", "year": "2004", "unstructured": "Shojaei-Brosseau T, Chompret A, Abel A, de Vathaire F, Raquin MA, Brugieres L et al (2004) Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France. Pediatr Blood Cancer 42:99\u2013105", "journal-title": "Pediatr Blood Cancer"}, {"key": "3_CR21", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1016/S1359-6101(01)00012-0", "volume": "12", "author": "M. Takahashi", "year": "2001", "unstructured": "Takahashi M (2001) The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev 12:361\u201373", "journal-title": "Cytokine Growth Factor Rev"}, {"key": "3_CR22", "first-page": "85", "volume": "7", "author": "G.P. Tonini", "year": "2001", "unstructured": "Tonini GP, McConville C, Cusano R, Rees SA, Dagnino M, Longo L et al. (2001) Exclusion of candidate genes and chromosomal regions in familial neuroblastoma. Int J Mol Med 7:85\u201389", "journal-title": "Int J Mol Med"}, {"key": "3_CR23", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1007/BF02072522", "volume": "152", "author": "A. Verloes", "year": "1993", "unstructured": "Verloes A, Elmer C, Lacombe D, Heinrichs C, Rebuffat E, Demarquez JL et al. (1993) Ondine-Hirschsprung syndrome (Haddad syndrome). Further delineation in two cases and review of the literature. Eur J Pediatr 152:75\u201377", "journal-title": "Eur J Pediatr"}, {"key": "3_CR24", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1002/1096-911X(20010101)36:1<37::AID-MPO1010>3.0.CO;2-L", "volume": "36", "author": "P.S. White", "year": "2001", "unstructured": "White PS, Thompson PM, Seifried BA, Sulman EP, Jensen SJ, Guo C et al. (2001) Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol 36:37\u201341", "journal-title": "Med Pediatr Oncol"}], "container-title": ["Pediatric Oncology", "Neuroblastoma"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/3-540-26616-X_3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 4]], "date-time": "2019-02-04T01:36:23Z", "timestamp": 1549244183000}, "score": 33.41509, "issued": {"date-parts": [[null]]}, "ISBN": ["354040841X"], "references-count": 24, "URL": "http://dx.doi.org/10.1007/3-540-26616-x_3", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T16:54:42Z", "timestamp": 1574873682796}, "edition-number": "2", "reference-count": 1, "publisher": "Garland Science", "isbn-type": [{"value": "9780203450383", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 12, 16]]}, "DOI": "10.4324/9780203450383-15", "type": "book-chapter", "created": {"date-parts": [[2018, 9, 4]], "date-time": "2018-09-04T00:48:22Z", "timestamp": 1536022102000}, "page": "335-361", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Genetics of neuroblastoma"], "prefix": "10.4324", "author": [{"given": "John M.", "family": "Maris", "sequence": "first", "affiliation": []}, {"given": "Garrett M.", "family": "Brodeur", "sequence": "additional", "affiliation": []}], "member": "301", "reference": [{"key": "ref15", "unstructured": "Altura, R.A. , Maris, J.M. , Li, H. , Boyett, J.M. , Brodeur, G.M. and Look, A.T. (1997) Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization. Genes Chrom. Cancer 19: 176\u2013184."}], "container-title": ["Molecular Genetics of Cancer"], "deposited": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T00:07:25Z", "timestamp": 1574640445000}, "score": 32.624058, "issued": {"date-parts": [[2003, 12, 16]]}, "ISBN": ["9780203450383"], "references-count": 1, "URL": "http://dx.doi.org/10.4324/9780203450383-15", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:59:11Z", "timestamp": 1574139551449}, "reference-count": 23, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Pediatric Hematology/Oncology"], "published-print": {"date-parts": [[2002, 11]]}, "DOI": "10.1097/00043426-200211000-00002", "type": "journal-article", "created": {"date-parts": [[2003, 4, 24]], "date-time": "2003-04-24T13:06:55Z", "timestamp": 1051189615000}, "page": "608-609", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Commentary on Kaneko et al.: Intensified Chemotherapy Increases the Survival Rates in Patients With Stage 4 Neuroblastoma With MYCN Amplification"], "prefix": "10.1097", "volume": "24", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Journal of Pediatric Hematology/Oncology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T12:16:36Z", "timestamp": 1518178596000}, "score": 32.295357, "subtitle": [""], "issued": {"date-parts": [[2002, 11]]}, "references-count": 23, "journal-issue": {"issue": "8"}, "URL": "http://dx.doi.org/10.1097/00043426-200211000-00002", "ISSN": ["1077-4114"], "issn-type": [{"value": "1077-4114", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:04:17Z", "timestamp": 1574147057396}, "reference-count": 47, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 6148, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Med. Pediatr. Oncol."], "published-print": {"date-parts": [[1998, 11]]}, "DOI": "10.1002/(sici)1096-911x(199811)31:5<394::aid-mpo2>3.0.co;2-i", "type": "journal-article", "created": {"date-parts": [[2004, 11, 13]], "date-time": "2004-11-13T11:24:53Z", "timestamp": 1100345093000}, "page": "394-400", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Biological aspects of neuroblastoma screening"], "prefix": "10.1002", "volume": "31", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}, {"given": "Peter F.", "family": "Ambros", "sequence": "additional", "affiliation": []}, {"given": "Marie C.", "family": "Favrot", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB1", "author": "Woods", "volume": "348", "first-page": "1682", "year": "1996", "journal-title": "Lancet"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB2", "author": "Nakagawara", "volume": "68", "first-page": "2037", "year": "1991", "journal-title": "Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB3", "author": "Hayashi", "volume": "14", "first-page": "342", "year": "1992", "journal-title": "Am J Pediatr Hematol Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB4", "author": "Look", "volume": "9", "first-page": "581", "year": "1991", "journal-title": "J Clin Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB5", "author": "Kerbl", "volume": "21", "first-page": "625", "year": "1993", "journal-title": "Med Pediatr Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB6", "author": "Schilling", "volume": "344", "first-page": "1157", "year": "1994", "journal-title": "Lancet"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB7", "author": "Kerbl", "volume": "29", "first-page": "1", "year": "1997", "journal-title": "Med Pediatr Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB8", "author": "Hayashi", "volume": "22", "first-page": "363", "year": "1986", "journal-title": "Cancer Genet Cytogenet"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB9", "author": "Hayashi", "volume": "63", "first-page": "126", "year": "1988", "journal-title": "Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB10", "author": "Kaneko", "volume": "8", "first-page": "2005", "year": "1990", "journal-title": "J Clin Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB11", "author": "Hachitanda", "volume": "74", "first-page": "3223", "year": "1994", "journal-title": "Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB12", "author": "Hayashi", "volume": "30", "first-page": "467", "year": "1995", "journal-title": "J Pediatr Surg"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB13", "author": "Kusafuka", "volume": "76", "first-page": "695", "year": "1995", "journal-title": "Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB14", "author": "Hiraiwa", "volume": "79", "first-page": "2036", "year": "1997", "journal-title": "Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB15", "author": "Saylors", "volume": "16", "first-page": "356", "year": "1994", "journal-title": "Am J Pediatr Hematol Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB16", "author": "Ho", "volume": "92", "first-page": "358", "year": "1995", "journal-title": "Pediatrics"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB17", "author": "Dominici", "volume": "25", "first-page": "242", "year": "1995", "journal-title": "Med Pediatr Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB18", "author": "Acharya", "volume": "80", "first-page": "304", "year": "1997", "journal-title": "Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB19", "author": "Ambros", "volume": "31A", "first-page": "510", "year": "1995", "journal-title": "Eur J Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB20", "author": "Brodeur", "volume": "31A", "first-page": "505", "year": "1995", "journal-title": "Eur J Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB21", "author": "Ambros", "volume": "334", "first-page": "1505", "year": "1996", "journal-title": "N Engl J Med"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB22", "author": "Brodeur", "volume": "14", "first-page": "111", "year": "1992", "journal-title": "Am J Pediatr Hematol Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB23", "author": "Brodeur", "volume": "19", "first-page": "93", "year": "1997", "journal-title": "J Pediatr Hematol Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB24", "author": "Brodeur", "volume": "224", "first-page": "1121", "year": "1984", "journal-title": "Science"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB25", "author": "Seeger", "volume": "313", "first-page": "1111", "year": "1985", "journal-title": "N Engl J Med"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB26", "author": "Brodeur", "volume": "40", "first-page": "2256", "year": "1977", "journal-title": "Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB27", "author": "Brodeur", "volume": "41", "first-page": "4678", "year": "1981", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB28", "author": "Fong", "volume": "86", "first-page": "3753", "year": "1989", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB29", "author": "Weith", "volume": "1", "first-page": "159", "year": "1989", "journal-title": "Genes Chrom Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB30", "author": "Maris", "volume": "55", "first-page": "4664", "year": "1995", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB31", "author": "Martinsson", "volume": "55", "first-page": "5681", "year": "1995", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB32", "author": "Caron", "volume": "24", "first-page": "215", "year": "1995", "journal-title": "Med Pediatr Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB33", "author": "Caron", "volume": "334", "first-page": "225", "year": "1996", "journal-title": "N Engl J Med"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB34", "author": "Gilbert", "volume": "44", "first-page": "5444", "year": "1984", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB35", "author": "Plantaz", "volume": "150", "first-page": "81", "year": "1997", "journal-title": "Am J Pathol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB36", "author": "Lastowska", "volume": "18", "first-page": "162", "year": "1997", "journal-title": "Genes Chrom Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB37", "author": "Brinkschmidt", "volume": "181", "first-page": "394", "year": "1997", "journal-title": "J Pathol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB38", "author": "Suzuki", "volume": "49", "first-page": "1095", "year": "1989", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB39", "author": "Srivatsan", "volume": "366", "first-page": "91", "year": "1991", "journal-title": "Prog Clin Biol Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB40", "author": "Fong", "volume": "52", "first-page": "1780", "year": "1992", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB41", "author": "Srivatsan", "volume": "7", "first-page": "32", "year": "1993", "journal-title": "Genes Chrom Cancer"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB42", "author": "Michon", "volume": "29", "first-page": "370", "year": "1997", "journal-title": "Med Pediatr Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB43", "author": "Bernstein", "volume": "16", "first-page": "164", "year": "1994", "journal-title": "Am J Pediatr Hematol Oncol"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB44", "author": "Cohn", "volume": "55", "first-page": "721", "year": "1995", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB45", "author": "Lorenzana", "volume": "17", "first-page": "875", "year": "1997", "journal-title": "Pediatr Pathol Lab Med"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB46", "author": "Brodeur", "volume": "47", "first-page": "4248", "year": "1987", "journal-title": "Cancer Res"}, {"key": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I-BIB47", "author": "Combaret", "volume": "25", "first-page": "1607", "year": "1989", "journal-title": "Eur J Cancer Clin Oncol"}], "container-title": ["Medical and Pediatric Oncology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1096-911X(199811)31:5%3C394::AID-MPO2%3E3.0.CO;2-I", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1096-911X(199811)31:5%3C394::AID-MPO2%3E3.0.CO;2-I", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 4]], "date-time": "2018-08-04T05:38:29Z", "timestamp": 1533361109000}, "score": 30.866323, "issued": {"date-parts": [[1998, 11]]}, "references-count": 47, "journal-issue": {"published-print": {"date-parts": [[1998, 11]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/(sici)1096-911x(199811)31:5<394::aid-mpo2>3.0.co;2-i", "relation": {"cites": []}, "ISSN": ["0098-1532", "1096-911X"], "issn-type": [{"value": "0098-1532", "type": "print"}, {"value": "1096-911X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:55:00Z", "timestamp": 1574153700802}, "reference-count": 175, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1989, 9, 1]], "date-time": "1989-09-01T00:00:00Z", "timestamp": 620611200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Genetics and Cytogenetics"], "published-print": {"date-parts": [[1989, 9]]}, "DOI": "10.1016/0165-4608(89)90243-4", "type": "journal-article", "created": {"date-parts": [[2003, 2, 13]], "date-time": "2003-02-13T18:09:46Z", "timestamp": 1045159786000}, "page": "153-174", "source": "Crossref", "is-referenced-by-count": 131, "title": ["Molecular biology and genetics of human neuroblastoma"], "prefix": "10.1016", "volume": "41", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}, {"given": "Chin-to", "family": "Fong", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Genetics and Cytogenetics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0165460889902434?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0165460889902434?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 27]], "date-time": "2019-03-27T13:26:49Z", "timestamp": 1553693209000}, "score": 29.512905, "issued": {"date-parts": [[1989, 9]]}, "references-count": 175, "journal-issue": {"published-print": {"date-parts": [[1989, 9]]}, "issue": "2"}, "alternative-id": ["0165460889902434"], "URL": "http://dx.doi.org/10.1016/0165-4608(89)90243-4", "ISSN": ["0165-4608"], "issn-type": [{"value": "0165-4608", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:51:13Z", "timestamp": 1574243473105}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Oncology"], "published-print": {"date-parts": [[1991, 6]]}, "DOI": "10.1097/00001622-199106000-00007", "type": "journal-article", "created": {"date-parts": [[2006, 11, 8]], "date-time": "2006-11-08T09:25:34Z", "timestamp": 1162977934000}, "page": "485-496", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Neuroblastoma, retinoblastoma, and brain tumors in children"], "prefix": "10.1097", "volume": "3", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}, {"suffix": "III", "given": "Robert L.", "family": "Saylors", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Oncology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T02:22:39Z", "timestamp": 1518142959000}, "score": 29.512905, "subtitle": [""], "issued": {"date-parts": [[1991, 6]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00001622-199106000-00007", "ISSN": ["1040-8746"], "issn-type": [{"value": "1040-8746", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T16:04:45Z", "timestamp": 1574870685924}, "reference-count": 0, "publisher": "Future Science Ltd", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BioTechniques"], "published-print": {"date-parts": [[2000, 4]]}, "DOI": "10.2144/00284st04", "type": "journal-article", "created": {"date-parts": [[2018, 8, 29]], "date-time": "2018-08-29T11:23:07Z", "timestamp": 1535541787000}, "page": "681-691", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Relative Quantitative RT-PCR Protocol for TrkB Expression in Neuroblastoma Using GAPD as an Internal Control"], "prefix": "10.2144", "volume": "28", "author": [{"given": "Angelika", "family": "Eggert", "sequence": "first", "affiliation": [{"name": "Children's Hospital of Philadelphia, Philadelphia, PA, USA"}]}, {"given": "Garrett M.", "family": "Brodeur", "sequence": "additional", "affiliation": [{"name": "Children's Hospital of Philadelphia, Philadelphia, PA, USA"}]}, {"given": "Naohiko", "family": "Ikegaki", "sequence": "additional", "affiliation": [{"name": "Children's Hospital of Philadelphia, Philadelphia, PA, USA"}]}], "member": "2641", "container-title": ["BioTechniques"], "language": "en", "link": [{"URL": "https://www.future-science.com/doi/pdf/10.2144/00284st04", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:58:55Z", "timestamp": 1574243935000}, "score": 29.512905, "issued": {"date-parts": [[2000, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2000, 4]]}, "issue": "4"}, "alternative-id": ["10.2144/00284st04"], "URL": "http://dx.doi.org/10.2144/00284st04", "ISSN": ["0736-6205", "1940-9818"], "issn-type": [{"value": "0736-6205", "type": "print"}, {"value": "1940-9818", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T16:21:06Z", "timestamp": 1575044466038}, "reference-count": 14, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 6048, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int. J. Cancer"], "published-print": {"date-parts": [[1999, 2, 9]]}, "DOI": "10.1002/(sici)1097-0215(19990209)80:4<630::aid-ijc24>3.0.co;2-7", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T20:07:13Z", "timestamp": 1030306033000}, "page": "630-631", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Wild- sequence ofMYCN in neuroblastoma cell lines"], "prefix": "10.1002", "volume": "80", "author": [{"given": "Michael D.", "family": "Hogarty", "sequence": "first", "affiliation": []}, {"given": "Garrett M.", "family": "Brodeur", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "BIB1", "author": "Bhatia", "volume": "5", "first-page": "56", "year": "1993", "journal-title": "Nature (Genet.)", "DOI": "10.1038/ng0993-56", "doi-asserted-by": "crossref"}, {"key": "BIB2", "author": "Brodeur", "volume": "19", "first-page": "93", "year": "1997", "journal-title": "J. Pediatr. Hematol. Oncol.", "DOI": "10.1097/00043426-199703000-00001", "doi-asserted-by": "crossref"}, {"key": "BIB3", "author": "Brodeur", "volume": "224", "first-page": "1121", "year": "1984", "journal-title": "Science", "DOI": "10.1126/science.6719137", "doi-asserted-by": "crossref"}, {"key": "BIB4", "author": "Chan", "volume": "3", "first-page": "1699", "year": "1997", "journal-title": "Clin. Cancer Res."}, {"key": "BIB5", "author": "Cohn", "volume": "5", "first-page": "1821", "year": "1990", "journal-title": "Oncogene"}, {"key": "BIB6", "author": "DePinho", "volume": "33", "first-page": "257", "year": "1987", "journal-title": "J. cell. Biochem.", "DOI": "10.1002/jcb.240330404", "doi-asserted-by": "crossref"}, {"key": "BIB7", "author": "Feng", "volume": "71", "first-page": "1116", "year": "1997", "journal-title": "Int. J. Cancer", "DOI": "10.1002/(SICI)1097-0215(19970611)71:6<1116::AID-IJC32>3.0.CO;2-8", "doi-asserted-by": "crossref"}, {"key": "BIB8", "author": "Grady-Leopardi", "volume": "46", "first-page": "3196", "year": "1986", "journal-title": "Cancer Res."}, {"key": "BIB9", "author": "Kawamata", "volume": "77", "first-page": "570", "year": "1996", "journal-title": "Cancer", "DOI": "10.1002/(SICI)1097-0142(19960201)77:3<570::AID-CNCR21>3.0.CO;2-0", "doi-asserted-by": "crossref"}, {"key": "BIB10", "author": "Leder", "volume": "222", "first-page": "765", "year": "1983", "journal-title": "Science", "DOI": "10.1126/science.6356357", "doi-asserted-by": "crossref"}, {"key": "BIB11", "author": "Nisen", "volume": "80", "first-page": "1633", "year": "1988", "journal-title": "J. nat. Cancer Inst.", "DOI": "10.1093/jnci/80.20.1633", "doi-asserted-by": "crossref"}, {"key": "BIB12", "author": "Seeger", "volume": "313", "first-page": "1111", "year": "1985", "journal-title": "N. Engl. J. Med.", "DOI": "10.1056/NEJM198510313131802", "doi-asserted-by": "crossref"}, {"key": "BIB13", "first-page": "41", "volume-title": "Advances in Neuroblastoma Research", "volume": "2", "author": "Seeger", "year": "1988", "unstructured": "and Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene. In: (eds.), Advances in Neuroblastoma Research, vol. 2, pp. 41-49, A.R. Liss, New York (1988)."}, {"key": "BIB14", "author": "Yano", "volume": "8", "first-page": "2741", "year": "1993", "journal-title": "Oncogene"}], "container-title": ["International Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0215(19990209)80:4%3C630::AID-IJC24%3E3.0.CO;2-7", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0215(19990209)80:4%3C630::AID-IJC24%3E3.0.CO;2-7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T02:40:10Z", "timestamp": 1533177610000}, "score": 29.512905, "issued": {"date-parts": [[1999, 2, 9]]}, "references-count": 14, "journal-issue": {"published-print": {"date-parts": [[1999, 2, 9]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/(sici)1097-0215(19990209)80:4<630::aid-ijc24>3.0.co;2-7", "relation": {"cites": []}, "ISSN": ["0020-7136", "1097-0215"], "issn-type": [{"value": "0020-7136", "type": "print"}, {"value": "1097-0215", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T15:28:53Z", "timestamp": 1574782133438}, "reference-count": 93, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100000065", "name": "National Institute of Neurological Disorders and Stroke", "doi-asserted-by": "crossref", "award": ["NS038569"]}, {"name": "NCI", "award": ["CA074289", "CA094194"]}, {"name": "Audrey E. Evans Endowed Chair at Children's Hospital of Philadelphia", "award": []}, {"name": "Crosby's Fund for Neuroblastoma Pediatric Cancer Research", "award": []}, {"name": "William H. Eilinger Endowed Chair at the University of Rochester", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Neurol."], "published-print": {"date-parts": [[2016, 7]]}, "DOI": "10.1002/ana.24659", "type": "journal-article", "created": {"date-parts": [[2016, 4, 4]], "date-time": "2016-04-04T16:48:26Z", "timestamp": 1459788506000}, "page": "13-23", "source": "Crossref", "is-referenced-by-count": 18, "title": ["The \u201cneuro\u201d of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder"], "prefix": "10.1002", "volume": "80", "author": [{"given": "Nancy", "family": "Ratner", "sequence": "first", "affiliation": [{"name": "Department of Pediatrics; Cincinnati Children's Hospital and University of Cincinnati; Cincinnati OH"}]}, {"given": "Garrett M.", "family": "Brodeur", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics; Children's Hospital of Philadelphia; Philadelphia PA"}]}, {"given": "Russell C.", "family": "Dale", "sequence": "additional", "affiliation": [{"name": "Clinical School, the Children's Hospital at Westmead; University of Sydney; Sydney New South Wales Australia"}]}, {"given": "Nina F.", "family": "Schor", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics; University of Rochester Medical Center; Rochester NY"}]}], "member": "311", "published-online": {"date-parts": [[2016, 4, 30]]}, "reference": [{"key": "10.1002/ana.24659-BIB0001|ana24659-cit-0001", "doi-asserted-by": "crossref", "first-page": "768", "DOI": "10.1177/0883073813483173", "article-title": "Aiming at neuroblastoma and hitting other worthy targets", "volume": "28", "author": "Schor", "year": "2013", "journal-title": "J Child Neurol"}, {"key": "10.1002/ana.24659-BIB0002|ana24659-cit-0002", "doi-asserted-by": "crossref", "first-page": "1578", "DOI": "10.1126/science.1222369", "article-title": "The dorsal aorta initiates a molecular cascade that instructs sympatho-adrenal specification", "volume": "336", "author": "Saito", "year": "2012", "journal-title": "Science"}, {"key": "10.1002/ana.24659-BIB0003|ana24659-cit-0003", "doi-asserted-by": "crossref", "first-page": "a020487", "DOI": "10.1101/cshperspect.a020487", "article-title": "Schwann cells: development and role in nerve repair", "volume": "7", "author": "Jessen", "year": "2015", "journal-title": "Cold Spring Harb Perspect Biol"}, {"key": "10.1002/ana.24659-BIB0004|ana24659-cit-0004", "doi-asserted-by": "crossref", "first-page": "a014415", "DOI": "10.1101/cshperspect.a014415", "article-title": "Neuroblastoma and MYCN", "volume": "3", "author": "Huang", "year": "2013", "journal-title": "Cold Spring Harb Perspect Med"}, {"key": "10.1002/ana.24659-BIB0005|ana24659-cit-0005", "first-page": "467", "article-title": "Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells", "volume": "9", "author": "Spengler", "year": "1997", "journal-title": "Oncol Res"}, {"key": "10.1002/ana.24659-BIB0006|ana24659-cit-0006", "doi-asserted-by": "crossref", "first-page": "3066", "DOI": "10.1038/sj.onc.1210965", "article-title": "In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin", "volume": "27", "author": "Bourdeaut", "year": "2008", "journal-title": "Oncogene"}, {"key": "10.1002/ana.24659-BIB0007|ana24659-cit-0007", "doi-asserted-by": "crossref", "first-page": "11180", "DOI": "10.18632/oncotarget.2611", "article-title": "Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells", "volume": "5", "author": "Pajtler", "year": "2014", "journal-title": "Oncotarget"}, {"key": "10.1002/ana.24659-BIB0008|ana24659-cit-0008", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1016/j.stem.2015.02.017", "article-title": "Premigratory and migratory neural crest cells are multipotent in vivo", "volume": "16", "author": "Baggiolini", "year": "2015", "journal-title": "Cell Stem Cell"}, {"key": "10.1002/ana.24659-BIB0009|ana24659-cit-0009", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1016/j.crvi.2007.04.004", "article-title": "Neural crest progenitors and stem cells", "volume": "330", "author": "Dupin", "year": "2007", "journal-title": "C R Biol"}, {"key": "10.1002/ana.24659-BIB0010|ana24659-cit-0010", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1242/dmm.018630", "article-title": "Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma", "volume": "8", "author": "Wylie", "year": "2015", "journal-title": "Dis Models Mech"}, {"key": "10.1002/ana.24659-BIB0011|ana24659-cit-0011", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1016/j.scr.2015.08.008", "article-title": "A distinct gene expression signature characterizes human neuroblastoma cancer stem cells", "volume": "15", "author": "Ross", "year": "2015", "journal-title": "Stem Cell Res"}, {"key": "10.1002/ana.24659-BIB0012|ana24659-cit-0012", "doi-asserted-by": "crossref", "first-page": "838", "DOI": "10.1593/neo.04310", "article-title": "Characteristics of stem cells from human neuroblastoma cell lines and in tumors", "volume": "6", "author": "Walton", "year": "2004", "journal-title": "Neoplasia"}, {"key": "10.1002/ana.24659-BIB0013|ana24659-cit-0013", "doi-asserted-by": "crossref", "first-page": "32821", "DOI": "10.18632/oncotarget.5104", "article-title": "Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells", "volume": "6", "author": "Nardella", "year": "2015", "journal-title": "Oncotarget"}, {"key": "10.1002/ana.24659-BIB0014|ana24659-cit-0014", "doi-asserted-by": "crossref", "first-page": "2985", "DOI": "10.1093/emboj/16.11.2985", "article-title": "Targeted expression of MYCN causes neuroblastoma in transgenic mice", "volume": "16", "author": "Weiss", "year": "1997", "journal-title": "EMBO J"}, {"key": "10.1002/ana.24659-BIB0015|ana24659-cit-0015", "doi-asserted-by": "crossref", "first-page": "e0133897", "DOI": "10.1371/journal.pone.0133897", "article-title": "Expression of MYCN in multipotent sympathoadrenal progenitors induces proliferation and neural differentiation, but is not sufficient for tumorigenesis", "volume": "10", "author": "Mobley", "year": "2015", "journal-title": "PLoS One"}, {"key": "10.1002/ana.24659-BIB0016|ana24659-cit-0016", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1016/j.cell.2010.06.004", "article-title": "NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome", "volume": "142", "author": "H\u00f6lzel", "year": "2010", "journal-title": "Cell"}, {"key": "10.1002/ana.24659-BIB0017|ana24659-cit-0017", "doi-asserted-by": "crossref", "first-page": "864", "DOI": "10.1038/ng.3333", "article-title": "Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations", "volume": "47", "author": "Eleveld", "year": "2015", "journal-title": "Nat Genet"}, {"key": "10.1002/ana.24659-BIB0018|ana24659-cit-0018", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1038/nrclinonc.2014.168", "article-title": "Mechanisms of neuroblastoma regression", "volume": "11", "author": "Brodeur", "year": "2014", "journal-title": "Nat Rev Clin Oncol"}, {"key": "10.1002/ana.24659-BIB0019|ana24659-cit-0019", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.3109/02841869009090048", "article-title": "The spontaneous regression of cancer. A review of cases from 1900 to 1987", "volume": "29", "author": "Challis", "year": "1990", "journal-title": "Acta Oncolog"}, {"key": "10.1002/ana.24659-BIB0020|ana24659-cit-0020", "first-page": "571", "article-title": "Spontaneous regression of cancer: possible mechanisms", "volume": "12", "author": "Papac", "year": "1998", "journal-title": "In Vivo"}, {"key": "10.1002/ana.24659-BIB0021|ana24659-cit-0021", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1007/s00268-012-1837-0", "article-title": "Long-term follow-up of the \u201cwait and see\u201d approach to localized perinatal adrenal neuroblastoma", "volume": "37", "author": "Cozzi", "year": "2013", "journal-title": "World J Surg"}, {"key": "10.1002/ana.24659-BIB0022|ana24659-cit-0022", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1200/JCO.1996.14.2.373", "article-title": "Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy", "volume": "14", "author": "Kushner", "year": "1996", "journal-title": "J Clin Oncol"}, {"key": "10.1002/ana.24659-BIB0023|ana24659-cit-0023", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1056/NEJMoa012277", "article-title": "Neuroblastoma screening at one year of age", "volume": "346", "author": "Schilling", "year": "2002", "journal-title": "NEJM"}, {"key": "10.1002/ana.24659-BIB0024|ana24659-cit-0024", "doi-asserted-by": "crossref", "first-page": "1041", "DOI": "10.1056/NEJMoa012387", "article-title": "Screening of infants and mortality due to neuroblastoma", "volume": "346", "author": "Woods", "year": "2002", "journal-title": "NEJM"}, {"key": "10.1002/ana.24659-BIB0025|ana24659-cit-0025", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1002/(SICI)1096-911X(199811)31:5<394::AID-MPO2>3.0.CO;2-I", "article-title": "Biological aspects of neuroblastoma screening", "volume": "31", "author": "Brodeur", "year": "1998", "journal-title": "Med Ped Oncol"}, {"key": "10.1002/ana.24659-BIB0026|ana24659-cit-0026", "doi-asserted-by": "crossref", "first-page": "3244", "DOI": "10.1158/1078-0432.CCR-08-1815", "article-title": "Trk receptor expression and inhibition in neuroblastomas", "volume": "15", "author": "Brodeur", "year": "2009", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/ana.24659-BIB0027|ana24659-cit-0027", "doi-asserted-by": "crossref", "first-page": "5962", "DOI": "10.1158/1078-0432.CCR-08-0651", "article-title": "On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology", "volume": "15", "author": "Thiele", "year": "2009", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/ana.24659-BIB0028|ana24659-cit-0028", "first-page": "1364", "article-title": "Inverse relationship between trk expression and N-myc amplification in human neuroblastomas", "volume": "52", "author": "Nakagawara", "year": "1992", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0029|ana24659-cit-0029", "doi-asserted-by": "crossref", "first-page": "847", "DOI": "10.1056/NEJM199303253281205", "article-title": "Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma", "volume": "328", "author": "Nakagawara", "year": "1993", "journal-title": "NEJM"}, {"key": "10.1002/ana.24659-BIB0030|ana24659-cit-0030", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1128/MCB.14.1.759", "article-title": "Expression and function of TRK-B and BDNF in human neuroblastomas", "volume": "14", "author": "Nakagawara", "year": "1994", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/ana.24659-BIB0031|ana24659-cit-0031", "first-page": "6756", "article-title": "Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3\u2032-kinase pathway", "volume": "62", "author": "Jaboin", "year": "2002", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0032|ana24659-cit-0032", "first-page": "1798", "article-title": "Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells", "volume": "55", "author": "Matsumoto", "year": "1995", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0033|ana24659-cit-0033", "doi-asserted-by": "crossref", "first-page": "2050", "DOI": "10.1016/S0959-8049(97)00280-3", "article-title": "Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study", "volume": "33", "author": "Nakagawara", "year": "1997", "journal-title": "Eur J Cancer"}, {"key": "10.1002/ana.24659-BIB0034|ana24659-cit-0034", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/j.ccr.2004.09.011", "article-title": "TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma", "volume": "6", "author": "Tacconelli", "year": "2004", "journal-title": "Cancer Cell"}, {"key": "10.1002/ana.24659-BIB0035|ana24659-cit-0035", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/0304-3835(93)90182-9", "article-title": "Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma", "volume": "73", "author": "Kataoka", "year": "1993", "journal-title": "Cancer Lett"}, {"key": "10.1002/ana.24659-BIB0036|ana24659-cit-0036", "doi-asserted-by": "crossref", "first-page": "1526", "DOI": "10.1212/WNL.62.9.1526", "article-title": "B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes", "volume": "62", "author": "Pranzatelli", "year": "2004", "journal-title": "Neurology"}, {"key": "10.1002/ana.24659-BIB0037|ana24659-cit-0037", "doi-asserted-by": "crossref", "first-page": "612", "DOI": "10.1002/mpo.1138", "article-title": "Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study", "volume": "36", "author": "Rudnick", "year": "2001", "journal-title": "Med Ped Oncol"}, {"key": "10.1002/ana.24659-BIB0038|ana24659-cit-0038", "doi-asserted-by": "crossref", "first-page": "4634", "DOI": "10.1038/sj.onc.1208594", "article-title": "Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications", "volume": "24", "author": "Raffaghello", "year": "2005", "journal-title": "Oncogene"}, {"key": "10.1002/ana.24659-BIB0039|ana24659-cit-0039", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1016/0022-3468(90)90375-J", "article-title": "The relationship of class I MHC antigen expression to stage IV-S disease and survival in neuroblastoma", "volume": "25", "author": "Squire", "year": "1990", "journal-title": "J Ped Surg"}, {"key": "10.1002/ana.24659-BIB0040|ana24659-cit-0040", "doi-asserted-by": "crossref", "first-page": "2011", "DOI": "10.1126/science.7605428", "article-title": "Specific association of human telomerase activity with immortal cells and cancer", "volume": "266", "author": "Kim", "year": "1994", "journal-title": "Science"}, {"key": "10.1002/ana.24659-BIB0041|ana24659-cit-0041", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1038/nm0395-249", "article-title": "Correlating telomerase activity levels with human neuroblastoma outcomes", "volume": "1", "author": "Hiyama", "year": "1995", "journal-title": "Nature Med"}, {"key": "10.1002/ana.24659-BIB0042|ana24659-cit-0042", "doi-asserted-by": "crossref", "first-page": "962", "DOI": "10.4161/epi.6.8.16516", "article-title": "Neuroblastoma epigenetics: from candidate gene approaches to genome-wide screenings", "volume": "6", "author": "Decock", "year": "2011", "journal-title": "Epigenetics"}, {"key": "10.1002/ana.24659-BIB0043|ana24659-cit-0043", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1038/ng.2529", "article-title": "The genetic landscape of high-risk neuroblastoma", "volume": "45", "author": "Pugh", "year": "2013", "journal-title": "Nature Genet"}, {"key": "10.1002/ana.24659-BIB0044|ana24659-cit-0044", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1016/j.semcancer.2004.06.005", "article-title": "The epigenetics of cancer etiology", "volume": "14", "author": "Feinberg", "year": "2004", "journal-title": "Semin Cancer Biol."}, {"key": "10.1002/ana.24659-BIB0045|ana24659-cit-0045", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1517/17460441.2015.974544", "article-title": "Neuroblastoma models for insights into tumorigenesis and new therapies", "volume": "10", "author": "Kiyonari", "year": "2015", "journal-title": "Expert Opin Drug Discov"}, {"key": "10.1002/ana.24659-BIB0046|ana24659-cit-0046", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1016/j.braindev.2014.10.010", "article-title": "A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children", "volume": "37", "author": "Hasegawa", "year": "2015", "journal-title": "Brain Dev"}, {"key": "10.1002/ana.24659-BIB0047|ana24659-cit-0047", "doi-asserted-by": "crossref", "first-page": "e388", "DOI": "10.1542/peds.2010-3114", "article-title": "Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life", "volume": "128", "author": "Brunklaus", "year": "2011", "journal-title": "Pediatrics"}, {"key": "10.1002/ana.24659-BIB0048|ana24659-cit-0048", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.1136/adc.2010.204792", "article-title": "Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome", "volume": "97", "author": "Brunklaus", "year": "2012", "journal-title": "Arch Dis Child"}, {"key": "10.1002/ana.24659-BIB0049|ana24659-cit-0049", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1002/mpo.1139", "article-title": "Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group", "volume": "36", "author": "Cooper", "year": "2001", "journal-title": "Med Pediatr Oncol"}, {"key": "10.1002/ana.24659-BIB0050|ana24659-cit-0050", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1111/dmcn.12594", "article-title": "Cerebellar and cortical abnormalities in paediatric opsoclonus-myoclonus syndrome", "volume": "57", "author": "Anand", "year": "2015", "journal-title": "Dev Med Child Neurol"}, {"key": "10.1002/ana.24659-BIB0051|ana24659-cit-0051", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.jneuroim.2013.11.004", "article-title": "CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders", "volume": "266", "author": "Pranzatelli", "year": "2014", "journal-title": "J Neuroimmunol"}, {"key": "10.1002/ana.24659-BIB0052|ana24659-cit-0052", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1002/ana.20539", "article-title": "Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome", "volume": "58", "author": "Blaes", "year": "2005", "journal-title": "Ann Neurol"}, {"key": "10.1002/ana.24659-BIB0053|ana24659-cit-0053", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1016/j.jneuroim.2015.07.007", "article-title": "Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome", "volume": "286", "author": "Panzer", "year": "2015", "journal-title": "J Neuroimmunol"}, {"key": "10.1002/ana.24659-BIB0054|ana24659-cit-0054", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1016/S0887-8994(02)00457-5", "article-title": "Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia", "volume": "27", "author": "Pranzatelli", "year": "2002", "journal-title": "Pediatr Neurol"}, {"key": "10.1002/ana.24659-BIB0055|ana24659-cit-0055", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1016/j.pediatrneurol.2011.02.012", "article-title": "Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus", "volume": "45", "author": "Pranzatelli", "year": "2011", "journal-title": "Pediatr Neurol"}, {"key": "10.1002/ana.24659-BIB0056|ana24659-cit-0056", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1002/mds.20125", "article-title": "CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity", "volume": "19", "author": "Pranzatelli", "year": "2004", "journal-title": "Mov Disord"}, {"key": "10.1002/ana.24659-BIB0057|ana24659-cit-0057", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1186/1742-2094-10-10", "article-title": "BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy", "volume": "10", "author": "Pranzatelli", "year": "2013", "journal-title": "J Neuroinflammation"}, {"key": "10.1002/ana.24659-BIB0058|ana24659-cit-0058", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1189/jlb.0213106", "article-title": "Role of BAFF in opsoclonus-myoclonus syndrome, a bridge between cancer and autoimmunity", "volume": "94", "author": "Raffaghello", "year": "2013", "journal-title": "J Leukoc Biol"}, {"key": "10.1002/ana.24659-BIB0059|ana24659-cit-0059", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1007/s10875-013-9867-4", "article-title": "CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids", "volume": "33", "author": "Pranzatelli", "year": "2013", "journal-title": "J Clin Immunol"}, {"key": "10.1002/ana.24659-BIB0060|ana24659-cit-0060", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.1177/08830738040190120201", "article-title": "Evidence of cellular immune activation in children with opsoclonus-myoclonus: cerebrospinal fluid neopterin", "volume": "19", "author": "Pranzatelli", "year": "2004", "journal-title": "J Child Neurol"}, {"key": "10.1002/ana.24659-BIB0061|ana24659-cit-0061", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1111/cei.12065", "article-title": "Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric opsoclonus-myoclonus syndrome", "volume": "172", "author": "Pranzatelli", "year": "2013", "journal-title": "Clin Exp Immunol"}, {"key": "10.1002/ana.24659-BIB0062|ana24659-cit-0062", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1177/0883073811428816", "article-title": "Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome", "volume": "27", "author": "Tate", "year": "2012", "journal-title": "J Child Neurol"}, {"key": "10.1002/ana.24659-BIB0063|ana24659-cit-0063", "doi-asserted-by": "crossref", "first-page": "976", "DOI": "10.1177/0883073814549581", "article-title": "Effect of increased immunosuppression on developmental outcome of opsoclonus myoclonus syndrome (OMS)", "volume": "30", "author": "Mitchell", "year": "2015", "journal-title": "J Child Neurol"}, {"key": "10.1002/ana.24659-BIB0064|ana24659-cit-0064", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1212/WNL.0000000000000570", "article-title": "Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease", "volume": "83", "author": "Dale", "year": "2014", "journal-title": "Neurology"}, {"key": "10.1002/ana.24659-BIB0065|ana24659-cit-0065", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1016/j.febslet.2013.11.030", "article-title": "Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy", "volume": "588", "author": "Ahmed", "year": "2014", "journal-title": "FEBS Lett"}, {"key": "10.1002/ana.24659-BIB0066|ana24659-cit-0066", "doi-asserted-by": "crossref", "first-page": "e1016704", "DOI": "10.1080/2162402X.2015.1016704", "article-title": "Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective phase II study", "volume": "4", "author": "Kushner", "year": "2015", "journal-title": "Oncoimmunology"}, {"key": "10.1002/ana.24659-BIB0067|ana24659-cit-0067", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1002/pbc.25197", "article-title": "Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children", "volume": "62", "author": "G\u00f6rges", "year": "2015", "journal-title": "Pediatr Blood Cancer"}, {"key": "10.1002/ana.24659-BIB0068|ana24659-cit-0068", "first-page": "1374", "article-title": "Modulatory effect of the sympathetic nervous system on neuroblastoma tumor growth", "volume": "38", "author": "Chelmicka-Schorr", "year": "1978", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0069|ana24659-cit-0069", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.1172/JCI115655", "article-title": "Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin. Studies in murine neuroblastoma cells", "volume": "89", "author": "Schor", "year": "1992", "journal-title": "J Clin Invest"}, {"key": "10.1002/ana.24659-BIB0070|ana24659-cit-0070", "first-page": "5620", "article-title": "Effects of chemical sympathectomy in neonatal and adult mice on C-1300 neuroblastoma tumor growth and catecholamine content", "volume": "47", "author": "Fink", "year": "1987", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0071|ana24659-cit-0071", "first-page": "2336", "article-title": "Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol", "volume": "56", "author": "Purpura", "year": "1996", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0072|ana24659-cit-0072", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.5603/NMR.2015.0024", "article-title": "124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma", "volume": "18", "author": "Cistaro", "year": "2015", "journal-title": "Nucl Med Rev Cent East Eur"}, {"key": "10.1002/ana.24659-BIB0073|ana24659-cit-0073", "first-page": "CD009263", "article-title": "123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma", "volume": "9", "author": "Bleeker", "year": "2015", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/ana.24659-BIB0074|ana24659-cit-0074", "doi-asserted-by": "crossref", "first-page": "2465", "DOI": "10.1016/j.ejca.2015.07.023", "article-title": "Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine [(131)I-MIBG]", "volume": "51", "author": "Zhou", "year": "2015", "journal-title": "Eur J Cancer"}, {"key": "10.1002/ana.24659-BIB0075|ana24659-cit-0075", "first-page": "4867", "article-title": "TrkA as a life and death receptor: receptor dose as a mediator of function", "volume": "62", "author": "Yan", "year": "2002", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0076|ana24659-cit-0076", "doi-asserted-by": "crossref", "first-page": "710", "DOI": "10.1124/mol.61.4.710", "article-title": "p75-nerve growth factor as an antiapoptotic complex: independence versus cooperativity in protection from enediyne chemotherapeutic agents", "volume": "61", "author": "Yan", "year": "2002", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/ana.24659-BIB0077|ana24659-cit-0077", "doi-asserted-by": "crossref", "first-page": "2935", "DOI": "10.1172/JCI65988", "article-title": "Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression", "volume": "123", "author": "Zhu", "year": "2013", "journal-title": "J Clin Invest"}, {"key": "10.1002/ana.24659-BIB0078|ana24659-cit-0078", "first-page": "2576", "article-title": "Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis", "volume": "55", "author": "Dole", "year": "1995", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0079|ana24659-cit-0079", "doi-asserted-by": "crossref", "first-page": "8700", "DOI": "10.18632/oncotarget.3901", "article-title": "Polo-like kinase 1 inhibition sensitizes neuroblastoma cells for vinca alkaloid-induced apoptosis", "volume": "7", "author": "Czaplinski", "year": "2016", "journal-title": "Oncotarget"}, {"key": "10.1002/ana.24659-BIB0080|ana24659-cit-0080", "doi-asserted-by": "crossref", "first-page": "1259", "DOI": "10.1046/j.1471-4159.1996.67031259.x", "article-title": "Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2", "volume": "67", "author": "Ellerby", "year": "1996", "journal-title": "J Neurochem"}, {"key": "10.1002/ana.24659-BIB0081|ana24659-cit-0081", "first-page": "1199", "article-title": "Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2", "volume": "56", "author": "Cortazzo", "year": "1996", "journal-title": "Cancer Res"}, {"key": "10.1002/ana.24659-BIB0082|ana24659-cit-0082", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1023/A:1006171406740", "article-title": "Neuroblastoma as a neurobiological disease", "volume": "41", "author": "Schor", "year": "1999", "journal-title": "J Neurooncol"}, {"key": "10.1002/ana.24659-BIB0083|ana24659-cit-0083", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1124/mol.61.1.142", "article-title": "Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2", "volume": "61", "author": "Liang", "year": "2002", "journal-title": "Mol Pharmacol"}, {"key": "10.1002/ana.24659-BIB0084|ana24659-cit-0084", "doi-asserted-by": "crossref", "first-page": "5515", "DOI": "10.1038/sj.onc.1206844", "article-title": "Bcl-2 mediates induction of neural differentiation", "volume": "22", "author": "Liang", "year": "2003", "journal-title": "Oncogene"}, {"key": "10.1002/ana.24659-BIB0085|ana24659-cit-0085", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1007/s00280-005-0054-z", "article-title": "Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2", "volume": "57", "author": "Mi", "year": "2006", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "10.1002/ana.24659-BIB0086|ana24659-cit-0086", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1007/s00280-008-0725-7", "article-title": "Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy", "volume": "62", "author": "Rogers", "year": "2008", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "10.1002/ana.24659-BIB0087|ana24659-cit-0087", "first-page": "CD010685", "article-title": "Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation", "volume": "1", "author": "Peinemann", "year": "2015", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1002/ana.24659-BIB0088|ana24659-cit-0088", "doi-asserted-by": "crossref", "first-page": "660", "DOI": "10.1016/j.yexcr.2012.12.027", "article-title": "Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model", "volume": "319", "author": "Rogers", "year": "2013", "journal-title": "Exp Cell Res"}, {"key": "10.1002/ana.24659-BIB0089|ana24659-cit-0089", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1002/cncr.29706", "article-title": "Advances in the translational genomics of neuroblastoma: from improving risk stratification and revealing novel biology to identifying actionable genomic alterations", "volume": "122", "author": "Bosse", "year": "2016", "journal-title": "Cancer."}, {"key": "10.1002/ana.24659-BIB0090|ana24659-cit-0090", "author": "Li", "year": "2014", "article-title": "Methylase meets phosphatase: roles of PRMT and EYA1 in neuroblastoma", "journal-title": "AACR Proc"}, {"key": "10.1002/ana.24659-BIB0091|ana24659-cit-0091", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1177/0883073808324217", "article-title": "Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil", "volume": "24", "author": "Pranzatelli", "year": "2009", "journal-title": "J Child Neurol"}, {"key": "10.1002/ana.24659-BIB0092|ana24659-cit-0092", "doi-asserted-by": "crossref", "first-page": "988", "DOI": "10.1002/pbc.23187", "article-title": "Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus", "volume": "58", "author": "Pranzatelli", "year": "2012", "journal-title": "Pediatr Blood Cancer"}, {"key": "10.1002/ana.24659-BIB0093|ana24659-cit-0093", "doi-asserted-by": "crossref", "first-page": "380", "DOI": "10.1158/2159-8290.CD-14-0892", "article-title": "The genetics of splicing in neuroblastoma", "volume": "5", "author": "Chen", "year": "2015", "journal-title": "Cancer Discov"}], "container-title": ["Annals of Neurology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.24659", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ana.24659", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 6]], "date-time": "2019-09-06T07:25:01Z", "timestamp": 1567754701000}, "score": 27.495262, "subtitle": ["The \u201cNeuro\u201d of Neuroblastoma"], "issued": {"date-parts": [[2016, 4, 30]]}, "references-count": 93, "journal-issue": {"published-print": {"date-parts": [[2016, 7]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/ana.24659", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0364-5134"], "issn-type": [{"value": "0364-5134", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T11:24:01Z", "timestamp": 1576754641098}, "reference-count": 68, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2012, 6, 7]], "date-time": "2012-06-07T00:00:00Z", "timestamp": 1339027200000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2012, 6, 7]], "date-time": "2012-06-07T00:00:00Z", "timestamp": 1339027200000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Evol Appl"], "published-print": {"date-parts": [[2012, 7]]}, "DOI": "10.1111/j.1752-4571.2012.00273.x", "type": "journal-article", "created": {"date-parts": [[2012, 6, 7]], "date-time": "2012-06-07T13:51:32Z", "timestamp": 1339077092000}, "page": "470-480", "source": "Crossref", "is-referenced-by-count": 37, "title": ["Host specificity in biological control: insights from opportunistic pathogens"], "prefix": "10.1111", "volume": "5", "author": [{"given": "Jacques", "family": "Brodeur", "sequence": "first", "affiliation": [{"name": "D\u00e9partement de Sciences Biologiques, Institut de Recherche en Biologie V\u00e9g\u00e9tale; Universit\u00e9 de Montr\u00e9al; Montr\u00e9al QC Canada"}]}], "member": "311", "published-online": {"date-parts": [[2012, 6, 7]]}, "reference": [{"key": "10.1111/j.1752-4571.2012.00273.x-BIB0001|eva273-cit-0001", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1094/PHYTO.1997.87.3.359", "article-title": "Ultrastructural and cytochemical investigations of the antagonistic effect of Verticillium lecanii on cucumber powdery mildew, Sphaerotheca fuliginea", "volume": "87", "author": "Askary", "year": "1997", "journal-title": "Phytopathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0002|eva273-cit-0002", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1080/09583159830405", "article-title": "Strain variability in pathogenicity of the fungus Verticillium lecanii to aphids and powdery mildew", "volume": "8", "author": "Askary", "year": "1998", "journal-title": "Biocontrol Science & Technology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0003|eva273-cit-0003", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1006/jipa.1999.4857", "article-title": "Ultrastructural and cytochemical characterization of aphid invasion by the Hyphomycete Verticillium lecanii", "volume": "74", "author": "Askary", "year": "1999", "journal-title": "Journal of Invertebrate Pathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0004|eva273-cit-0004", "author": "Bellows", "first-page": "505", "year": "1999", "volume-title": "Handbook of Biological Control: Principles and Applications of Biological Control", "DOI": "10.1016/B978-012257305-7/50064-3", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0005|eva273-cit-0005", "doi-asserted-by": "crossref", "first-page": "932", "DOI": "10.1094/PHYTO.2000.90.9.932", "article-title": "Evidence for antibiosis and induced host defense reactions in the interaction between Verticillium lecanii and Penicillium digitatum, the causal agent of green mold", "volume": "90", "author": "Benhamou", "year": "2000", "journal-title": "Phytopathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0006|eva273-cit-0006", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1006/pmpp.2001.0322", "article-title": "Antifungal and eliciting properties of the mycoparasite, Verticillium lecanii, mediate the interaction between Pythium ultimum and Ri T-DNA transformed cucumber roots", "volume": "58", "author": "Benhamou", "year": "2001", "journal-title": "Plant Molecular and Physiological Pathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0007|eva273-cit-0007", "author": "Chang", "first-page": "103", "year": "1999", "volume-title": "Theoretical Approaches to Biological Control", "DOI": "10.1017/CBO9780511542077.009", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0008|eva273-cit-0008", "first-page": "229", "article-title": "Biological control of weeds by means of plant-pathogens: significance for integrated weed management in modern agro-ecology", "volume": "46", "author": "Charudattan", "year": "2001", "journal-title": "Biological Control"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0009|eva273-cit-0009", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1016/0022-2011(82)90180-X", "article-title": "Insecticidal secondary metabolic products from the entomopathogenous fungus Verticillium lecanii", "volume": "40", "author": "Claydon", "year": "1982", "journal-title": "Journal of Invertebrate Pathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0010|eva273-cit-0010", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1007/s10526-009-9234-9", "article-title": "Do new access and benefit sharing procedures under the convention on biological diversity threaten the future of biological control?", "volume": "55", "author": "Cock", "year": "2010", "journal-title": "BioControl"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0011|eva273-cit-0011", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1146/annurev.py.31.090193.000413", "article-title": "Making greater use of introduced microorganisms for biological control of plant pathogens", "volume": "31", "author": "Cook", "year": "1993", "journal-title": "Annual Review of Phytopathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0012|eva273-cit-0012", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1080/07352680590961649", "article-title": "Benefits of classical biological control for managing invasive pants", "volume": "24", "author": "Culliney", "year": "2005", "journal-title": "Critical Reviews in Plant Sciences"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0013|eva273-cit-0013", "first-page": "135", "article-title": "A taxonomic revision of Metarhizium based on sequence analysis of ribosomal DNA", "volume": "104", "author": "Driver", "year": "2000", "journal-title": "Mycology Resources"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0014|eva273-cit-0014", "first-page": "751", "article-title": "Trichoderma: the genomics of opportunistic success", "volume": "9", "author": "Druzhinina", "year": "2001", "journal-title": "Nature Reviews"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0015|eva273-cit-0015", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1046/j.1461-0248.2002.0_285.x", "article-title": "Invasion theory and biological control", "volume": "5", "author": "Fagan", "year": "2002", "journal-title": "Ecology Letters"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0016|eva273-cit-0016", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1128/AEM.01974-06", "article-title": "Increased insect virulence in Beauveria bassiana strains overexpressing an engineered chitinase", "volume": "73", "author": "Fan", "year": "2007", "journal-title": "Applied Environmental Microbiology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0017|eva273-cit-0017", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/j.biocontrol.2007.08.001", "article-title": "Mycoinsecticides and mycoacaricides: a comprehensive list with worldwide coverage and international classification of formulation types", "volume": "43", "author": "Faria", "year": "2007", "journal-title": "Biological Control"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0018|eva273-cit-0018", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.2307/1312875", "article-title": "Host specificity in microbe-insect interactions", "volume": "46", "author": "Federici", "year": "1996", "journal-title": "BioScience"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0019|eva273-cit-0019", "author": "Federici", "first-page": "15", "year": "2008", "volume-title": "PathoBiotechnology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0020|eva273-cit-0020", "doi-asserted-by": "crossref", "first-page": "1534", "DOI": "10.1093/ee/19.5.1534", "article-title": "Survey of entomopathogenic fungi naturally infecting cereal aphids (Homoptera: Aphididae) of irrigated grain crops in southwestern Idaho", "volume": "19", "author": "Feng", "year": "1994", "journal-title": "Environmental Entomology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0021|eva273-cit-0021", "doi-asserted-by": "crossref", "first-page": "568", "DOI": "10.1603/0046-225X-29.3.568", "article-title": "Dose-response susceptibility of pest aphids (Homoptera: Aphididae) and their control of hydroponically grown lettuce with the entomopathogenic fungus Verticillium lecanii, azarid- actin, and insecticidal soap", "volume": "29", "author": "Fournier", "year": "2000", "journal-title": "Environmental Entomology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0022|eva273-cit-0022", "doi-asserted-by": "crossref", "first-page": "e1001264", "DOI": "10.1371/journal.pgen.1001264", "article-title": "Genome sequencing and comparative transcriptomics of the model entomopathogenic fungi Metarhizium anisopliae and M.\u00a0acridum", "volume": "7", "author": "Gao", "year": "2011", "journal-title": "PLoS Genetics"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0023|eva273-cit-0023", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1007/BF02980318", "article-title": "Effect of endotoxic compounds isolated from Verticillium lecanii on the sweet potato whitefly, Bemesia tabaci", "volume": "22", "author": "Gidin", "year": "1994", "journal-title": "Phytoparasitica"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0024|eva273-cit-0024", "author": "Goettel", "volume": "6", "first-page": "361", "year": "2005", "volume-title": "Comprehensive Molecular Insect Science", "DOI": "10.1016/B0-44-451924-6/00088-0", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0025|eva273-cit-0025", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1016/j.jip.2008.01.009", "article-title": "Potential of Lecanicillium spp. For management of insects, nematodes and plant diseases", "volume": "98", "author": "Goettel", "year": "2008", "journal-title": "Journal of Invertebrate Pathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0026|eva273-cit-0026", "author": "Greathead", "first-page": "53", "year": "1995", "volume-title": "Biological Control: Benefits and Risks", "DOI": "10.1017/CBO9780511661730.007", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0027|eva273-cit-0027", "author": "Gressel", "first-page": "297", "year": "2007", "volume-title": "Novel Biotechnologies for Biocontrol Agent Enhancement and Management", "DOI": "10.1007/978-1-4020-5799-1_16", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0028|eva273-cit-0028", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1007/s10526-009-9253-6", "article-title": "Fungal pathogens as classical biological control agents against arthropods", "volume": "55", "author": "Hajek", "year": "2010", "journal-title": "BioControl"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0029|eva273-cit-0029", "author": "Hajek", "first-page": "15", "year": "2003", "volume-title": "Environmental Impacts of Microbial Insecticides", "DOI": "10.1007/978-94-017-1441-9_2", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0030|eva273-cit-0030", "author": "Hassell", "year": "1978", "volume-title": "The Dynamics of Arthropods Predator-Prey Systems"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0031|eva273-cit-0031", "author": "Hopper", "first-page": "78", "year": "2006", "volume-title": "Environmental Impact of Invertebrates for Biological Control of Arthropods: Methods and Risk Assessment", "DOI": "10.1079/9780851990583.0078", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0032|eva273-cit-0032", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1146/annurev.en.36.010191.002413", "article-title": "Environmental impacts of classical biological control", "volume": "36", "author": "Howarth", "year": "1991", "journal-title": "Annual Review of Entomology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0033|eva273-cit-0033", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/j.biocontrol.2005.04.004", "article-title": "Microevolution in biological control: mechanisms, patterns, and processes", "volume": "35", "author": "Hufbauer", "year": "2005", "journal-title": "Biological Control"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0034|eva273-cit-0034", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.jtbi.2008.09.036", "article-title": "A generic theoretical model for biological control of foliar plant diseases", "volume": "256", "author": "Jeger", "year": "2009", "journal-title": "Journal of Theoretical Biology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0035|eva273-cit-0035", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1016/j.biocontrol.2006.12.002", "article-title": "Potential of Lecanicillium species for dual microbial control of aphids and the cucumber powdery mildew fungus, Sphaerotheca fuliginea", "volume": "40", "author": "Kim", "year": "2007", "journal-title": "Biological Control"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0036|eva273-cit-0036", "doi-asserted-by": "crossref", "first-page": "540", "DOI": "10.1016/j.cropro.2009.12.011", "article-title": "Evaluation of Lecanicillium longisporum, Vertalec\u00ae against the cotton aphid, Aphis gossypii, and cucumber powdery mildew, Sphaerotheca fuliginea in a greenhouse environment", "volume": "29", "author": "Kim", "year": "2010", "journal-title": "Crop Protection"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0037|eva273-cit-0037", "author": "Koike", "first-page": "193", "year": "2012", "volume-title": "Soybean Physiology & Biochemistry"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0038|eva273-cit-0038", "doi-asserted-by": "crossref", "first-page": "930", "DOI": "10.1016/j.fgb.2004.07.003", "article-title": "The analysis of the complete mitochondrial genome of Lecanicillium muscarium (synonym Verticillium lecanii) suggests a minimum common gene organization in mtDNAs of Sordariomycetes: phylogenetic implications", "volume": "41", "author": "Kouvelis", "year": "2004", "journal-title": "Fungal genetics and Biology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0039|eva273-cit-0039", "author": "Kuhlmann", "first-page": "15", "year": "2006", "volume-title": "Environmental Impact of Invertebrates for Biological Control of Arthropods: Methods and Risk Assessment", "DOI": "10.1079/9780851990583.0015", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0040|eva273-cit-0040", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/s10526-011-9395-1", "article-title": "The state of commercial augmentative biological control: plenty of natural enemies, but a frustrating lack of uptake", "volume": "57", "author": "Lenteren", "year": "2012", "journal-title": "BioControl"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0041|eva273-cit-0041", "author": "Lenteren", "first-page": "181", "year": "2003", "volume-title": "Quality Control and Production of Biological Control Agents: Theory and Testing Procedures", "DOI": "10.1079/9780851996882.0181", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0042|eva273-cit-0042", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1146/annurev.ento.51.110104.151129", "article-title": "Assessing risks of releasing exotic biological control agents of arthropod pests", "volume": "51", "author": "Lenteren", "year": "2006", "journal-title": "Annual Review of Entomology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0043|eva273-cit-0043", "author": "Lynch", "first-page": "xvii", "year": "1995", "volume-title": "Biological Control: Benefits and Risks"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0044|eva273-cit-0044", "doi-asserted-by": "crossref", "first-page": "1872", "DOI": "10.1890/1051-0761(2002)012[1872:TROBTI]2.0.CO;2", "article-title": "The risks of biocontrol: transient impacts and minimum nontarget densities", "volume": "12", "author": "Lynch", "year": "2002", "journal-title": "Ecological Applications"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0045|eva273-cit-0045", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1098/rstb.1988.0002", "article-title": "Population dynamics and biological control", "volume": "318", "author": "May", "year": "1988", "journal-title": "Philosophical Transactions of the Royal Society of London, Series B"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0046|eva273-cit-0046", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1007/s10526-006-9013-9", "article-title": "Evaluation of phytoseiid predators for control of western flower thrips on greenhouse cucumber", "volume": "51", "author": "Messelink", "year": "2006", "journal-title": "BioControl"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0047|eva273-cit-0047", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1016/j.jip.2008.05.004", "article-title": "Increased pathogenicity against coffee berry borer, Hypothenemus hampei (Coleoptera: Curculionidae) by Metarhizium anisopliae expressing the scorpion toxin (AaIT) gene", "volume": "99", "author": "Pava-Ripoll", "year": "2008", "journal-title": "Journal of Invertebrate Pathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0048|eva273-cit-0048", "author": "Pimentel", "first-page": "149", "year": "1986", "volume-title": "Ecology of Biological Invasions of North America and Hawaii", "DOI": "10.1007/978-1-4612-4988-7_9", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0049|eva273-cit-0049", "doi-asserted-by": "crossref", "first-page": "400", "DOI": "10.1016/S0167-7799(03)00193-8", "article-title": "Using fungi and yeasts to manage vegetable crop diseases", "volume": "21", "author": "Punja", "year": "2003", "journal-title": "Trends in Biotechnology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0050|eva273-cit-0050", "author": "Ravensberg", "year": "2011", "volume-title": "A Roadmap to the Successful Development and Commercialization of Microbial Pest Control Products for Control of Arthropods", "DOI": "10.1007/978-94-007-0437-4", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0051|eva273-cit-0051", "doi-asserted-by": "crossref", "first-page": "889", "DOI": "10.1038/nrg1201", "article-title": "Genes in new environments: genetics and evolution in biological control", "volume": "4", "author": "Roderick", "year": "2003", "journal-title": "Nature Reviews Genetics"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0052|eva273-cit-0052", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.3725/jjn.38.9", "article-title": "Potential of Verticillium lecanii (Lecanicillium spp.) hybrid strains as biological control agents for soybean cyst nematode: is protoplast fusion an effective tool for development of plant-parasitic nematode control agents?", "volume": "38", "author": "Shinya", "year": "2008", "journal-title": "Japanese Journal of Nematology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0053|eva273-cit-0053", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/0006-3207(96)00027-4", "article-title": "Risks of species introduced for biological control", "volume": "78", "author": "Simberloff", "year": "1996", "journal-title": "Biological Conservation"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0054|eva273-cit-0054", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1016/j.jip.2008.01.007", "article-title": "Studies on adaptations of Metarhizium anisopliae to life in the soil", "volume": "98", "author": "St. Leger", "year": "2008", "journal-title": "Journal of Invertebrate Pathology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0055|eva273-cit-0055", "doi-asserted-by": "crossref", "first-page": "901", "DOI": "10.1007/s00253-009-2306-z", "article-title": "Genetic engineering of fungal biocontrol agents to achieve greater efficacy against insect pests", "volume": "85", "author": "St. Leger", "year": "2010", "journal-title": "Applied Microbiology and Biotechnology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0056|eva273-cit-0056", "first-page": "907", "article-title": "Characterization and ultrastructural localization of chitinases from Metarhizium anisopliae, M.\u00a0flavoviride, and Beauveria bassiana during fungal invasion of host (M.\u00a0sexta) cuticle", "volume": "62", "author": "St. Leger", "year": "1996a", "journal-title": "Applied Environmental Microbiology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0057|eva273-cit-0057", "doi-asserted-by": "crossref", "first-page": "6349", "DOI": "10.1073/pnas.93.13.6349", "article-title": "Construction of an improved mycoinsecticide over-expressing a toxic protease", "volume": "93", "author": "St. Leger", "year": "1996b", "journal-title": "Proceedings of the National Academy of Sciences of the USA"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0058|eva273-cit-0058", "doi-asserted-by": "crossref", "first-page": "422", "DOI": "10.2307/1312876", "article-title": "Host specificity of insect parasitoids and predators", "volume": "46", "author": "Strand", "year": "1996", "journal-title": "BioScience"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0060|eva273-cit-0060", "doi-asserted-by": "crossref", "first-page": "5944", "DOI": "10.1073/pnas.96.11.5944", "article-title": "Ecological approaches and the development of truly integrated. Pest management", "volume": "96", "author": "Thomas", "year": "1999", "journal-title": "Proceedings of the National Academy of Sciences of the USA"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0061|eva273-cit-0061", "author": "Thompson", "year": "1994", "volume-title": "The Coevolutionary Process", "DOI": "10.7208/chicago/9780226797670.001.0001", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0062|eva273-cit-0062", "author": "Vinson", "first-page": "14", "year": "1975", "volume-title": "Evolutionary Strategies of Parasitic Insects and Mites", "DOI": "10.1007/978-1-4615-8732-3_2", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0063|eva273-cit-0063", "author": "Waage", "first-page": "93", "year": "1995", "volume-title": "Biological Control: Benefits and Risks", "DOI": "10.1017/CBO9780511661730.011", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0064|eva273-cit-0064", "author": "Waage", "first-page": "1", "year": "2001", "volume-title": "Evaluating Indirect Ecological Effects of Biological Control"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0065|eva273-cit-0065", "author": "Wardle", "year": "1923", "volume-title": "The Principles of Insect Control"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0066|eva273-cit-0066", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1146/annurev.en.38.010193.001005", "article-title": "Bionomics of the braconidae", "volume": "38", "author": "Wharton", "year": "1993", "journal-title": "Annual Review of Entomology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0067|eva273-cit-0067", "first-page": "1061", "article-title": "Induction of defense responses in cucumber by the biocontrol agent Trichoderma harzianum", "volume": "65", "author": "Yedidia", "year": "1999", "journal-title": "Applied and Environmental Microbiology"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0068|eva273-cit-0068", "first-page": "1", "article-title": "A revision of Verticillium sect. Prostrata. IV. The genera Lecanicillium and Simplicillium", "volume": "73", "author": "Zare", "year": "2001", "journal-title": "Nova Hedwigia"}, {"key": "10.1111/j.1752-4571.2012.00273.x-BIB0069|eva273-cit-0069", "first-page": "465", "article-title": "A revision of Verticillium Sect. Prostrata. I. Phylogenetic studies using ITS sequences", "volume": "71", "author": "Zare", "year": "2000", "journal-title": "Nova Hedwigia"}], "container-title": ["Evolutionary Applications"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1752-4571.2012.00273.x", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1752-4571.2012.00273.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1752-4571.2012.00273.x/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 13]], "date-time": "2019-02-13T16:27:54Z", "timestamp": 1550075274000}, "score": 27.056028, "issued": {"date-parts": [[2012, 6, 7]]}, "references-count": 68, "journal-issue": {"published-print": {"date-parts": [[2012, 7]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1111/j.1752-4571.2012.00273.x", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1752-4571"], "issn-type": [{"value": "1752-4571", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T07:05:30Z", "timestamp": 1574147130981}, "reference-count": 13, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 5722, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Med. Pediatr. Oncol."], "published-print": {"date-parts": [[2000, 12, 1]]}, "DOI": "10.1002/1096-911x(20001201)35:6<573::aid-mpo17>3.0.co;2-a", "type": "journal-article", "created": {"date-parts": [[2004, 11, 14]], "date-time": "2004-11-14T03:49:49Z", "timestamp": 1100404189000}, "page": "573-576", "source": "Crossref", "is-referenced-by-count": 15, "title": ["p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA"], "prefix": "10.1002", "volume": "35", "author": [{"given": "Angelika", "family": "Eggert", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Sieverts", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Ikegaki", "sequence": "additional", "affiliation": []}, {"given": "Garrett M.", "family": "Brodeur", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2000]]}, "reference": [{"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB1", "author": "Bothwell", "volume": "272", "first-page": "506", "year": "1996", "journal-title": "Science"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB2", "author": "Barbacid", "volume": "25", "first-page": "1386", "year": "1994", "journal-title": "J Neurobiol"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB3", "author": "Hempstead", "volume": "350", "first-page": "678", "year": "1991", "journal-title": "Nature"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB4", "author": "Barrett", "volume": "45", "first-page": "117", "year": "1996", "journal-title": "J Neurosci Res"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB5", "author": "Casaccia-Bonnefil", "volume": "383", "first-page": "716", "year": "1996", "journal-title": "Nature"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB6", "author": "Yoon", "volume": "18", "first-page": "3273", "year": "1998", "journal-title": "J Neurosci"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB7", "author": "Eggert", "volume": "19", "first-page": "2043", "year": "2000", "journal-title": "Oncogene"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB8", "author": "Eggert", "volume": "28", "first-page": "681", "year": "2000", "journal-title": "Biotechniques"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB9", "author": "Mosmann", "volume": "65", "first-page": "55", "year": "1983", "journal-title": "J Immunol Methods"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB10", "author": "Rabizadeh", "volume": "261", "first-page": "345", "year": "1993", "journal-title": "Science"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB11", "author": "Davey", "volume": "8", "first-page": "915", "year": "1998", "journal-title": "Curr Biol"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB12", "author": "Bunone", "volume": "14", "first-page": "1463", "year": "1997", "journal-title": "Oncogene"}, {"key": "10.1002/1096-911X(20001201)35:6<573::AID-MPO17>3.0.CO;2-A-BIB13", "author": "Gu", "volume": "19", "first-page": "3043", "year": "1999", "journal-title": "J Neurosci"}], "container-title": ["Medical and Pediatric Oncology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1096-911X(20001201)35:6%3C573::AID-MPO17%3E3.0.CO;2-A", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/1096-911X(20001201)35:6%3C573::AID-MPO17%3E3.0.CO;2-A", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 4]], "date-time": "2018-08-04T05:56:36Z", "timestamp": 1533362196000}, "score": 26.36407, "issued": {"date-parts": [[2000]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[2000, 12, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/1096-911x(20001201)35:6<573::aid-mpo17>3.0.co;2-a", "relation": {"cites": []}, "ISSN": ["0098-1532", "1096-911X"], "issn-type": [{"value": "0098-1532", "type": "print"}, {"value": "1096-911X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:22:15Z", "timestamp": 1574162535184}, "reference-count": 65, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1986, 1, 1]], "date-time": "1986-01-01T00:00:00Z", "timestamp": 504921600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Genetics and Cytogenetics"], "published-print": {"date-parts": [[1986, 1]]}, "DOI": "10.1016/0165-4608(86)90377-8", "type": "journal-article", "created": {"date-parts": [[2003, 4, 24]], "date-time": "2003-04-24T22:48:16Z", "timestamp": 1051224496000}, "page": "101-111", "source": "Crossref", "is-referenced-by-count": 78, "title": ["Gene amplification in human neuroblastomas: Basic mechanisms and clinical implications"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Garrett M.", "family": "Brodeur", "sequence": "first", "affiliation": []}, {"given": "Robert C.", "family": "Seeger", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Genetics and Cytogenetics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0165460886903778?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0165460886903778?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 21]], "date-time": "2019-03-21T22:22:47Z", "timestamp": 1553206967000}, "score": 25.141294, "issued": {"date-parts": [[1986, 1]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[1986, 1]]}, "issue": "1-2"}, "alternative-id": ["0165460886903778"], "URL": "http://dx.doi.org/10.1016/0165-4608(86)90377-8", "ISSN": ["0165-4608"], "issn-type": [{"value": "0165-4608", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}